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ABSTRACT
The transport of serine and the activity of serine
hydroxymethyitransferase (SHMT) have been investigated in relation to
the supply of one-carbon units for purine synthesis in MOLT-4 cells, a
iyrhphobiastic leukaemia ceil line. Serine transport Into these cells, in
the absence of other amino acids, involved systems A, ASC and L; in
the presence of other amino acids, influx by system L was lost. Total
serine transport did not have any control on purine synthesis de novo
at the normal medium serine concentration of 0.25mM as determined by
metabolic control analysis. Furthermore, the serine efflux rate was the
same as the influx rate, which implicates an endogenous source of
serine to satisfy the metabolic requirements for this amino acid. The
possibility for an endogenous source of serine, or for an alternative
source of one-carbon units, for purine synthesis, was substantiated
upon observation of a lower rate of incorporation of radiolabel 
from [3-i4c]serine into purine than from p^ClNaHCOs. Neither
extracellular glycine, tryptophan, histidine, leucovorin or glucose, nor 
constituents of serum, contributed significantly to the one-carbon pool.
Treatment of cells with 3-fiuoro-D-aianine, an Inhibitor of SHMT, 
resulted in a stimulation of incorporation of radioiabel from 
[3-^"*C]serine into purine, principally into adenine. This stimulation 
resulted from an increase in the actual rate of purine synthesis da novo 
(rather than from an isotope dilution effect) and could not be explained 
by inhibition of SHMT.
Growth phase-related changes in purine synthesis de novo were 
observed in the absence of changes in the activity of SHMT. The 
regulation of purine synthesis in these cells is therefore not 
accomplished through regulation of the expression of SHMT. The 
possible involvement of mitochondrial SHMT in the supply of 
one-carbon units for purine synthesis has been discussed in relation to 
the quantification of serine metabolism as measured In this thesis, in 
respect of this possibility, it was interesting that 90% of the total SHMT 
activity was localized in the mitochondria in MOLT-4 ceils.
The studies reported in this thesis were carried out between 
October 1988 and July 1991 at the School of Biological 
Sciences, University of Surrey and at the Wellcome Research 
Laboratories, Beckenham, Kent. The investigations are the 
original work of the author and no portion of this work has been 
submitted for any other degree or qualification to any other 
University or institution of learning. All procedures were carried 
out by the author with the exception of the acclimatization of the 
cells to growth on leucovorin-supplemented medium (section 
2.1.3) and the amino acid analysis (section 2.7). These 
procedures were carried out by Mark Edeistein (Division of Cell 
Biology, Burroughs-Wellcome, RTF, North Carolina, U. S. A.) 
and Eric Ah-Sing (School of Biological Sciences, University of 
Surrey) respectively.
(c) Mark C. Bolton 1992
"A student is not an empty vessel to be filled, 
but a lamp to be lit"
The Talmud
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CHAPTER 1
GENERAL INTRODUCTION
Chapter 1 : General Introduction
1.1 Biosynthesis and utilization of serine
The amino acids commonly found in the proteins of all organisms have 
been classically divided Into two groups; those which are nutritionally 
essential and those which are nutritionally non-essential (Eagle, 1959). 
Serine Is a nutritionally non-essential amino acid because it can be 
endogenously synthesized from glucose via the glycolytic Intermediate, 3- 
phosphoglycerate. There are two possible routes by which this conversion 
can be accomplished; these are termed the phosphorylated and the non- 
phosphorylated pathways (Fig. 1.1) and the contribution of each with respect 
to serine biosynthesis was a matter of controversy for some time. However, 
the phosphorylated pathway Is now thought to be Important In serine 
biosynthesis and the non-phosphorylated pathway involved In 
gluconeogenesis, at least In the liver (Snell, 1986). This idea Is supported by 
the fact that the activity of serine aminotransferase, an enzyme of the non- 
phosphorylated pathway, has to date only been detected in the liver and the 
kidney, the only two tissues believed to be active In gluconeogenesis (Snell, 
1985). Another enzyme, serine dehydratase (Fig. 1.2), catalyses the 
deamination of serine to pyruvate which can also be utilized for 
gluconeogenesis. As for serine aminotransferase, serine dehydratase activity 
has only been detected In the liver and kidney (Yoshlda & KIkuchI, 1973; 
Snell, 1985) consistent with a role In gluconeogenesis. The conversion of 
serine into glycolytic Intermediates by serine dehydratase and by the activity 
of the non-phosphorylated pathway means that serine could also be utilized 
for the synthesis of Important energy reserves such as glycogen and fatty 
acids as well as for energy production.
Biosynthesis of serine from glucose by the phosphorylated pathway to 
provide a carbon skeleton for gluconeogenesis Is obviously a metabollcally 
futile pathway but the serine formed can be utilized In alternative ways. The 
amino acid may of course be Incorporated Into protein or Into phospholipid 
(as phosphatidyl serine). It Is also a precursor for cysteine biosynthesis 
through a condensation reaction with homocysteine to form cystathionine and 
subsequent hydrolysis to cysteine and 2-ketobutyrate.
There is one further enzyme which utilizes serine as a substrate which 
Is called serine hydroxymethyitransferase (SHMT). This enzyme shows a 
more ubiquitous distribution than serine aminotransferase and serine 
dehydratase (Snell, 1985). SHMT catalyses the transfer of a one-carbon unit 
from carbon 3 of serine to tetrahydrofolate (THF) with the production of 
glycine and 5,10-methylenetetrahydrofolate (5,10-CH2THF) (Fig. 1.3). The
latter product Is a direct substrate for the thymldylate synthetase reaction 
which catalyses the méthylation of deoxyurldlne monophosphate (dUMP) to 
deoxythymldine monophosphate (dTMP), and thus participates directly In 
pyrimidine biosynthesis (Fig. 1.3). The 5,10-CH2THF, through Its conversion
to 10-formyltetrahydrofolate (10-CHOTHF), Is also used for two of the 
reactions of purine synthesis de novo. Furthermore, the carbon and nitrogen 
atoms of glycine are Incorporated Into the purine ring by a reaction with 5- 
phosphorlbosylamlne (Fig. 1.4). Serine hydroxymethyitransferase therefore 
provides three precursors for nucleotide synthesis de novo and thereby plays 
an important role in cell proliferation.
1.2 Recognition of good chemotherapeutic targets in purine 
biosynthesis
The important role of serine In the provision of precursors for 
nucleotide synthesis might make SHMT a good target for chemotherapy. The 
rationale for the design of chemotherapeutic compounds has to be based 
upon defined criteria used for the assessment of the Importance of a potential 
target for neoplastic transformation and proliferation. The underlying 
difference between the neoplastic and the normal cell is the ability of the 
former to undergo continuous, often rapid and uncontrolled proliferation. This 
difference presumably arises from a reprogramming of gene expression, 
manifest In an alteration In the biochemistry of the cancer cell, and which 
confers a growth advantage upon It over the normal cells present in the tissue 
In which It originates or migrates to. Alterations In the expression of enzymes 
involved In nucleotide biosynthesis have been linked with neoplastic 
transformation and two types of alterations have been defined (Weber, 
1983a). Progression-linked alterations are those where the differences 
between the normal and the neoplastic state correlate with the degree of 
tumour malignancy. Transformation-linked alterations are those which exhibit
a difference between normal and tumour tissue but which do not correlate 
with the extent of tumour progression (Weber, 1983a). These alterations not 
only refer to enzyme expression but also to the concentration of certain 
metabolites. The lower the enzyme activity or metabolite concentration In the 
normal cell, the greater the Increase tends to be in the rapidly proliferating 
tumour cell. Furthermore, reciprocal regulation of the activities of Important 
enzymes of anabolic and catabolic pathways occurs. These Ideas all form 
part of the "Molecular Correlation" concept which was developed and tested 
In studies with hepatoma cells (Weber, 1983a). The altered biochemistry of 
the cancer cell Is also exploited to gain a degree of selectivity for potential 
chemotherapeutic agents (Ellon, 1985).
The "Key Enzyme" concept was also enunciated by Weber (1983a) 
which enables further assessment of whether a particular enzyme Is likely to 
be a good chemotherapeutic target. The "key" enzymes are often the first or 
last In a particular pathway and have relatively low activities compared to 
other enzymes when measured under optimal, saturating conditions in vitro. 
They tend to catalyse Irreversible reactions and are frequently targets of 
feedback or multiple regulation, exhibit allosteric properties and have an 
Isozyme pattern. The expression of these enzymes Is also often subject to 
nutritional or hormonal control (Weber, 1983a). It should be noted that these 
characteristics are only guidelines for the Identification of an Important 
enzyme within a defined pathway. The actual enzymes which do exert 
control may not necessarily exhibit all, or Indeed, any of these properties. 
The metabolic control theory (see Kacser & Burns, 1973; Heinrich & 
Rapoport, 1974; also see Chapter 6) Is an alternative concept which provides 
a way In which the control exerted by a particular step within a pathway can 
be quantified. Application of this concept to nucleotide biosynthesis Is 
therefore a more confident way In which to Identify a good chemotherapeutic 
target.
The "Molecular Correlation" and "Key Enzyme” concepts have been 
applied to purine metabolism for the Identification of potential 
chemotherapeutic targets. The enzymes of the de novo pathway (depicted In 
Fig. 1.4) which showed transformation-linked Increases In activity were 5- 
phosphorlbosylpyrophosphate amldotransferase and phosphorlbosylamino 
Imidazole carboxamide transformylase (AICAR transformylase) (Weber, 
1983b). The amldotransferase Is the first enzyme in the pathway and has 
been considered an Important control site of the de novo synthetic pathway
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for some time. Feedback inhibition by AMP and GMP is known to occur and 
PRPP activates the enzyme, possibly by interaction with the purine nucleotide 
inhibitors (Becker & Kim, 1987). The amldotransferase therefore fulfils some 
of the criteria detailed In the "Molecular Correlation" and "Key Enzyme" 
concepts and therefore could be a promising target for chemotherapy.
One of the substrates for the amldotransferase Is glutamine which Is 
Important for cell growth. Glutamine Is In fact a precursor for three other 
reactions in purine and pyrimidine biosynthesis - those catalysed by GMP 
synthetase, CTP synthetase and carbamoylphosphate synthetase II. Aclvlcin 
Is a glutamine antimetabolite which Inhibits all these activities, the 
amldotransferase actually showing the weakest Inhibition of them all. 
Nevertheless, treatment of hepatoma 3924A cells with aclvlcin did result In an 
accumulation of PRPP, presumably as a consequence of Inhibition of the 
amldotransferase (Weber et al., 1984), and was effective In retarding the 
growth of this hepatoma cell line (Weber eta!., 1982).
Once IMP has been formed by the ten reactions of the de novo 
pathway, a branch point occurs which dictates whether adenine or guanine 
nucleotides are to be formed (Fig. 1.5). The two enzyme activities Involved In 
adenylate synthesis, adenylosuccinate synthetase and adenylosuccinate 
lyase, show transformation-linked increases In their expression In hepatoma 
cells (Weber, 1983b). Progression-linked Increases are apparent for IMP 
dehydrogenase and GMP synthetase, the two enzymes which catalyse the 
synthesis of guanylate (Weber, 1983b). Of these four enzymes, IMP 
dehydrogenase has received much attention as a possible chemotherapeutic 
target, partly because It has the lowest specific activity of all the enzymes 
Involved In purine metabolism (Weber et a!., 1984). It has also been shown 
to exist In Isozymic forms, the genes for which are differentially regulated |n 
neoplastic and normal cells (Natsumeda et a!., 1990). TIazofur?n% ^ n  
analogue which apparently acts as an antitumour agent by specifically 
Inhibiting IMP dehydrogenase. Treatment of hepatoma 3924A cells In culture 
with tiazofurin resulted In a decrease in the GTP and, to a lesser extent, the 
ATP pools and also the survival rate together with an Increase In the 
concentration of CTP, UTP, IMP and PRPP (Weber eta!., 1984). Tiazofurin 
also Induces differentiation of HL-60 leukaemia cells, an effect which appears 
to be exerted when the cells are In the Gi phase of the cell cycle (SokoloskI
et a!., 1989). Mycophenollc acid, another Inhibitor of IMP dehydrogenase, 
also Induced differentiation of the breast cancer cell line, MOF-7 (SidI et a!.,
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1988). Both of these inhibitors induced growth inhibition and differentiation of 
a second leukaemic cell line, CEM-2, but no general association existed 
between Induction of cell differentiation and the extent of IMP dehydrogenase 
expression (KIkuchI et ai, 1990). Recently, an anti neoplastic agent, triclrlblne 
phosphate (NSC 280594) has been shown to Inhibit both IMP dehydrogenase 
and the amldotransferase In dialysed extracts of CCRF-CEM human 
leukaemic lymphoblasts (Moore eta!., 1989).
One problem with the design of chemotherapeutic agents aimed at 
enzymes of the de novo pathway is that tumours can still synthesize 
nucleotides by the salvage reactions (Flg.1.6). Although more pronounced 
differences In the expression of the de novo enzymes Is apparent between 
neoplastic and normal human colon tissue, the absolute activities are higher 
for the salvage enzymes (Natsumeda et ai, 1985). A combination of drugs 
targeted at both pathways could therefore be useful for chemotherapy as 
exemplified by treatment of hepatoma cells with aclvlcin and dipyridamole, an 
Inhibitor of nucleoside transport and therefore involved in the salvage 
pathway (Weber, 1983a).
Alternatively, one enzyme Involved In both the de novo and salvage 
pathways could be targeted If It were an important control site. One 
possibility is PRPP synthetase which catalyses the synthesis of PRPP from 
rlbose-5-phosphate and thereby Is Involved In the de novo synthesis of 
purines and pyrimidines as well as purine salvage. The rate of purine 
synthesis de novo in cultured human lymphoblasts and mitogen-stlmulated 
lymphocytes was shown to be dependent on the availability of PRPP (Pilz et 
ai, 1984; Boss, 1984). Increases In the expression of PRPP synthetase and 
of the concentration of PRPP were observed upon transition of hepatoma 
3924A cells from the plateau to the proliferative phase of growth (Natsumeda 
et ai, 1988). Furthermore, fibroblasts which exhibit PRPP synthetase 
superactlvlty had higher rates of purine synthesis de novo and of purine 
excretion (Becker et ai, 1987). These observations all Implicate an Important 
role of PRPP synthetase In the expression of the proliferative program of cells 
but not necessarily in transformation to the neoplastic state.
Phosphorlbosylpyrophosphate synthetase also exhibits some 
regulatory properties. PRPP synthetase activity In crude extracts from 
normal and leukaemic white blood cells (Danks & Scholar, 1982) and in 
partially purified enzyme extracts from erythrocytes (Fox & Kelley, 1972) was 
Inhibited to various extents by a variety of purine and pyrimidine nucleosides
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and nucleotides as well as some other compounds. The Inhibition by 
pyrimidine nucleotides may occur via sequestration of magnesium by these 
compounds which prevents the subunit aggregation of PRPP synthetase 
required for Its activity (Lachant et al., 1989). The naturally occurring 
metabolite, pyrrol I ne 5-carboxylate, an Intermediate In the interconversion of 
proline, ornithine and glutamate, stimulates PRPP synthesis via an effect on 
the oxidative branch of the pentose phosphate pathway (Yeh & Phang, 
1988). Whether or not this effect Is of physiological importance In the 
regulation of PRPP synthesis Is not known. PRPP synthetase therefore does 
have some of the necessary characteristics of an Important control site, and 
Inhibition of this enzyme by the exocycllc amino nucleosides 4-amlno- 
(ARPP) and 4-methoxy-8-(D-rlbofuranosylamlno) pyrlmldo [5,4-d] pyrimidine 
(MRPP) does result In antitumour activity (Nord et al., 1989).
Another feature of the "Molecular Correlation" concept was the 
reciprocal regulation of enzyme activities associated with anabolic and 
catabolic pathways. The increase In the expression of some enzymes of 
purine synthesis have already been mentioned but transformation-linked 
decreases In the catabolic enzymes 5'-nucleotldase, Inoslne phosphorylase, 
xanthine oxidase and uricase (Fig. 1.7) have also been observed In rat 
hepatomas (Weber, 1983a). A progression-linked Increase was observed, 
however, for the enzyme AMP deaminase which catalyses the conversion of 
AMP to IMP (Weber, 1983b). This enzyme Is usually associated with purine 
catabolism (Fig. 1.7) and as such its activity might be expected to decrease 
upon transformation. One possible reason for this observation Is the 
operation of the purine nucleotide cycle In tumour cells to Increase the 
ATP/ADP ratio (Kovacevic et ai, 1988). Tumour cells often have to adapt to 
anaerobic conditions during which the ATP concentration can decrease. In 
order to maintain a high ATP/ADP ratio, which Is an index of the cellular 
energy state, AMP deaminase converts AMP to IMP so that the equilibrium 
reaction catalysed by adenylate kinase Is displaced In favour of the 
conversion of 2ADP to ATP and AMP. A second Interesting feature of AMP 
deaminase Is that different Isozymes are present In the hepatoma 3924A 
whereas only one enzyme form occurs In normal liver (Jackson et a i, 1977). 
The progression-linked Increase In AMP deaminase activity is in fact 
accounted for largely by the expression of an Isozyme In the hepatoma cell 
with the characteristics of the enzyme normally expressed In muscle tissue.
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1.3 Importance of serine metabolism for celi proliferation
Although serine is a nutritionally non-essential amino acid, 
circumstances have been reported in which inclusion of serine in the growth 
medium becomes essential. This was first observed for the case where a 
small cell population was propagated in a large volume of medium (Eagle, 
1959). Lectln-stlmulated human lymphocytes had a requirement for serine 
(Snell & Fell, 1990) which could be partially relieved by glycine (Dubrow et ai, 
1973). The key effect of serine deprivation on lymphocyte proliferation may 
lie at the level of protein synthesis rather than In the provision of one-carbon 
units (Rowe et ai, 1985). The necessity for the presence of extracellular 
serine In leukocytes Is due to low activities of the enzymes of the 
phosphorylated pathway of serine biosynthesis relative to other cells In 
culture (Pizer & Regan, 1972). Furthermore, these activities were also low In 
leukaemic cells (Regan et ai, 1969). In the absence of high activities of 
enzymes of the phosphorylated pathway for serine biosynthesis, the transport 
of serine Into the normal and leukaemic lymphocyte may play an Important 
role In the provision of serine for cell proliferative processes. The transport 
step is often overlooked as a potential control point within a metabolic 
pathway (see Knowles et ai, 1990; Pogson et ai, 1991) and this possibility 
was therefore examined In the present work.
In other cell types, an Increase In the activity of enzymes of the 
phosphorylated pathway have been associated with cell proliferation. Higher 
activities of 3-phosphoglycerate dehydrogenase were measured In 
logarithmic cells compared to confluent cells of a rat epithelial cell line and 
also in tumour cells relative to normal tissue (Isom & Plzer, 1978; Snell & 
Weber, 1986). The ability preferentially to channel serine In the direction of 
nucleotide biosynthesis as opposed to other pathways of serine utilization 
would be likely to confer a growth advantage to cells which are proliferating. 
Selective channeling of serine in this way occurs In rat liver during neonatal 
development (Snell, 1980). During the late foetal-perinatal period. In which 
the liver undergoes a rapid phase of growth, activities of phosphoserlne 
aminotransferase (an enzyme of the phosphorylated pathway) and SHMT 
were found to be high whereas those of serine aminotransferase and serine 
dehydratase were only low. An Increase in the biosynthesis of serine is 
Important for protein synthesis as well as for nucleotide biosynthesis during 
this period. In the adult rat liver, serine aminotransferase and serine
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dehydratase are expressed because they play a role in gluconeogenesis and 
a preferential channeling of serine through SHMT would not be required 
because cellular proliferation does not normally occur. However, It has been 
observed that upon transition from the normal to the neoplastic state, serine 
aminotransferase and serine dehydratase cease to be expressed whereas 
SHMT activity Is retained (Snell & Weber, 1986). In addition, the activity of 
3-phosphoglycerate dehydrogenase was found to be markedly Increased In 
the hepatoma. These observations are therefore consistent with the 
"Molecular Correlation" concept In that serine aminotransferase and serine 
dehydratase, enzymes of serine catabolism not Involved In de novo 
nucleotide synthesis, show transformation-linked loss of activity In hepatoma 
cells. The pattern of Incorporation of radiolabelled carbon from [3-i4C]serlne 
Into nucleotide bases of total cellular nucleic acids correlated with the pattern 
of expression of 3-phosphoglycerate dehydrogenase and SHMT activity 
expressed during the growth curve for the hepatoma cell line 3924A (Snell et 
al., 1987). These results support the hypothesis that the biosynthesis of 
serine Is metabollcally coupled to Its utilization via the SHMT reaction for 
nucleotide formation.
In tissues In which serine aminotransferase and serine dehydratase 
are not expressed, a transformation-linked increase in the activity of SHMT 
was observed. Increases In the activity of SHMT and 3-phosphoglycerate 
dehydrogenase relative to control tissues were demonstrated In human colon 
carcinoma and rat sarcoma (Snell et ai, 1988). In certain forms of leukaemia 
SHMT activity was higher than in normal lymphocytes (Thorndike et al., 
1979). Increases in SHMT activity which correlate with Increased 
incorporation of radiolabel from serine into nucleic acid have also been 
observed upon mitogenic stimulation of human lymphocytes (Thorndike et al., 
1979; Elchler et al., 1981 ; Snell & Barnett, 1988).
The "Key Enzyme" concept may also be applied to SHMT as an 
Indication as to whether It may be a good target for chemotherapy. SHMT Is 
the first enzyme In the pathway of the production of one-carbon units from 
serine for nucleotide synthesis de novo but does not catalyse an Irreversible 
reaction as Is often the case for an Important control point enzyme. 
Furthermore, no specific nutritional or hormonal controls of the expression of 
the mammalian enzyme have been demonstrated nor have any reports of 
feedback or multiple regulation been published for mammalian cells. Even 
the allosteric nature of the enzyme once proposed for the substrate THF
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(Kumar et al., 1976; Ramesh & Appaji Rao, 1978) was only an artefact of the 
assay procedure (Schirch & Quashnock, 1981). The enzyme does however 
have an isozyme pattern in that both cytosolic and mitochondrial forms have 
been Identified. The Involvement of mitochondrial SHMT in the supply of 
one-carbon units for cytoplasmic processes Is now under consideration 
(Barlowe & Appling, 1988). The possible Importance of mitochondrial SHMT 
In the supply of one-carbon units for purine synthesis de novo has been 
discussed In relation to the findings presented In this thesis.
1.4 Aims of the present work
As mentioned earlier, the activity of the phosphorylated pathway of 
serine biosynthesis Is low In normal and leukaemic white blood cells (Plzer & 
Regan, 1972). For this reason, the transport of serine from the extracellular 
medium Into the cell may be an Important process in serine metabolism In 
these cells. In this report, the transport of serine Into MOLT-4 cells, a 
lymphoblastic leukaemia cell line (Minowada ef a/., 1972), was extensively 
characterized (Chapter 3) and the Importance of this process with respect to 
purine biosynthesis was studied by the quantitative technique of metabolic 
control analysis (Chapter 6). The activity of SHMT was also measured In 
these cells and the effect of a potentially specific Inhibitor, 3-fluoro-D-alanlne, 
on both the cytosolic and mitochondrial Isozymes, was studied (Chapter 4). 
The purpose of this Inhibition analysis was to apply the metabolic control 
theory to SHMT to quantify the Importance of the enzyme with respect to 
purine synthesis de novo (Chapter 6). The possibility that extracellular serine 
Is not the only source of one-carbon units for purine synthesis de novo was 
also addressed (Chapter 5).
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Phosphorylated Non-phosphorylated
Glucose
Glycolysis Phosphoglyceromuiase
 3-Phosphoglycerate <------- ► 2-Phosphoglycerate
Gluconeogenesls
3-Phosphoglycerate
dehydrogenase
3-Phosphohydroxypyruvate
Phosphoserine
aminotransferase
3-Phosphoserine
Glycerate
Kinase
D-Glycerate
D-glycerate
dehydrogenase
Hydroxypyruvate
Phosphoserine 
phosphatase
Serine
aminotransferase
Serine
Fig. 1.1 Pathways of serine and glucose Interconversion. The
phosphorylated pathway is now accepted as one of serine biosynthesis and 
the non-phosphorylated pathway as one of serine utilization.
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Serine
Serine dehydratase
Pyruvate
Lipogenesis 
Fatty acids CO2
Gluconeogenesis 
Glucose
Fig. 1.2 Deamination of serine catalysed by serine dehydratase and 
possible fates of the pyruvate formed.
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Purines Pyrimidines
4 i
dTMPdUMP
10-CHO-THF
TS
DHF
Glycine NADPHDHFRSHMT
THF
Serine NADP
Fig. 1.3 The thymidyiate synthesis cycle. The three enzymes Involved In 
the cycle are thymidyiate synthetase (TS), dihydrofolate reductase (DHFR) 
and serine hydroxymethyltransferase (SHMT).
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5-Phosphoribosyl-1 -pyrophosphate (PRPP) 
Phosphoribosylpyrophosphate Glutamine 
amidotransferase Glutamate
5-Phosphoribosyl-1 -amine
Phosphoribosylglycinamide 1 ^  ATP + Glycines---------------Serine
synthetase ^  ADP + Phosphate
5-Phosphoribosylglycinamide (GAR)
Phosphoribosylglycinamide ^  10-CHOTHF <----------------- Serine
formyltransferase |^ T H F  
5-Phosphoribosyl-A/-formylglycinamide (FGAR) 
Phosphoribosylformylglycinamide ^  Glutamine + ATP
synthetase Glutamate + ADP + phosphate
5-Phosphoribosyl-A/-formylglycinamidine (FGAM) 
Phosphoribosylaminoimidazole ^  ATP
synthetase |S^ADP + phosphate
5-Phosphoribosyl-5-aminoimldazole (AIR) 
Phosphoribosylaminoimidazole 1/^ CO2 
carboxylase 4
5-Phosphoribosyl-4-carboxy-5-amlnoimidazole 
Phosphoribosylaminoimidazole ^  Aspartate + ATP 
succinocarboxamide synthetase ADP + phosphate 
5-Phosphoribosyl-4-(A/-succinocarboxamide)-5-amlnoimidazole 
Adenylosuccinate I
lyase Fumarate
5-Phosphoribosyl-5-amino-4-imidazolecarboxamlde
Phosphoribosylaminoimidazole 1 ^  10-CHOTHF <--------------  Serine
carboxamide formyltransferase |v^THF
5-Phosphorlbosyl-5-formamido-4-imidazolecarboxamlde 
Inosinate I 
cyclohydrolase HgO
lnosine-5-phosphate (IMP)
Fig. 1.4 The ten reactions of the purine synthesis de novo pathway 
from PRPP to Inosinate. The substrates which can be formed from serine 
are shown in bold.
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NADH + H+
IMP dehydrogenaseNAD+
IMP
Glutamine Glutamate
ATP AMP + PP,
Xanthylate   ► GMP
GMP synthetase
Aspartate Adenylosuccinate
GTP jKsynthetase
GDP + P| <4/  X  Adenylosuccinate lyase
Adenylosuccinate ..............  ► AMP
Fumarate
Fig. 1.5 Branch point at IMP for the de novo synthesis of adenine and 
guanine nucleotides.
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Adenine phosphoribosyi
Adenine + PRPP ---------------------------------------- ► AMP + pyrophosphate
transferase (APRT)
Hypoxanthine-guanine
Guanine + PRPP  ► GMP+ pyrophosphate
phosphoribosyi transferase (HGPRT)
Hypoxanthine-guanine
Hypoxanthine + PRPP --------------------------------— IMP + pyrophosphate
phosphoribosyi transferase (HGPRT)
S'-nucieoside
Purine + Ribose-1 -phosphate 4--------------- ► Purine nucleoside + phosphate
phosphorylase
Fig. 1.6 Preformed purine bases as precursors for nucleotide 
biosynthesis. The first three reactions are the salvage reactions and are 
important in purine nucleotide synthesis. The fourth reaction is usually 
associated with purine nucleoside catabolism (see Fig. 1.7) but is reversible 
for nucleoside synthesis.
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AMP
AMP ----------------- ► IMP
GMP
XMP 4. GMP
deaminase deaminase
5'-NT 5 ’-NT 5’-NT
1 Adenosine , r ' Guanosine ▼
Adenosine -► Inosine Xanthosine 4-
deaminase deaminase
5'-NP 5’-NP 5'-NP
y Adenine 1r Xanthine '^ Guanine ▼
Adenine
deaminase
Hypoxanthine
oxidase
Xanthine 4-
deaminase
S'-ATT
Guanosine
5'-A/P
Guanine
Xanthine
oxidase
Uric acid 
Uncase 
Allantoin
Fig. 1.7 Catabolism of purine nucleoside monophosphates. The
abbreviated enzymes are 5'-NT : 5'-nucleotidase; 5-NP : 5'-nucleoside 
phosphorylase. The reaction catalysed by uricase does not occur in humans.
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CHAPTER 2
MATERIALS AND METHODS
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Chapter 2: Materials and Methods
2.1 Cell Culture
2.1.1 Preparation of RPM11640 medium
The RPMI 1640 medium used for cell culture was prepared from a 
powdered preparation with folic acid and NaHCOg omitted. The contents of 
one package were dissolved in 950ml of distilled water and 2g of NaHGOg
added. The volume was made up to one litre and the solution was gassed 
thoroughly with carbogen (95% 02/5% COg) with continuous stirring until the
pH stabilised at approximately 7.40. The solution was filtered through a 
sterile 0.22p.m disposable filter (Nalgene, Nalge, Rochester, N. Y.) and stored 
at +4^0 for no longer than four weeks.
2.1.2 Dialysis of foetal calf serum
Dialysis tubing (45mm width) was cut into ten 45cm lengths. The 
tubing was pretreated by heating to 90°C in 0.2% (w/v) NaCI with 0.2% (w/v) 
EDTA followed by a thorough wash in distilled water. The heating and 
washing steps were repeated three times after which the tubing was 
autoclaved in 0.9% (w/v) NaCI and cooled to +4^0 before use.
The foetal calf serum (PCS) was transferred to dialysis bags in aliquots 
of 50ml. Dialysis against 4 litres of 0.9% (w/v) NaCI containing 3g of Norit A 
charcoal was carried out for 24h at +4°C. This was repeated three more 
times with fresh diaiysing medium, the charcoal being omitted from the final 
medium replacement. The dialysed PCS was filtered through a sterile 
0.22|xm disposable filter and stored at -20°C in aliquots of 50ml.
2.1.3 Preparation of leucovorin
Leucovorin (5-formyltetrahydrofoiic acid (5-CHOTHF); folinic acid) was 
used in the final growth medium as an alternative to folic acid. For this 
substitution to be successful, the MOLT-4 cells originally had to be
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acclimatized to this change (see next section). The leucovorin solution used 
for celi culture was prepared as a 0.25mM stock in 3mM-NaOH. It was fiiter- 
sterilized and stored at -20°C prior to use. The actual concentration was 
calculated from spectrophotometric measurements at a wavelength of 282nm 
using an absorption coefficient of 32.6mM'icrff.The appropriate volume of 
leucovorin stock solution, diluted if necessary with 3mM-NaOH, was added to 
the growth medium to give a finai concentration of 10nM.
2.1.4 Acclimatization of ceils to growth in leucovorin-supplemented medium
Acclimatization was achieved by first passaging the MOLT-4 cells in 
complete RPMI 1640 plus 10% (v/v) foetal calf serum (regular growth 
medium). The acclimatization itself was initiated by seeding the cells at a low 
density in regular growth medium plus 25% (v/v) folate-free RPMI 1640 plus 
50^iM-hypoxanthine and 20|xM-thymidine. If growth was satisfactory, the 
folate-free RPMI 1640 was increased to 50% (v/v). If growth was poor, 
further passages were performed before changing the percentage of folate- 
free RPMI 1640 used. The folate-free RPM11640 was increased to 75% and 
finally to 100% with 10% (v/v) undialysed PCS included. Up to this point, 
50p,M-hypoxanthine and 20|xM-thymidine were always included. Folate-free 
RPMI 1640 with 10% (v/v) dialysed PCS plus 10nM-leucovorin was then 
introduced to the above medium (folate-free RPMI 1640 with 10% (v/v) 
undialysed PCS plus 20}xM-thymidine and 50p.M-hypoxanthine) first at 25% 
(v/v), then 50%, 75% and finally 100%. The reason for using leucovorin in 
the growth medium is that it is a more physiological substrate than folic acid 
with respect to its redox state. This is because the main derivative which
circulates in plasma is the fully reduced 5-methyltetrahydrofolate (5- 
CHgTHF).
The MOLT-4 cells used for the present work were obtained from Dr. 
Gary Smith at Burroughs-Weilcome, Research Triangle Park, North Carolina, 
U. 8 . A. and were already acclimatized to growth in leucovorin-supplemented 
medium.
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2.1.5 Initiation of celi culture
Complete growth medium used for cell culture consisted of the folate-
free RPM11640 supplemented with 10% (v/v) dialysed PCS, lOnM-leucovorin
and 0.01 mg of gentamicin sulphate/ml. MOLT-4 cells originally frozen in the
same medium plus 10% DMSO were thawed rapidly in a water bath at 37°C.
The ampoule was wiped with 70% ethanol and the contents (see section
2.1.7) aseptically transferred to 25ml of growth medium. The cell suspension
was centrifuged (200 g , 5min), the supernatant discarded and the cell pellet
resuspended in 25mi of complete growth medium. This ceil suspension was 
incubated at 37°C in a humidified atmosphere containing 5%C02 in air untii
the ceil concentration was approximately 1x10® viable cells/ml (4 days). 
Routine passage was then carried out as described below for no longer than 
3 months before initiation of a new cuiture.
2.1.6 Determination of celi number and viabiiity
Cell number was determined using a haemocytometer, the grid for 
which is represented in Fig. 2.1. An appropriate dilution of celi suspension 
was used such that between 10-50 cells were counted per 1 mm^ area. The 
number of Imm^ squares counted (not randomly) was such that 90-200 cells 
were counted in total. Samples of cell suspension were counted in triplicate 
and the mean number of cells/1 mm^ area (n) calculated. Since the depth of 
the haemocytometer chamber is 0.1mm, the total volume represented by the 
1mm2 area is 0.1 mm^ or IxlO-^ml. Therefore the number of cells per ml of 
cell suspension can be represented by equation (2.1).
Number of cells/ml = n x 104 x dilution (2.1)
For determination of cell viability, one volume of trypan blue (1% (w/v) 
in phosphate-buffered saline) was added to one volume of cell suspension. 
Viable cells exclude the dye whereas non-viable cells are stained blue. The 
percentage viability is calculated from equation (2.2).
% Viability = (Number of viable cells/Total number of cells) x 100 (2.2)
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The growth curve for these MOLT-4 cells for a culture initiated at a cell 
concentration of 1x10^ viabie celis/ml is shown in Fig. 2.2. Celis reached a 
concentration of 1.5x10® ceils/ml in the plateau phase (96h) and retained 
greater than 98% viability with a decrease in viable cell number thereafter. 
The cell doubling time during the logarithmic phase of growth was 17h with a 
lOh lag phase (Fig. 2.2). Routine passage involved dilution of the cells after 
72h of growth (approximately 1x10® viable cells/ml) by a factor of ten into 
fresh complete growth medium. For ease of passage within a 7 day week, 
ceils could also be grown from an initial cell concentration of 5x104 viable 
cells/ml. Under this condition, cells reached a concentration of approximately 
1x10® viable cells/ml after 96h of growth and were thereby available for 
passage. Cells could therefore be passaged after 3 or 4 days as appropriate.
Celis used for experimental purposes were taken at 48h (logarithmic 
phase) or 72h (late-iogarithmic phase) when an initial cell concentration of 
1x10® viabie ceils/ml was used. From an initial cell concentration of 5x104 
viable ceiis/ml, logarithmic cells were taken at 72h and late-logarithmic cells 
at 96h of growth.
2.1.7 Preservation of living ceils
Logarithmically growing celis were centrifuged (200 g, 5min) and the 
pellet resuspended at a concentration of 4x10® viable cells/ml in ice-cold 
complete growth medium containing 10% (v/v) dimethyl sulphoxide (DMSO). 
Aliquots of 1 ml were transferred to sterile ampoules and frozen using a rate- 
controlled freezer. Ampoules were stored in liquid nitrogen until being used 
to initiate a cell culture as described in section 2.1.5.
2.2 Biochemical Assays
2.2.1 Serine hydroxymethyltransferase
Serine hydroxymethyltransferase (SHMT; EC 2.1.2.1) was assayed by 
a modified version of that detailed by Snell (1980) based on an assay 
originally described by Taylor and Weissbach (1965). The reasons for the 
modifications are described in section 4.2.1 (p. 103).
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2.2.1.1 Preparation of solutions
Hepes buffer was prepared as a 1M stock buffered to pH 7.4 using 
10M-KOH. Pyridoxal phosphate (2mM) was neutralized to approximately 
pH7 with IM-NaOH and stored at -20°C. Tetrahydrofoiic acid (THF) was 
prepared as a lOmM stock in 50mM-Hepes, pH7.4 containing 
60mM-2-mercaptoethanoI. The appropriate volume of buffer was first 
saturated with humidified nitrogen gas after which the tetrahydrofolate was 
added. The solution was briefly sonicated in a sonicating water bath to 
dissolve the solid and the solution replaced under nitrogen. Aliquots of 0.5ml 
were transferred to glass tubes, gassed with nitrogen and stoppered. 
These were stored at -20°C and thawed immediately prior to use.
Sodium acetate (1M) was buffered to pH4.5 using glacial acetic acid. 
Formaldehyde (0.1 M) was prepared by adding 1ml of 37% stock to 120ml of 
distilled water. Dimedone was dissolved in 50% (v/v) ethanol to give a final 
concentration of 0.4M.
2.2.1.2 Preparation of cell extract for assay
Cultured cells in suspension were centrifuged (200 g, 5min) and the 
growth medium discarded. The cell pellet was washed with 0.32M-sucrose, 
lOmM-Hepes, ImM-EDTA buffered to pH7.4 with KOH (sucrose buffer) and 
the centrifugation repeated. The supernatant was discarded and the cell 
pellet resuspended in sucrose buffer to give a final concentration of 
2.5-4 X 10® viabie cells/ml (0.8-1.2mg totai protein/ml). A sample of the cell 
suspension in sucrose buffer was taken for a cell count and viability 
assessment. The remainder was sonicated for 5s bursts with 25s intervals 
over a period of 2min on ice using an MSE Soniprep 150 set at 8 amplitude 
microns. Triton X-100 was added to a final concentration of 0.5% (v/v) and 
the sonicate kept on ice prior to the assay. Alternatively, after 30min on ice, 
the samples were frozen in liquid nitrogen and stored at -20°C prior to assay. 
Under these conditions the enzyme was assayed without loss of activity after 
13 days of storage, no assays being carried out on samples stored for longer 
than this period.
29
2.2.1.3 Assay procedure
Preincubations were carried out at 37^0 for 5min and contained 
310mM-Hepes, pH7.4, 0.2mM-PLP, 2mM-THF, 12mM-2-mercaptoethanol 
and enzyme extract (16-24jxg total protein) in a total volume of 80|xl. For the 
blank tubes, enzyme extract was replaced by the buffer In which the extract 
had been prepared. The assay was initiated by the addition of 20|xi of 
1.25mM-[3-i4C]serine (5jxCi/ml; 4p.Ci/p,mole) and carried out for 10min at 
370c. The reaction was terminated by the sequential addition of 60|il of 
ice-cold 1 M-sodium acetate, pH4.5, 40|xl O.IM-formaldehyde and 60|xl 
0.4M-dimedone. Samples were then boiled for 5min, after which 1ml of 
toluene was added. Tubes were shaken in a water bath at room temperature 
for at least lOmin and then centrifuged in the microfuge (12000 g, Imin). 
From the toluene layer, 0.8ml were removed to scintillation vials and 2ml of 
scintillant were added. The radioactivity in samples of the original 
1.25mM-[3-i4C]serine was also determined.
2.2.2 Lactate dehydrogenase
Lactate dehydrogenase (EC 1.1.1.27) was assayed as described by 
Bergmeyer et a i (1974). Quartz cuvettes containing 47.5mM-potassium 
phosphate buffer, pH7.5, 0.2mM-NADH and 1-1.5p,g protein in a total volume 
of 590|xl were preincubated at OO^ C and the absorbance at 340nm monitored 
for 3min to check the background rate. The assay was initiated by the 
addition of sodium pyruvate (prepared freshly) to a final concentration of 
0.87mM and initial rates measured over 4min by the change in absorbance at 
340nm. Results were expressed as p,moles NADH oxidized/min per mg 
protein using an absorption coefficient of 6220M-icm'i.
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2.2.3 Citrate synthase
Citrate synthase (EC 4.1.3.7) was assayed according to Srere (1969). 
All reagents (except Tris buffer) were prepared freshly on the day of use. 
Quartz cuvettes containing O.ImM-acetyl CoA, 110mM-Tris-HCI, pHS.I, 
0.013mg 5,5'-dithiobis-(2-nitrobenzoate) (DTNB) (Eiiman's reagent) and 
8-12[xg protein in a total volume of 288^il were preincubated at 30°C and the 
absorbance at 412nm measured to check for any background rate. The 
assay was initiated by the addition of oxaioacetic acid to a final concentration 
of 0.5mM and initial rates measured over 3min by the change in absorbance 
at 412nm. Results were expressed as nmol CoA formed/min per mg protein 
using an absorption coefficient of 13.6mM'i cm-i.
2.2.4 Protein
Totai celiular protein was assayed using the BCA protein assay
reagent. The working assay reagent consisted of 50 volumes reagent A
(sodium bicarbonate, sodium carbonate, bicinchoninic acid and sodium 
tartrate in 0.1 M NaOH) and 1 voiume of 4% (w/v) CUSO4 5H2O. A standard
curve was prepared over the range 0-1 .Omg protein/ml using bovine serum 
aibumin (BSA) dissolved and diluted in sucrose buffer. Appropriately diluted 
samples of protein (50p.i) and aliquots of standards (50p,l) were transferred to 
plastic cuvettes on ice and 1 ml of working assay reagent added. Cuvettes 
were incubated at 37°C for 30min, left at room temperature for 10min and the 
absorbance at 562nm measured thereafter as quickly as possible. Protein 
concentrations (mg/ml) were calculated from the standard curve.
The mean amount of protein per 10® cells for cells taken from the 
late-logarithmic phase of growth was 0.29 ± 0.016mg (mean ± S.E.M. from 16 
experiments). The presence of the inhibitor, 3-fluoro-D-alanine, did not result 
in a statisticaliy significant difference from this value (0.31 ± 0.021 mg protein 
per 10® ceiis). For the purposes of calculations in Chapter 4, a value of 
0.3mg protein per 10® cells was used to convert rates of enzyme activity 
normalized per mg protein to rates normalized per 10® cells.
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2.2.5 Adenosine triphosphate (ATP)
Celi viability can be assessed by the measurement of cellular ATP 
(Stanley and Williams, 1969). The assay reagent was prepared by mixing 
equal voiumes of SOmM-MgSO^, 10OmM-NaHAsO^ and 10mM-KH2PO4
buffered to pH7.40 with KOH. Samples were prepared in 0.3M-perchloric 
acid (PCA) and 3|il transferred to cuvettes to which 1 mi of the above assay 
reagent was added. Tubes were kept in the dark prior to measurement of the 
bioluminescence using 30jil of firefiy luciferin-luciferase In an LKB 1251 
luminometer in the integration mode. The luciferin-luciferase extract was 
produced by homogenization of 50mg firefly lantern extract (Sigma Cat. No. 
FLE-50) in 20ml H2O (6-8 passes in a tight-fitting teflon pestle) and stirring at
4°C for 1h. The suspension was centifuged (12000 g, 2.5min) at 4°C three 
times before storage at -20°C. ATP contents were caiculated by reference to 
known standards prepared on the same day.
2.3 Digitonin fractionation
Digitonin was prepared by dissolving the solid (50% pure) in sucrose 
buffer, heating to 90°C and filtering whilst hot. The fractionation itself was 
carried out by mixing 100p,l ice-cold digitonin with 400|xl cell suspension such 
that the ratio of mg totai protein to mg digitonin was approximately 40 : 1. 
Incubations were carried out on ice for appropriate times and terminated by 
centrifugation (12000 g, 30s). A portion of supernatant was immediately 
removed (350|xl) to another tube and 350|xl of sucrose buffer (including 
digitonin at an appropriate concentration to keep all samples comparable) 
added to the pellet plus remainder of supernatant. This latter sample was 
mixed immediately to disperse gelatinous material precipitated above the 
pellet. Total activity samples were carried out by omission of the 
centrifugation step. All samples were then sonicated once for 5s bursts with 
25s intervals over a total period of 2min on ice and triton X-100 added at 
concentrations as indicated in the results in Chapter 4. Samples were left on 
ice for 30min before assay or were frozen in liquid nitrogen and stored 
at -20^0 prior to assay.
Lactate dehydrogenase (LDH) and citrate synthase (OS) were 
assayed as cytosolic and mitochondrial matrix enzymes respectively.
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together with SHMT, in the total, supernatant and pellet samples. The pellet 
activities were corrected for the activity in the supernatant left above the 
pellet during the fractionation procedure. Protein content was determined in 
the totai samples for normalization of data obtained from different cell 
suspensions.
2.4 Measurement of purine synthesis
2.4.1 Preparation of assay medium
Two different types of RPMi 1640 medium were used for purine 
synthesis assays. The first consisted of the folate-free RPMI 1640 (section
2.1.1 ; p. 25) (not sterilized and stored at -20°C) supplemented with 10% (v/v) 
dialysed PCS and lOnM-leucovorin (NaHCOg-buffered medium). The second
was prepared from a different RPMI 1640 powdered medium in which 
glucose, glutathione (reduced form), serine, glutamine, glutamate, histidine, 
glycine, tryptophan, folic acid and NaHCOg were absent. The contents of
one package were dissolved in 950mi of distilled water and the various 
omitted components added back as required. Hepes was then added to a 
final concentration of 25mM and the medium buffered to pH7.4 using NaOH. 
The total volume was made up to 1 litre and the medium warmed to 37^0. 
The pH of the medium was then adjusted back to pH7.4 using NaOH, having 
calibrated the pH meter for measurement at 37^0. The medium 
(Hepes-buffered RPMI 1640) was stored at -20°C. For use in the purine 
synthesis assay the Hepes-buffered RPMi 1640 medium was supplemented 
with 10% (v/v) dialysed PCS, 10nM-leucovorin and any further components 
required which were omitted earlier. Glutamine was always made up freshly 
and added on the day of use to a final concentration of 0.6mM. The resulting 
medium has been termed Hepes-buffered medium throughout this thesis. 
Sodium bicarbonate was freshly prepared and added to this medium as 
described in section 2.4.3 at the concentrations indicated for individual 
experiments.
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2.4.2 Incubation of cells in NaHCOg-buffered medium
Cultured cells were centrifuged (200 g, 5min) and the supernatant 
discarded. The pellet was washed in NaHCOg-buffered medium and the
centrifugation repeated. The final pellet was resuspended in 
NaHCOg-buffered medium to give a cell concentration of 2 x 10® viable
cells/ml and a sample taken for a cell count. The remaining suspension was 
thoroughly gassed with carbogen (95%02/5%C02) whenever exposed to the
atmosphere. Two 650^ .1 aliquots were transferred to incubation viais which 
were capped with rubber seals. Vials were gassed with carbogen for a few 
minutes and then preincubated at 37°C in a shaking water bath for 20min. 
Purine synthesis measurements were initiated by the addition of 10p.1 of 
[3-i^C]serine (12.5|iCi/ml) or 10|xl [1-i^Cjglycine or [2-i4C]gIycine (25|iCi/ml) 
and viais were incubated for appropriate times. Incubations were terminated 
by centrifugation of 1ml of celi suspension through 0.5ml silicone oil (Dow 
Corning DC 550 : Dinonyl phthalate (2:1) (v/v)) into 100|il 2.5M-PCA.
2.4.3 Incubation of ceils in Hepes-buffered medium
Cultured ceils were centrifuged (200 g, 5min) and the supernatant 
discarded. The pellet was washed with Hepes-buffered medium (with 
whichever omissions necessary) and the centrifugation repeated. The final 
cell pellet was resuspended in Hepes-buffered medium to give a cell 
concentration of 2 x 10® viable cells/ml and a sample taken for a cell count. 
Two 650|xl aliquots were transferred to Incubation vials containing 13|xl of 
lOOx strength solutions of components as yet omitted. Vials were capped 
with rubber seals and preincubated at 37°C in a shaking water bath for 
20min. After this time 13jxl of freshly dissolved 300mM-NaHCOg (unless
otherwise indicated) were added through the rubber seal using a Hamilton 
syringe. The rationalefor using this concentration of NaHCOg is detailed in
section 5.2.3.2 (p. 145). Purine synthesis measurements were then initiated 
by the addition of 10|xl of either [3-*i4C]serine (12.5|xCi/ml), [1-i4C]glycine 
or [2-i4C]glycine (25jxCi/ml) or [l-l^CJgiucose or [6-i4C]glucose (20|xCi/ml).
For measurement of purine synthesis from [i4C]NaHCOg, after the 
preincubation 13|il of 300mM-[i4C]NaHCOg (0.18mCi/ml) were added 
through the rubber seal. This [l4C]NaHC0g solution was prepared
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immediately before use by adding 3 volumes of p^CjNaHCOg (0.8mCi/ml) to 
10 volumes of 350mM-NaHCOg in an HPLC vial. The vial was sealed and
radiolabel dispensed from the HPLC vial to the Incubation vial using a 
Hamilton syringe. All operations using [i4C]NaHCOg were carried out in a
fume cupboard.
Incubations at 37°C were carried out for the appropriate time and the 
assay terminated by centrifugation of 1 ml of cell suspension through 0.5ml of 
silicone oil (Silicone fluid DC550 : Dinonyl phthalate (2:1) (v/v)) into lOOjxl 
2.5M-PCA.
2.4.4 Isolation of purines
Samples were taken from the extracellular medium left above the oil to 
determine the amount of radiolabel lost during the incubations. The 
remaining supernatant was discarded and the surface of the oil washed with 
1 ml of water. This water and most of the oil was then removed and 0.9ml of 
water added and mixed to loosen the pellet. The tubes were capped and 
boiled for 1h, after which they were centrifuged (12000 g, Imin) and 25^il of 
the aqueous phase (now 0.25M-PCA) removed into 475jil of 0.1M-HCI for 
U.V. analysis (absorbance measurements at 260nm; see section 5.2.1; 
p. 138). A further 0.9ml of the aqueous phase were transferred to clean 
tubes and 50^1 of [8-®H]adenine (0.4|xCi/ml) were added followed by 40|xl of 
ammonia solution and 50|xl of 8.5% (w/v) silver nitrate. Tubes were capped, 
vortex mixed and placed in the fridge for 2h, after which they were 
centrifuged (12000 g, Imin). The supernatant was carefully removed and the 
pellet washed with 1ml of water and the tubes recentrifuged (12000 g, 1min). 
The pellet was washed once more in the same way and the final pellet 
resuspended in 0.5ml of 0.1M-HC1. The samples were boiled for 30min, 
centrifuged (12000 g, Imin) and the supernatant removed for application 
onto the "Bond Eiut" columns (Analytichem International).
The "Bond Elut" columns were equilibrated by running through 5ml of 
5mM-1-heptane suiphonate in 95% methanol (solution B) followed by 3ml of 
5mM-1-heptane suiphonate, pH3.0 (solution A) (If columns were being used 
for the first time, then 5ml of solution B were run through the columns which 
were then left to stand in more solution B. After 1 h, 5ml of solution A were 
run through the columns, followed by 3ml of solution B and then another 3ml
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of solution A.) The supernatant was then loaded onto the columns 
equilibrated with solution A and drawn through the columns by vacuum. This 
was followed by 1ml of 6% solution B (5%B/95%A) and the tips of the 
columns were rinsed with water. Purines were eluted from the columns with 
1.5mls of 20% solution B (20%B/80%A) which were collected in scintillation 
vials and 10ml scintillant added for determination of radioactivity associated 
with purine. The columns were stored in 20%B and were turned off just 
before going dry.
2.4.5 HPLC analysis of purines
HPLC was carried out using the Beckman System Gold system 
(Beckman, High Wycombe, U.K.) which comprised a model 126 binary 
solvent delivery module and a model 507 autosampler. Samples (175p.l) 
eluted from the Bond Elut columns (see above) were chromatographed on a 
4.60mm x 25cm Whatman Partisil 10 ODS-2 column (Whatman Ltd., 
Maidstone, Kent) equipped with a precolumn packed with pellicular ODS 
(Whatman Inc., Clifton, N.J., U.S.A.)
The mobile phases were 5mM-1 -heptane suiphonate set to pH3.0 with 
sulphuric acid (solution A) and 5mM-1-Heptane suiphonate in 95% methanol 
(solution B). Both these solutions were prepared by dilution of a 
IOOmM-1-heptane suiphonate stock (pH3.0) but solution B was not 
readjusted to pH3.0 after dilution. Both solutions were filtered and degassed 
by bubbling helium through them before use.
Purines were eluted using a gradient from 10% solution B (in solution 
A) to 40% solution B (in solution A) over 20min at a flow rate of Iml/min. 
Return to 10%B was carried out over lOmin and a further lOmin used to 
equilibrate column at 10%B. Purine peaks were detected by monitoring the 
absorbance at 254nm using a model 167 scanning ultraviolet detector. 
Where necessary, the outflow from the U.V. detector was collected with a 
Frac-100 fraction collector (Pharmacia). Fractions (0.5ml) were collected 
directly into scintillation vials (Mini 'Poly-Q' viais, Beckman) for determination 
of radioactivity. Purine standards (hypoxanthine, adenine and guanine) were 
prepared in 20%B (equivalent to samples) although guanine had to be initially 
dissolved in O.IM-HCi and then diluted with 20%B. Both guanine and 
hypoxanthine had to be warmed to achieve a final concentration of 3mM.
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2.5 Serine transport measurements
2.5.1 Determination of intracellular volume
Centrifugation of celi suspensions through an oil layer necessarily 
implies contamination of the PCA by a proportion of the extracellular medium. 
The total space (intracellular + extracellular) was measured using pH]water 
at an activity of 4jxCi per ml of cell suspension (approximately 2x10® viable 
cells/ml). The extracellular space was measured using 50mM-[U-l4C] 
sucrose at an activity of 0.8|xCi per ml of cell suspension. Cells used for 
space measurements were preincubated for 20min in the presence of the 
pH]water after which the 50mM-[U-'i^C]sucrose was added, vortex mixed 
and a portion of the cell suspension centrifuged through oil as described in 
section 2.5.4 (p. 39).
2.5.2 Measurement of serine influx
Cultured cells were centrifuged (200 g, 5min) and the supernatant 
discarded. The cell pellet was washed with Earle's Balanced Salts solution 
(EBBS) and the centrifugation repeated. The supernatant was again 
discarded and the cells resuspended in EBBS at a concentration of 2 x 10® 
viable cells/ml. The cell suspension was gassed with carbogen as necessary 
to maintain the correct pH and a sample was taken for a cell count and 
assessment of viability. To the remaining cells was added 4pCi of pH]water 
(0.5mCi/mi) per ml of cell suspension and 245|il aliquots transferred to 
incubation tubes. These were then individually gassed, capped and 
preincubated at 37°C. Transport measurements were initiated by the 
addition of 5p,i of 12.5mM-[3-i4C]serine (5.4|xCi/ml) for incubation times up to 
and including 60s. For longer incubation times 5[il of 12.5mM-[3-i4C]serine 
(1.8|xCi/mi) was used and the tubes were regassed, recapped and 
reincubated at 37°C. Berine uptake was terminated by centrifugation of 
200|xl of cell suspension through silicone oil. To precooled aliquots of cell 
suspension (on ice) was added [3-i4C]serine, the contents of the tube mixed 
and 0.2mi centrifuged immediately through oil for zero-time samples.
Two main modifications of this procedure were necessary in certain 
circumstances. The first involved the use of inhibitors. Due to the iarge final
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concentrations often required, Inhibitors were prepared in EBSS at only twice 
the final required concentration. Similarly cell suspensions were prepared at 
twice the usual cell concentration (4 x 10® viable cells/ml). EBSS containing 
all inhibitors required (120|xl) plus the radiolabelled serine (5|il) was 
transferred to incubation tubes, gassed with carbogen, capped and 
preincubated at 37°C. The cell suspension was preincubated separately at 
37°C with repeated gassing with carbogen. Transport measurements were 
initiated by the addition of 125|xl of ceil suspension to the incubation tubes 
containing the radiolabelled serine and the inhibitors. Tubes were vortex 
mixed and 200^ii centrifuged through oil (section 2.5.4; p. 39) after 10s or 20s 
from addition of cells.
The second modification invoived the use of cells suspended in 
Hepes-buffered medium instead of EBSS. No gassing with carbogen is 
necessary for this medium. Aliquots of cell suspension (430|xi) were 
transferred to incubation vials which were then capped with rubber seals. 
Using a Hamilton syringe, lOjxi of 135mM-NaHC0g (dissolved in medium)
were added. Ali tubes were preincubated for 20min and transport 
measurements initiated by the addition of 170)xl from the preincubated 
inhibitor solutions to the 430|ii of cell suspension. Tubes were vortex mixed 
and 500|xl of celi suspension centrifuged through oil after the appropriate time 
(see section 2.5.4; p. 39).
2.5.3 Measurement of serine efflux
For efflux measurements, cells were resuspended in Hepes-buffered 
medium at a concentration of 2 x 10® cells/ml (no [®H]water was added yet.) 
Aliquots of 480|il were transferred to incubation tubes which were capped 
with rubber seals. Using a Hamilton syringe, IOp.1 of 150mM-NaHCOg
(dissolved in Hepes-buffered medium) were added and tubes preincubated at 
37°C. After 20min, lOjxl of [3-'i4C]serine (6^iCi/ml) were added through the 
rubber seals and incubations carried out at 37^0 for a further 20min (for 
efflux determination) or 20, 40 and 60min (for steady-state determination). 
After the appropriate time, 450jxi were removed to an Eppendorf tube and 
centrifuged (12000 g, 5s). 405p.l of supernatant were removed to scintillation 
viais and 4ml scintillation fluid added. The remaining 45|xl were mixed with a 
pipette to resuspend the celis and incubated at 37®C for 4min.
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To measure the efflux rate, 405|xl of efflux medium (Hepes-buffered 
medium containing pH]water at 4)xCi/ml and SmM-NaHCOg) was added to
the 45|xl, the cell suspension mixed and the contents transferred to another 
incubation tube. Tubes were capped and incubated at 37°C for appropriate 
times after which 400|xl were centrifuged through oil.
To measure the steady-state [3-i4C]serine radioactivity, 405p.l of 
steady-state medium (Hepes-buffered medium containing pH]water at 
4|xCi/ml and [3-i4C]serine at 0.12|xCi/ml) were added to the 45|xl of cell 
suspension, mixed and 400|xl centrifuged immediately through silicone oil. 
Parallel tubes to these steady-state measurements were set up in which the 
radioactivity associated with purine in the PCA-soluble layer was determined. 
The steady-state values could then be corrected for metabolism of [3-i^C] 
serine to purine.
To measure the spaces, 10fxi of Hepes-buffered medium replaced the 
[3-i4c]serine. To the 45jxl of resulting cell suspension was added 395p,l of 
efflux medium plus 10|xl of 50mM-[U-i4c]sucrose (40jiCi/ml). Contents were 
vortex mixed and 400|xl centrifuged immediately through silicone oil (see 
section 2.5.4).
2.5.4 Termination of transport measurements
Aii transport measurements were terminated by centrifugation 
(12000 g, 30s) of a portion of the cell incubation through a layer of silicone oil 
(Silicone fiuid DC 550/Dinonyl phthalate (2:1) (v/v)) into 2.5M-PCA. 
"Stopping" tubes were set up containing 25|il of 2.5M-PGA and 0.5ml of 
silicone oil and were then centrifuged (12000 g, 10s) to fully separate the 
layers.
2.5.5 Preparation of samples for determination of radioactivity
Aiiquots of extracelluiar medium left above the oil were removed for 
determination of radioactivity. The additional medium was discarded and the 
surface of the oil washed with Imi distilled water. This too was discarded 
together with most of the oil and 175}il of distilled water added and mixed to 
loosen the pellet. Samples were centrifuged (12000 g, 30s) and 150|il of the
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aqueous layer removed to scintillation vials. Two ml of scintillation fluid was 
added and radioactivity determined using a Beckman scintillation counter.
2.6 Measurement of Protein Degradation
Cells were cultured in the presence of [r/ng-2-l4C]tryptophan 
(1p-Ci/|xmoie) such that the overall increase in celi number was approximately 
50-fold. The cell suspension was then centrifuged (200 g, 5min) and the 
pellet washed in Hepes-buffered medium minus tryptophan. The 
centrifugation and the wash step were repeated. At each stage of the 
washing procedure samples of cell suspension were centrifuged through 
0.5ml silicone oil into 100(xl 2.5M-PCA and the Hepes-buffered medium was 
gradually warmed to 37°C during washing. The finai washed cell pellet was 
resuspended in Hepes-buffered medium plus tryptophan to give a final cell 
concentration of 2 x 10® viable cells/ml. As rapidly as possible 2 x 650^1
aliquots were transferred to incubation viais, which were capped using rubber 
seals and 13p.l of OOOmM-NaHCOg added using a Hamilton syringe. All vials
were placed simultaneously in a shaking water bath at 37°C and 1 ml samples 
of cell suspension were immediately centrifuged (12000 g, Imin) through 
silicone oil as mentioned above for zero-time measurements. After the 
appropriate incubation time, 1 ml samples of cell suspension were centrifuged 
through oil.
From the extracellular medium above the oil, 900|xl were removed to 
scintillation vials and 9ml scintillant added. The remaining medium was 
discarded and the surface of the oil washed with 1 ml water. This was then 
discarded together with most of the oil and 900p,l water added and mixed to 
disrupt the pellet. Samples were centrifuged (12000 g, 1min) and 900jxl of 
the aqueous layer transferred to scintillation vials and 9ml scintillant added.
At zero time, 1ml samples of the final cell suspension were centrifuged 
(12000 g, 15s), the supernatant removed and the pellet washed with 1ml 
sucrose buffer (see section 2.2.1.2; p. 29). The washed cells were 
centrifuged again and the final pellet resuspended in ice-cold sucrose buffer 
to give a final cell concentration of 4 x 10® celis/ml. The resulting cell 
suspension was sonicated on ice for 5s bursts with 25s Intervals over a total 
period of 2min using an MSE soniprep 150 set at 8 amplitude microns. Triton 
X-100 was added to a final concentration of 0.5% (v/v) and samples kept on
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ice for 30min before freezing in liquid nitrogen. Samples were stored at 
-2Q0C prior to assay for total cell protein. A proportion of the samples were 
taken for determination of radioactivity.
2.7 Amino acid analysis
2.7.1 Preparation of sample of cellular amino acids
Conditions were employed to mimic those for the serine transport 
measurements. Ceils from the logarithmic phase were washed once with 
Hepes-buffered medium and resuspended in the same medium to a 
concentration of 2 x 10® cells/ml. Aliquots of 440p,l were transferred to
incubation tubes which were then preincubated at 37°C for 20min. To each 
tube was added 4.5^1 of 300mM-NaHCOg (dissolved in Hepes-buffered
medium) and 4.5jxl water (instead of the radiolabelled serine usually added 
for transport measurements). Incubations were carried out for 20, 40 or 
60min and terminated by centrifugation of 400|xl of cell suspension through 
silicone oil into 25{xl 2.5M-PCA. The samples were then processed as 
described in section 2.5.5 (p. 39) except that the final 150^il of the aqueous 
layer (now 0.3M-PCA) was used for amino acid analysis. These samples 
were stored at -20°C prior to further analysis. Measurements of the 
extracellular and intracellular volume were made for individual experiments 
as described in section 2.5.1 (p. 37).
2.7.2 Derivatization of cellular amino acids
From the 150jxl of sample (prepared in 0.3M-PCA as described in the 
previous section) was taken 20p,l for derivatization. This volume was dried 
down in a vacuum and 10|xl of redrying solution (2:2:1 mixture (by volume) of 
methanol: 1M-sodium acetate: triethylamine) added. Samples were mixed 
and dried again in a vacuum.
The derivatization reagent was prepared by mixing 7 volumes of 
methanol with 1 volume each of triethylamine, phenylisothiocyanate (PITC) 
and water. The solution was mixed for a few seconds and 20|xl added to 
each redried sample. The tube contents were mixed for a few seconds and
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left at room temperature for 20min. The sample was again dried under 
vacuum to remove all traces of PITC. Finally 10|xl of methanol was added, 
mixed and the sample dried thoroughly. The dessicated samples may now 
be stored at -20°C for a couple of weeks before HPLC analysis.
2.7.3 HPLC analysis
Amino acid standard solution (containing each amino acid at a 
concentration of 10|xg/ml) was derivatized as for the sample. The derivatized 
standard and samples were reconstituted in 10Opi of sample diluent solution 
(5% acetonitrile in 5mM-Na2HP04, pH7.40). HPLC was carried out using a
Waters gradient system which comprised two Model 510 solvent pumps, a 
Waters autosampler (WISP 712) and installed data software Maxima 820. 
The samples were chromatographed on a NOVA PAK (150 x 3.9mm) column 
according to the Waters Pico Tag amino acid analysis procedure. The mobile 
phases were 6% (v/v) acetonitrile in 140mM-sodium acetate trihydrate (with 
0.05% triethylamine), pH6.40 (Eluent A) and 60% (v/v) acetonitrile in water 
(Eluent B). The gradients used were as shown in Table 2.3. Amino acid 
derivatives were detected by monitoring the absorbance at 254nm using a 
Waters Model 440 U.V. detector. The concentration of serine in the samples 
was calculated by reference to the standard. A standard sample of serine 
was also prepared from a stock of 20^iM-serine in 0.3M-PCA for comparison 
with the commercially supplied standards to check that the 0.3M-PCA did not 
affect the peak areas.
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1mm
1mm
Fig. 2.1 Diagram of a haemocytometer grid. The cell suspension was
diluted such that 10-50 cells were counted in a 1 mm^ area. The number of 
these areas counted was such that 90-200 cells were counted in total. The
number of cells per 1 mm^ area is the number of cells x 10^ per ml.
43
100
Plateau phase
"03o
0)
■>
“oT—
4
17h
Cell
doubling
time
10h
Lag
Phase
0.1
7224 480 96 120
Hours of growth
Fig. 2.2 Growth curve for MOLT-4 cells. Cells were seeded at an Initial
concentration of 1 x 10^ viable cells/ml. Cell counts were made by using a 
haemocytometer and cell viability assessed by trypan blue exclusion at the 
times shown. The results are the means ± S.E.M. from 5 to 24 experiments. 
The lag phase was lOh, the cell doubling time was 17h and the cell
concentration at the plateau phase (96h) was 1.5 x 10^ viable cells/ml.
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Table 2.1 Composition of RPMi 1640 medium used in the present work.
Component mg/litre Mr Concentration (mM)
Ca(N0 g)2 4H2O 100.00 236.2 0.42
KCI 400.00 74.55 5.37
MgS04 •7H2O 100.00 246.47 0.41
NaCI 6000.00 58.44 102.67
NaMCOg» 2000.00 84.01 23.81
Na2HP04 7H2O 1512.00 267.96 5.64
Glucose 2000.00 180.16 11.10
Glutathione (reduced) 1.00 307.3 0.003
Phenol red 5.00 376.4 0.013
Arginine NCI 200.00 210.7 0.949
Asparagine 50.00 132.1 0.379
Aspartic acid 20.00 133.1 0.150
Cystine 50.00 242.2 0.206
Glutamic acid 20.00 147.1 0.136
Glutamine‘s 300.00 146.1 2.053
Glycine 10.00 75.07 0.133
Histidine HCI • H2O 15.00 209.7 0.072
Hydroxyproline 20.00 131.1 0.153
isoleucine (alio free) 50.00 131.2 0.381
Leucine (methionine free) 50.00 131.2 0.381
Lysine HCI 40.00 182.7 0.219
Methionine 15.00 149.2 0.101
Phenylalanine 15.00 165.2 0.091
Proline (hydroxyproline free) 20.00 115.1 0.174
Serine 30.00 105.1 0.285
Threonine (alio free) 20.00 119.1 0.168
Tryptophan 5.00 204.2 0.024
Tyrosine 20.00 181.2 0.110
Valine 20.00 117.1 0.171
Biotin 0.200 244.3 0.0008
D-Ca pantothenate 0.250 238.3 0.0010
Choline diloride 3.000 139.6 0.0215
i-inositol 35.000 180.2 0.1942
Nicotinamide 1.000 122.1 0.0082
Para-amin obenzoic acid 1.000 137.1 0.0073
Pyridoxine HCI 1.000 205.6 0.0049
Riboflavin 0.200 376.4 0.0005
Thiamine HCI 1.000 337.3 0.0030
Vitamin 8^2 0.005 1355.4 0.0000037
® In some experiments in this report, the NaHCOg was replaced by 25mM-Hepes and the 
medium buffered to pH7.4 at 37®C using NaOH (Hepes-buffered RPM11640). NaHGOg was 
then later added to lower final concentrations as detailed for individual experiments.
 ^The glutamine concentration was decreased to 0.6mM in the Hepes-buffered medium.
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Table 2.2 Composition of Earle's Baianced Saits solution (EBBS) used
in the present work.
Component mg/litre M, Concentration (mM)
NaCI 6800.00 58.44 116.36
KOI 400.00 74.55 5.37
MgS047H20 200.00 246.47 0.81
Na2P04-2H20 158.00 156.01 1.01
CaCl2-2H20 264.00 147.02 1.80
NaHCOs 2200.00 84.01 26.19
Glucose 1000.00 180.16 5.55
Phenol red 10.00 376.4 0.03
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Table 2.3 Gradients used for amino acid analysis by the Waters 
Pico Tag procedure.
The number for the curve relates to different curve functions as defined by 
Waters. N.A. Not applicable.
Time (min) Flow rate (ml/min) %A %B Curve
Initial 1.0 100 0 N.A.
10.0 1.0 54 46 5
10.5 1.0 0 100 6
11.5 1.0 0 100 6
12.0 1.5 0 100 6
12.5 1.5 100 0 6
20.0 1.5 100 0 6
20.5 1.0 100 0 6
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CHAPTER 3
CHARACTERIZATION OF SERINE 
TRANSPORT IN MOLT-4 CELLS
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Chapter 3; Characterization of serine transport In MOLT-4 cells
3.1 Introduction
Normal and leukaemic leukocytes have a limited capacity to 
synthesize serine from glucose relative to some other cell types (Regan et al., 
1969). This limitation is thought to arise because of the low specific 
activity of 3-phosphoglycerate dehydrogenase, an enzyme of the 
phosphorylated pathway of serine biosynthesis (Pizer & Regan, 1972). The 
supply of serine from the blood may therefore be the only significant source 
of one-carbon units required for nucleotide de novo synthesis. In this 
respect, the transport of serine across the plasma membrane of these cells 
could be an important control site with regard to nucleotide synthesis and cell 
proliferation. Quantification of the importance of this transport step was 
attempted by the application of metabolic control analysis (see Chapter 6). 
The total transport of a particular amino acid may however be accomplished 
by more than one transport system and the experiments in this chapter were 
designed to characterize the transport of serine into MOLT-4 cells. If the 
transport of serine is indeed an important control site with regard to 
nucleotide synthesis, cellular regulation of this process might be expected. 
The present understanding of the regulation of amino acid transport has 
therefore been briefly discussed. Knowiedge of which transport systems are 
regulated together with the characterization of serine transport into MOLT-4 
cells is required to implicate whether this process is a potential site of 
reguiation in this cell type.
3.1.1 Heterogeneity of amino acid transport
Transport of amino acids across the plasma membrane has been 
studied in many different cell types and occurs via a number of distinct 
transport systems often having a broad range of substrates and overlapping 
specificity. The range of transport systems characterized to date are 
summarized in Table 3.1. Discrimination between the various systems is far 
from simple and several different techniques used for observing 
heterogeneity ought to be employed before confident assignment of particular
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systems to the transport of selected amino acids. Methods for discrimination 
between transport systems include inhibition analysis, observation of biphasic 
kinetics, sodium dependence, stereospecificity, concentrative properties, 
sensitivity to pH and the ability to carry out exchange.
3.1.1.1 Inhibition analysis
The original observation that the transport of certain neutral amino 
acids occurred by at least two distinct systems was based on the pattern of 
competitive interactions between leucine, valine, methionine, alanine and 
glycine, which could not be explained by the presence of only one transport 
mediation (Oxender & Christensen, 1963). These two systems were termed 
the L system and the A system and their discrimination was greatly facilitated 
by the discovery of substrates (and also therefore of competitive inhibitors) 
specific to a particular system. N-methylation of amino acids was found to 
result in retention of transport by system A whereas these derivatives showed 
no affinity for the L system (Christensen et a/.,1965). The non-metabolizable 
amino acid analogue, 2-(methylamino)-isobutyric acid (MeAlB; see Fig. 3.1), 
has proved to be the most useful compound for specifically inhibiting system 
A, especially with regard to its discrimination from a third neutral amino acid 
transport system termed system ASC (Christensen et ai, 1967). A number of 
amino acids including serine are transported by both systems A and ASC and 
characterization of these two individual systems when expressed together 
would have been extremely difficult without a specific inhibitor of at least one 
of them.
The non-N-methylated analogue, 2-aminoisobutyric acid (AIB), was 
also provisionally proposed as a specific substrate for the A system on the 
basis of studies in the Ehrlich cell (Oxender & Christensen, 1963) but 
subsequent studies have shown that this is not necessarily the case. 
Suppression of system A activity in the Ehrlich cell by decreasing the pH of 
the assay medium revealed that a proportion of AIB uptake was 
accomplished through system L, although maybe only at the lower pH values 
(Garcia-Sancho et a/., 1977). In Chinese Hamster Ovary cells a significant 
proportion of the uptake of AIB by system L was measured even in the 
presence of the usual system A activity (Shotwell et al., 1981). No AIB 
transport by system L could be detected in the hepatocyte (Le Cam &
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Freychet, 1977) but instead these workers and others (Kilberg et al., 1979) 
found AIB transport to be shared by both system A and system ASC. In 
contrast, some studies with monolayer cultures of rat hepatocytes have 
indicated a much lower proportion of transport of AIB by system ASC (Kelley 
& Potter, 1978) utilizing the same substrate concentration as Le Cam and 
Freychet (1977). Although this difference could apparently be explained on 
the basis of isolated hepatocyte versus monolayer culture, other workers also 
using isolated rat hepatocytes found that the total saturable uptake of AIB 
occurred via system A (Edmondson et al., 1979). All these experiments on 
liver cells characterized the ASC component of uptake as the Na+-dependent 
uptake not inhibited by saturating concentrations of MeAIB. It is however 
worthy of note that higher concentrations of MeAIB were required to totally 
inhibit AIB uptake in the last case where no ASC component was detected 
compared to the other studies where at least a small component of AIB 
uptake by the ASC system was suggested. More recently, experiments with 
human liver plasma membrane vesicles showed that MeAIB inhibited 90% of 
the Na+-dependent uptake of AIB (Mailliard & Kilberg, 1990). Whatever the 
discrepancy, it is quite clear that AIB should not be used necessarily as a 
specific inhibitor of system A.
A useful model substrate for the L system is 2-aminobicyclo- 
[2.2.1 ]heptane-2-carboxylic acid (BCH; see Fig. 3.1), the uptake of which was 
found to be totally Na+-independent and not inhibited by a large excess of 
MeAIB in the Ehrlich cell (Christensen et al., 1969). It should be noted that 
BCH did show significant inhibition of the ASC system in these cells, albeit 
with low affinity, as judged by the Na+-dependent MeAIB insensitive portion of 
serine uptake. This however does not necessarily imply BCH as a potential 
substrate for the ASC system, especially with regard to the fact that inhibition 
of this system often occurs by compounds which are not transported by it 
(Christensen et al., 1967). Further limitations on the use of BCH became 
evident upon observation of its possible inhibition of the more recently 
discovered system T in human red blood cells (Vadgama & Christensen, 
1985). Even earlier experiments with isolated rat hepatocytes in primary 
culture demonstrated heterogeneity of Na+-independent BCH transport, the 
two components then being tentatively described as system L and system T 
(Handlogten etal., 1982b). However, because amino acids other than those 
with aromatic side chains inhibited both these Na+-independent systems, 
BCH transport was rather assigned to as yet unidentified systems LI and L2
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(Weissbach et al., 1982). In addition, a system responsible for the transport 
of aromatic amino acids in isolated rat hepatocytes which is not inhibited by 
BCH has been characterized as system T (Salter et al., 1986). It is not 
unreasonable on the basis of current knowledge to suggest the potential 
presence of the three systems LI, L2 and T in hepatocytes, system LI 
becoming much more prominent upon incubation of hepatocytes in primary 
culture (Weissbach ef a/., 1982).
Although systems L and T could alternatively be discriminated by use 
of the system T-specific inhibitors, 4-azidophenylalanine (Fig. 3.1) or 
D-tryptophan (Vadgama & Christensen, 1985), the situation is further 
complicated by the identification of yet another Na+-independent system, 
termed asc, which was found to be inhibited by BCH in foetal rat erythroid 
cells (Vadgama et al., 1987). The realization over the past decade that 
Na+-independent transport cannot be ascribed to a single transport agency 
(system L) as previously suspected has undoubtedly left a degree of 
non-clarity in the identification of Na+-independent transport systems at 
present. However, regardless of the absence of absolute characterization of 
the various systems, it seems quite clear that BCH may have to relinquish its 
position as a specific model substrate at least in some cell types. In respect 
of this possibility, another analogue, 3-aminobicyclo-[3.2.1]octane-3- 
carboxylic acid (BCO) with a higher affinity for system L than
BCH, has been developed (Christensen et al., 1983). However, to my 
knowledge, application of this inhibitor to the discovery of further 
heterogeneity of Na+-independent neutral amino acid transport, has not been 
accomplished.
Recently another inhibitor, azaserine, has presented itself as
a useful tool for studying the L system in a different way. Following 
photolysis of radiolabelled azaserine in a suspension of lymphocytes, 
radioactivity was detected within a crude cytoplasmic membrane preparation 
and this could be inhibited by an excess of BCH. Furthermore the photolysis 
results in a specific irreversible inhibition of L system transport meaning that 
the radiolabelled product is likely to be associated with the membranes at or 
near the L system transport site (Segel et al., 1989). The importance of this 
work is that it could provide an initial step towards the identification of the 
transport protein responsible for L system activity.
Some model inhibitors have been proposed for other transport 
systems. The natural p-amino acid, taurine (Fig. 3.1), serves adequately as a
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model substrate for the Na+-dependent p-system (Christensen, 1979). With 
regard to the cationic transport system originally called Ly+, arginine and 
homoarginine (Fig. 3.1) tend to be used as model substrates because they 
do not readily lose the positive charge from their side chain. This is in 
contrast to lysine which has been shown to be transported by the neutral 
amino acid systems in addition to the Ly+ system at least in the Ehrlich cell 
(Christensen & Liang, 1966a). The situation with regard to transport of 
anionic amino acids is more complicated due to the presence of four distinct 
systems (Christensen, 1989). The only one which may have the potential to 
be identified by use of a model substrate, and only in human skin fibroblasts, 
foetal hepatocytes and HTC cells, is system Xc", as this is the only one with
the capacity to transport cystine (see Fig. 3.1) (Bannai, 1984). By utilization 
of any of these specific transport system inhibitors, the total inhibitable portion 
of transport at saturating concentrations of inhibitor can be determined from 
the reciprocal of the y-intercept from a plot of 1/(Vo-v;) versus 1 /[l]  (Inui & 
Christensen, 1966). The parameters Vq and v; are the transport rates in the 
absence and presence of inhibitor respectively and [I] is the concentration of 
inhibitor.
3.1.1.2 Kinetic analysis
A common feature of the representation of amino acid transport rate 
versus substrate concentration is the presence of a non-saturable component 
of uptake (Fig. 3.2a) which only becomes evident at higher substrate 
concentrations (Oxender & Christensen, 1963). A method for the analysis of 
this type of kinetic data is by the use of a Hanes plot (Fig. 3.2b) to determine 
independently the kinetic parameters of a carrier-mediated uptake process 
regardless of the presence of a linear component (Sepulveda & Smith, 1978). 
These authors claim that the linear component of transport should be 
non-mediated to ensure non-interference with calculations of kinetic 
parameters. Evidence has however been reported that suggests that the 
non-saturable uptake observed in the Ehriich cell and the rat jejunum is not a 
result of simple diffusion but of a very low-affinity carrier-mediated uptake 
process (Christensen & Liang, 1966b).
Even after correction for non-saturable uptake, kinetic analysis of 
transport is still open to misinterpretation. Lineweaver-Burk or Eadie-Hofstee
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plots of transport kinetic data showing linearity could be interpreted as 
corresponding to a homogeneous transport route. Heterogeneity of transport 
can however remain undetected if the kinetic parameters for the two 
processes are not sufficiently different (Christensen, 1985). Similarly, 
observation of biphasic kinetics has often been interpreted as an indication of 
the presence of at least two distinct transport systems. A contribution of 
cooperativity to the kinetic data cannot however be ruled out without 
additional experimental approaches (Christensen, 1985). Further to these 
iimitations, kinetic analysis provides no means for the actual assignment of 
amino acid transport systems to one of those already characterized. Kinetic 
data without further characterization was used to observe heterogeneity of 
serine and glycine transport but homogeneity of proline transport in isolated 
chick embryo heart cells (Guidotti et ai, 1971). The transport of glycine by 
two distinct systems in HTC cells (Christensen & Handlogten, 1981) was 
characterized on the basis of preliminary observations of biphasic kinetic data 
(Reichberg & Gelehrter, 1980).
The induced expression of a transport system upon administration of 
certain stimuli can often be observed by kinetic analysis. The emergence of 
a low-capacity, high-affinity transport system for AIB upon treatment of 
isolated rat hepatocytes with insuiin or glucagon was demonstrated by kinetic 
analysis (Fehlmann etal., 1979a). Similarly, biphasic kinetics were observed 
for the uptake of AIB and MeAIB in isolated hepatocytes from fasted rats 
whilst cells from fed rats yielded linear data (Fehlmann et al., 1979b). 
Another interesting observation of possible importance to neoplastic 
transformation is the absence in HTC cells of one of the two Na+-independent 
transport systems (LI or L2) present in hepatocytes in primary culture. This 
conclusion was based on the observation of linear versus biphasic kinetics for 
histidine uptake by HTC cells and normal hepatocytes respectively 
(Weissbach etal., 1982).
A further use of kinetic data is in the comparison of the K^ for 
transport of particular substrates with the K; for their competitive inhibition of 
the uptake of each other. When the K^ equals the K;, it is highly probable 
that the two substrates in question share the same transport system, as was 
shown for the Na+-independent uptake of methionine, valine and leucine in 
the Ehrlich cell (Inui & Christensen, 1966). If the parameters K^ and K; are
significantly different, the substrates in question are considered not to share 
the same transport system. Both circumstances were illustrated by kinetic
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analysis of the uptake of glycine, alanine, serine, proline and sarcosine into 
the pigeon erythrocyte (Eavenson & Christensen, 1967). The measured 
for glycine was equal to the K; for the inhibition of sarcosine uptake by 
glycine, whereas the K; values for the inhibition of uptake of serine, alanine 
and proline by glycine differed from its by an order of magnitude. These 
results indicated that glycine and sarcosine shared a transport system which 
was not responsible for the uptake of serine, alanine or proline. These 
conclusions are valid only if kinetic analysis has been applied for a 
homogeneous transport process; this is a reasonable assumption for these 
studies in the pigeon erythrocyte because the absence of system A means 
that transport of amino acids such as serine and alanine is likely to occur only 
by system ASC. However, it was the overlooked heterogeneity of methionine 
uptake by the Ehrlich cell which resulted in the and K| values describing
the interaction between methionine and glycine being inconsistent with each 
other. This led to a false conclusion that methionine and glycine do not share 
the same transport system. Subsequent studies have however established 
that approximately half the uptake of methionine and nearly all the uptake of 
glycine actually occurs by system A in the Ehrlich cell (Christensen,1969).
3.1.1.3 Characterization of the ASC system
The absence of a specific inhibitor for the ASC system to date has 
made unequivocal characterization of this system difficult. The frequent 
attribution of a Na+-dependent MeAIB-insensitive portion of transport to the 
ASC system is not satisfactory, as illustrated by the transport of glutamine by 
system N in rat hepatocytes (Kilberg et al., 1980) and the transport of glycine 
by system Gly in HTC cells (Christensen & Handlogten, 1981). Measurement 
of the inhibition of uptake of a potential substrate via the ASC system by a 
large range of inhibitors is useful, as illustrated by the characterization of 
system ASC in CHO cells (Shotwell et al., 1981). Discrimination of the ASC 
system from the A system can additionally be aided by its lower sensitivity to 
decreased pH and to metabolic inhibitors and its greater stereospecificity 
(Christensen et al., 1967). Furthermore, the V^ax values for transport by
system A tend to be similar whereas those for the ASC system are 
characteristically variable (Christensen, 1969).
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Some special cases for the characterization of the ASC system have
been reported. As mentioned earlier, the system can be studied in the
absence of system A in the pigeon erythrocyte (Eavenson & Christensen, 
1967) and in the rabbit erythrocyte (Winter & Christensen, 1965). The only 
other Na+-dependent transport system for neutral amino acids known to
occur in these cells is the Gly system. This system is however specific to
glycine and sarcosine and its presence should not therefore interfere with the 
uptake of any ASC substrates. In certain other cell types the ASC system 
has been characterized through recognition of specific substrates. The 
minimal involvement of system ASC in glycine transport in HTC cells was 
supported by threonine being the most specific substrate for the ASC system 
in these cells (Christensen & Handlogten, 1981). In isolated rat hepatocytes 
cysteine was identified as a specific substrate on the basis that MeAIB could 
not inhibit any of its Na+-dependent transport (Kilberg et al., 1979). In 
contrast, two systems were implicated in cysteine transport in rat liver slices 
as a result of observed biphasic kinetics but no distinction between 
Na+-dependent and Na+-independent activity was made in this study 
(Crawhall & Davis, 1971). More importantly Na+-dependent cysteine 
transport into human liver plasma membrane vesicles occurs via system A, 
system ASC and a third system yet to be characterized (Mailliard and Kilberg, 
1990).
3.1.2 Sodium dependence of amino acid transport
Whether or not the uptake of amino acids by the various transport 
systems so far characterized is dependent on Na+ is shown in Table 3.1. 
Effects of alkali-metal ions on amino acid transport had been established as 
early as the 1950s but it was not until 1967 that amino acid influx was shown 
to be associated with an actual influx of Na+, at least in the pigeon 
erythrocyte (Wheeler & Christensen, 1967). Most initial work studying 
Na+-dependence was carried out on the erythrocyte because of the 
conspicuous absence of the Na+-dependent system A capable of transporting 
a large range of amino acids. In these cells, the Na+-dependent transport of 
most neutral amino acids is accomplished via either system ASC or system 
Gly. Heterogeneity of Na+-dependent transport is therefore not a problem 
because these two systems do not share the same substrates.
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The transport of glycine by system Gly of the pigeon erythrocyte may 
be associated with two sodium ions because of observed non-hyperbolic 
kinetics for the effect of Na+ concentration on glycine uptake (Vidaver, 1964). 
This conclusion has been reinforced for the uptake of glycine in HTC cells 
(Christensen & Handlogten, 1981). An alternative method used to assign 
stoichiometries to amino acid and Na+ influx involves calculation of a coupling 
ratio (Koser & Christensen, 1971). This value describes the observed 
increase in Na+ influx associated with the presence of an extracellular amino 
acid relative to the increase in influx of that same amino acid because of the 
presence of Na+. A value not significantly different from 2 obtained for 
glycine and Na+ uptake by the pigeon erythrocyte (Wheeler & Christensen, 
1967) was in agreement with the results of Vidaver. However, similar 
calculations for a number of ASC substrates revealed values ranging from 0.2 
for proline to 4.5 for cysteine despite observation of first-order kinetics of 
amino acid uptake for Na+ (Koser & Christensen, 1971). Evidence that the 
composition of the intracellular amino acid pool as well as the structure of the 
extracellular amino acid being transported affected the coupling ratio led to 
the formulation of an alternative hypothesis. This suggested that the variable 
coupling ratios were not due to differing stoichiometries between particular 
amino acids and Na+ but rather that the different amino acid structures 
dictated whether only the amino acid or only the Na+ were replaced inside the 
cell for ensuing efflux. If Na+ was retained on the transporter, then the 
apparent measured Na+ influx would be smaller than the real influx and the 
coupling ratio correspondingly lower. Structures causing rapid replacement 
of Na+ at the intracellular side of the membrane would result in higher 
coupling ratios (Koser & Christensen, 1971).
Studies involving arginine uptake by the Ehrlich cell and the rabbit 
reticulocyte revealed inhibition of this process by neutral amino acids only in 
the presence of Na+ (Thomas etal., 1971). These results suggested that the 
Na+ fulfilled the normal role of the cationic group distal to the a-carbon 
present in the side chain of usual substrates for the Ly+ system. This 
observation inspired experiments for the determination of the spatial position 
of Na+ with respect to amino acids transported by the ASC system (Thomas 
& Christensen, 1971). Based on the strength of interaction between an 
amino acid and its transporter in the presence of Na+, it was concluded that 
the two co-substrates bind in juxtaposition at the receptor site, the Na+ 
binding directly between the receptor and the amino acid. Similarly, Na+ was
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thought to bind close to the amino acids transported by system A but in this 
case at a position much closer to the a-carbon (Christensen & Handlogten,
1977). This latter study was based upon the ability of Li+ to substitute for Na+ 
to varying degrees in system A, whereas in system ASC Li+ makes no 
observable contribution to amino acid uptake. This is in contrast to 
suggestions that Li+ may reliably substitute for Na+ for ASC transport in 
isolated rat hepatocytes and may indeed be used to identify this system 
(Edmondson etal., 1979).
The effect of increasing Na+ concentration on amino acid uptake is to 
decrease the Km for the amino acid whiist leaving Vmax unaffected. This
result indicates that the translocation of amino acid plus Na+ across the 
membrane is not rate-determining (Koser & Christensen, 1971). Contrasting 
results were again obtained for AIB transport into isolated rat hepatocytes 
where Na+ was found to affect Vmax hut not Km (Le Cam & Freychet, 1977).
However, these results are difficult to interpret because of the heterogeneity 
of AIB transport in these cells.
Na+-dependent transport often results in the net uphill accumulation of 
amino acids and the energy required for this active process was thought to be 
derived from the Na+-gradient maintained by the Na+-K+-ATPase. However 
it is now apparent that, although energy may well be derived in this way, ATP 
hydrolysis and possibly H+ movements could also be important (Christensen 
et a!., 1973). A role of reducing equivalents supplied by mitochondria has 
also been suggested as well as a possible involvement of an NADH 
dehydrogenase located in the plasma membrane (Christensen, 1977).
3.1.3 Regulation of amino acid transport
Characterization of amino acid transport has now been studied 
extensively in a large number of different cell types and tissues but the 
concept of regulation of this process is still poorly understood. Adaptive 
regulation (in response to the availability of amino acids) and hormonal 
effects are two forms of regulation of transport which have been identified. 
Furthermore, some changes in the transport of amino acids have been 
associated with development and neoplastic transformation.
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3.1.3.1 Adaptive regulation
The term adaptive regulation defines the phenomenon whereby 
transport of certain amino acids is shown to increase upon incubation of cells 
in amino acid-free medium. The early work studying this concept in isolated 
chick embryo heart cells formally identified system A as the only transport 
system responsible for this increased uptake (Gazzola etal., 1973). Inclusion 
of an amino acid known to be a substrate for the A system in the amino acid- 
free medium repressed the stimulation but substrates for the L system did not 
(Gazzola et al., 1972). In contrast to this view is the ability of threonine, 
phenylalanine, tyrosine and tryptophan to cause repression in HTC cells 
(Heaton & Gelehrter, 1977). The mechanism by which some amino acids 
exert these repressive effects is not known but experiments using inhibitors of 
protein synthesis (cycloheximide) and RNA synthesis (actinomycin D) 
suggest a role of translation and transcription respectively (Gazzola et al., 
1972). In a series of experiments in which cells were first incubated in amino 
acid-free medium containing cycloheximide followed by transfer to amino 
acid-free medium containing actinomycin D, alanine was only able to repress 
a stimulatory response if initially included along with the cycloheximide. This 
resuit was interpreted as evidence that system A substrates may cause 
repression of adaptive regulation at the level of transcription (Franchi- 
Gazzola et al., 1973). Such a mechanism is thought to be exerted by the 
system A substrates per se rather than by possible metabolites since non- 
metabolizable analogues such as MeAIB also induce repression (Gazzola et 
al., 1973). The increase in transport activity is associated with an increase in 
Vmax with no change in Km in chick embryo heart cells (Gazzola et al., 1972)
and in monolayer cultures of rat hepatocytes (Kelley & Potter, 1978), 
consistent with a model involving synthesis of extra carrier proteins. The 
latter results ought, however, to be interpreted with caution because AIB 
transport by the ASC system was overlooked on the grounds that it 
contributed to only 5% of total transport, albeit only at the one concentration 
tested.
Adaptive regulation has been demonstrated in a number of cell types 
and is not surprisingly absent in erythrocytes which lack both the A system 
and active gene transcription (Guidotti et al., 1975). In macrophages and 
thymic lymphocytes adaptive regulation is restricted to a discrete subgroup of 
amino acids including proline, glycine and AIB, the transport of serine and
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alanine being noticeably unaffected by derepressive conditions (Guidotti et 
al., 1975). This observation is most likely explained by the preferential 
transport of serine and alanine by an alternative system in these cells, a view 
consistent with more recent studies with mouse peritoneal macrophages in 
which virtually all serine and alanine transport is attributed to system L (Sato 
etal., 1987).
The more recently characterized system N in hepatocytes has also 
been shown to be responsive to amino acid starvation aithough not to so 
great an extent as for system A (Kilberg et al., 1980). In this case, only one 
substrate, histidine, was able to repress the response, glutamine and 
asparagine being ineffective (Handlogten etal., 1982a). Furthermore, MeAIB 
which is neither a substrate nor an inhibitor of system N exhibited repressive 
action. It is also of interest that glutamine is transported to a certain extent by 
system A and does repress this system (Handlogten et al., 1982a). The 
anionic transport system for glutamate and cystine, Xq~, is also responsive to
adaptive regulation in human skin fibroblasts (Dall'Asta etal., 1983).
System L is generally believed not to undergo adaptive regulation 
although an increase in activity was observed in Chinese Hamster Ovary cells 
in response to leucine deprivation or to a lesser extent to starvation from 
valine, isoleucine or phenylalanine (Shotwell & Oxender, 1983). This 
derepression was different to that seen for system A in that leucine starvation 
was effective even in the presence of other amino acids and control appeared 
to be exerted at the level of translation and not at transcription. The general 
lack of response of system L to amino acid deprivation, together with the 
observation that adaptive regulation is associated with increases in efflux as 
well as influx in monolayer cultures of rat hepatocytes, implies that system A 
is involved in efflux and not just system L (Kelley & Potter, 1978). The 
problem that the increased efflux in starved cells was due to higher 
accumulated intracellular concentrations of AIB relative to that in control cells 
was overcome by using different extracellular concentrations of AIB to give 
comparable intracellular concentrations. Under these conditions efflux was 
still stimulated in starved cells (Fehlmann etal., 1979b).
A totally distinct concept which should not be confused with adaptive 
regulation of system A is that of trans-inhibition when pre-accumulated 
system A substrates inhibit further uptake by that system (White & 
Christensen, 1983). The possibility that amino acid starvation could cause 
increased transport activity by a release from trans-inhibition is unlikely
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because the adaptive response is not apparent after incubation times during 
which the intracellular amino acid pools have already been depleted, at least 
in HTC cells (Heaton & Gelehrter, 1977). Furthermore, the loading of cells 
with an appropriate amino acid after starvation did not inhibit the adaptive 
response. In contrast, starved monolayer cultures of rat hepatocytes did 
exhibit a rapid decline in stimulated transport activity upon incubation with 
AIB; this was attributed to trans-inhibition but, in addition, a slower decrease 
was also observed and this was attributed to repression by accumulated AIB 
(Kelley & Potter, 1978). It is possible that this difference arises from an 
inability of the neoplastic cell to respond to trans-inhibition.
3.1.3.2 Hormonal effects on amino acid transport
At about the same time that adaptive regulation was defined, 
stimulatory effects of insulin on amino acid uptake by isolated chick embryo 
heart cells were also observed (Guidotti etal., 1969). These effects were due 
to an increase in V^ax while leaving the K^ unaltered at least with respect to 
serine uptake (Guidotti etal., 1971). In fact, increases in V^ax is normally the 
way in which hormones exert their effects on amino acid transport (Shotwell 
et al., 1983). Glucagon was shown to stimulate the uptake of AIB in isolated 
rat hepatocytes by a mechanism which involves cyclic AMP and an increase 
in the initial rate of system A only (Le Cam & Freychet, 1976). Insulin also 
stimulated the activity of system A in the same cell type (Fehlmann et al., 
1979a). In addition to system A, glucagon and experimental diabetes also 
stimulated activity of system Ly+ and to a lesser extent of systems ASC and 
N, but no effect on systems LI or L2 were observed in isolated rat 
hepatocytes in primary culture (Handlogten & Kilberg, 1984).
Hormone-stimulated system A activity decays to a basal level with a 
half time of 1.5h if hepatocytes are transferred to a medium lacking hormone 
but with substrate amino acids present (Handlogten & Kilberg, 1984). Such 
decay does not occur in the total absence of amino acids but addition of a 
single substrate amino acid, whether metabolizable or not, will initiate the 
decay (Handlogten e ta l, 1985). Trans-inhibition is unlikely to be a possible 
cause of this effect because inhibitors of RNA or protein synthesis prevent 
the decay (Handlogten & Kilberg, 1984). The current hypothesis for the 
mechanism of hormone action on system A suggests that a newly-
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synthesized mRNA and protein, termed the Transport Inactivating Protein 
(TIP)", influences the expression of the system (Kilberg, 1986). This 
postulated protein appears to be translated from mRNA which does not 
require polyadenylation because cordycepin and adenine-9-p-D- 
arabinopyranoside (ara-A) are unable to prevent decay of glucagon-induced 
transport activity (Handlogten etal., 1985).
Insulin and glucagon are by no means the only hormones to influence 
amino acid transport and a summary of hormonal effects on this process has 
been presented recently (Christensen & Kilberg, 1987).
3.1.3.3 Changes in amino acid transport associated with development, 
maturation and neoplastic transformation
One of the first developmental patterns for which changes in amino 
acid transport were realised was the maturation of the red blood cell from the 
blast cell to the reticulocyte to the mature erythrocyte. Maturation of the 
rabbit reticulocyte involved a loss of saturable concentrative transport of 
alanine and glycine whilst saturable non-concentrative transport was retained 
(Winter & Christensen, 1965). Further studies revealed that the cationic 
amino acid transport system was also retained to a considerable degree at 
maturity and that the uptake of alanine was lost much more rapidly than the 
uptake of glycine (Antonioli & Christensen, 1969). The maturation process in 
rat erythroid cells was shown to involve a loss of Na+-dependence, which 
would be consistent with loss of concentrative transport, as well as a 
reduction in the number of transport systems (Wise, 1976). Erythroblastic 
leukaemia cells were used as the most immature cells and were shown to 
exhibit transport properties characteristic of system A which almost totally 
disappeared in the reticulocyte. The activity of this system with respect to 
MeAIB uptake was also very low in the rabbit reticulocyte (Winter & 
Christensen, 1965) and these observations suggest that either system A 
activity is decreased upon maturation of the erythroblast to the reticulocyte or 
that its expression is characteristic of the neoplastic erythroid cell. Later 
studies with foetal erythroid cells confirmed a developmental pattern of 
system A expression (Vadgama et al., 1987) which indicates its importance in 
the normal immature erythrocyte as well as in the erythroblastic leukaemia 
cell (Wise, 1976).
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The possible importance of system A for cell proliferation is 
exemplified on studies with lectin-stimulated normal human lymphocytes. 
The transition of lymphocytes from the resting to the proliferative state upon 
interaction with phytohaemaggiutinin or concanavalin A is considered a useful 
model for studying biochemical events associated with neoplastic 
transformation and has been shown to involve an increase in AIB uptake in 
both rat lymphocytes (Van den Berg & Betel, 1971) and human lymphocytes 
(Mendelsohn et al., 1971). This effect is probably attributable to system A, 
but increased activities of transport systems L and ASC have also been 
observed upon : lectin-stimulation of human lymphocytes (Segel & 
Lichtman, 1981). Mitogenic stimulation of pig lymphocytes also resulted in an 
increase in ASC activity as well as the emergence of system A (Borghetti et 
al., 1981). In addition, AIB uptake was shown to be higher in polyoma 
virus-transformed baby hamster kidney (BHK) 21 cells and Simian Virus 40 
(SV-40)-transformed BALB/3T3 (mouse fibroblast) cells compared to their 
non-transformed counterparts (Isselbacher, 1972) and also in four hepatoma 
cell lines compared to the normal hepatocyte (Kelley et al., 1978). The 
increased transport of AIB in the hepatoma may not however necessarily be 
via system A because of the involvement of the ASC system in the transport 
of this amino acid in the hepatocyte (Le Cam & Freychet, 1977; Kilberg et al., 
1979). Recent experiments have used foetal hepatocytes transformed with a 
temperature-sensitive mutant of SV-40 which enabled a change from rapid 
growth at a growth-permissive temperature of 33°C to full differentiation at a 
growth-restrictive temperature of 40°C. Cells grown at 33°C showed high 
rates of system A transport which was at least halved within 24 hours of 
transfer of the cells to 40°C (Handlogten & Kilberg, 1988). All these 
observations suggest that system A is an important transport system for 
proliferating cells and it has recently been implicated as the main growth 
regulatory system and possible target of oncogene action (Saier etal., 1988).
Whereas increases in system A activity tend to be associated with 
neoplastic transformation, decreases in system L activity have been observed 
in chronic leukaemia of B lymphocytes compared to normal blood 
lymphocytes (Segel & Lichtman, 1982). Human blood contains a much larger 
proportion of T cells than B cells which suggests that the decreased L system 
activity may be due to the immunological subtype of the cells rather than to 
their neoplastic nature. This was shown not to be the case however from 
further experiments which compared leukaemic B lymphocytes with a
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preparation of B lymphocytes from human blood free from contaminating T 
cells (Segel et ai, 1984). Furthermore, the differentiation and maturation of 
chronic leukaemic B lymphocytes which resulted from treatment with phorbol 
ester coincided with a restoration of system L activity (Woodlock etal., 1988). 
When factors which arrest celi growth were applied to cultured BALB/3T3 
mouse cells, an increase in system L activity was noted together with a 
decrease in that of system A (Oxender et al., 1977). Thus rapid proliferation 
seems to be associated with increased system A and decreased system L 
activity while the converse appears to be true upon differentiation, maturation 
and cessation of cell growth.
The transport system for cationic amino acids shows a similar 
developmental pattern in rat hepatocytes to that observed for system A in 
erythrocytic cells. Regression of system Ly+ occurs during maturation of the 
rat hepatocyte but the system reappears in the hepatoma cell (White & 
Christensen, 1982). These workers discuss the possible importance of the 
inability of the hepatocyte to transport arginine as a means of maintaining 
high enough concentrations of this amino acid in the plasma together with the 
possible necessity of the Ly+ system activity for neoplastic transformation. 
Similarly, the activity of a Na+-independent anionic amino acid transport 
system transporting cystine and glutamate, x^-, is expressed in foetal
hepatocytes and hepatoma cells but not to any great extent in the adult 
hepatocyte (Makowske & Christensen, 1982). Other workers have reported a 
minimal activity of this system in the adult hepatocyte and transport by this 
system can be further induced by insulin and dexamethasone (Takada & 
Bannai, 1984). In contrast to systems Ly+ and Xq-, system N has been
specifically reported to exhibit constant properties regardless of whether cells 
are studied at the foetal, differentiated or cultured hepatoma stages 
(Vadgama & Christensen, 1983).
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3.2. Results and Discussion
3.2.1. intracellular volume of MOLT-4 cells
Centrifugation of cells through a silicone oil layer inevitably results in a 
proportion of extracellular fluid being carried down with the cells. The 
contribution of this extracellular volume to the total volume was assessed by 
measurement of the [U-'i^CJsucrose- and pH]water-permeated spaces 
simultaneously. Radioactivity measured from [U-l^CJsucrose in the 
acid-soluble fraction below the silicone oil corresponds to that found in the 
extracellular space only because sucrose does not permeate the plasma 
membrane. The tritiated water readily equilibrates throughout the 
extracellular and intracellular spaces and this therefore enables 
measurement of the total space centrifuged through the oil. A simple 
subtraction of the extracellular space from the total space allows the 
intracellular space (ICW) to be calculated. These measurements were 
carried out in each individual experiment. The overall mean for cells 
suspended in Earle's Balanced Salts Solution (EBSS) was 1.16 ± 0.094p,l 
ICW per 10® cells (mean ± S.E.M.; n=26) compared to 1.36 ± 0.050|xl ICW per 
10® cells (mean ± S.E.M.; n=13) for cells suspended in Hepes-buffered 
medium. These two values are not significantly different (P<0.1). The 
percentage of the ICW relative to the total space centrifuged through the oil 
was different for the two media; 70 ± 1.5% (mean ± S.E.M.; n=26) and 
86 ± 0.6% (mean ± S.E.M.; n=13) for EBSS and Hepes-buffered medium 
respectively. This difference is significant (/?<0.001) and could be because of 
the larger volume of cell suspension centrifuged through the oil in 
experiments in which Hepes-buffered medium was used. The mean volume 
of total space centrifuged through the oil in the Hepes-buffered medium 
experiments was 1.40 ± 0.067\l\ (mean ± S.E.M.; n=13) compared to 
0.58 ± 0.056|xl (mean ± S.E.M.; n=26) in the EBSS experiments (P<0.001).
In each experiment, the transport data obtained were calculated as 
nmol serine transported per \l\ ICW. The resulting values were converted to 
nmol serine transported per 10® cells using the overall means for p,l ICW per 
10® cells given above for the appropriate medium. This enables comparison 
of the transport rates with other metabolic fluxes measured in the cells.
The total cell volume for normal human lymphocytes has been 
measured as approximately 0.2|xl per 10® cells (Segel et a!., 1981). This
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value does not exclude the contribution of macromolecular structures, such 
as membranes for example, to the total cell volume and therefore the actual 
volume of intracellular water will be lower. These results therefore show that 
the volume of the transformed lymphocyte, as represented by the MOLT-4 
cell, is at least six times larger than that of a normal lymphocyte.
A number of alternative methods have been used for determination of 
actual intracellular volume. Some have simply employed alternative 
extracellular markers such as [‘i^Cjpolyethylene glycol (Fehlmann et al., 
1979b) or pH]inulin (Finkelstein & Adelberg, 1977). Others involve using 
[I4c]urea (Elsas et al., 1975) or differences between wet and dry weights 
(Finkelstein & Adelberg, 1977) as a measure of the total water space. These 
methods can only be used with celis in suspension, and therefore 
determinations of intracellular volumes for cells growing in monolayer culture 
would involve their removal from the substratum and thus disruption of their 
normal morphology. A method using the non-metabolizable sugar, 
3-O-methyl-D-glucose, was therefore developed to measure the Intracellular 
space of cells which remain attached to a culture flask (Kletzien et al., 1975). 
This method relies upon the fact that hexose transport attains an equilibrium 
when the intracellular concentration is equal to the extracellular concentration 
of the sugar and that the compound is not metabolized or irreversibly 
sequestered in the cell. Once these conditions have been satisfied, a plot of 
nmol 3-O-methyl-D-glucose taken up per 10® cells at equilibrium versus the 
extracellular concentration (mM) gives a straight line which passes through 
the origin, the slope of which is equivalent to jil ICW per 10® cells. Examples 
of studies in which these various methods have been used are shown in 
Table 3.2.
3.2.2. Serine influx In MOLT-4 cells
3.2.2.1. Time course for serine influx
The time course for serine influx into MOLT-4 cells suspended in 
EBSS is shown in Fig. 3.3. Rates measured up to Imin suggested that the 
initial rate was linear only up to 20s. However, inclusion of the 5min point in 
the initial rate measurements indicated that linearity was evident over a 5min 
time course. The initial rate calculated from incubation times up to and
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including 5min was 113nmol serine transported/h per 10® cells. This value is 
comparable to that observed in studies in a mouse lymphocytic cell line, 
GF-14 (120nmol serine/h per 10® cells), which utilized modified EBSS and 
the same concentration of serine (Finkelstein & Adelberg, 1977). In this 
study steady-state was achieved at lOmin but in the present studies it is not 
clear whether or not steady-state has been achieved by 20min or indeed by 
40min. Assuming that steady-state has been attained by 40min, and that no 
significant metabolism occurs from [3-i^C]senne in cells suspended in EBSS, 
these results indicate that serine from the extracellular medium has 
accumulated to an intracellular amount of 21.3nmol serine per 10® cells. This 
is equivalent to 18.3nmol serine per |xl ICW which in turn is equivalent to an 
intracellular serine concentration of 18.3mM. The extracellular serine 
concentration is 0.25mM and therefore the concentration gradient for serine 
across the plasma membrane is 73-fold.
Earle's Balanced Salts Solution does not contain any amino acids and 
therefore represents a non-physiological environment for the cells. Other 
amino acids would be expected to compete with serine for transport into cells 
and may therefore significantly affect both the initial rate of serine influx and 
the concentration gradient. The time course for serine uptake into cells 
suspended in Hepes-buffered medium, which does contain other amino 
acids, is shown in Fig. 3.4 and clearly demonstrates this point. Initial rates 
were measured under zero-trans (cold serine added simultaneously with 
[3-i4C]serine) and steady-state (cells preincubated with cold serine before 
addition of [3-i4C]serine) conditions. The zero-trans condition is directly 
comparable to the EBSS experiment and the initial rate was linear for at least 
Imin and measured as 22.0nmol serine/h per 10® cells, only 19.5% of the 
initial rate measured in EBSS. The initial rate measured under steady-state 
conditions is more relevant to a physiological situation and was linear over 
5min with a value of 29.4nmol serine transported/h per 10® cells.
Incorporation of radioactivity into the acid-soluble material clearly does 
not reach steady-state values by 20min which may be due to metabolism of 
the [3-l4C]serine. Extrapolation of the linear rate of metabolism observed at 
the longer incubation times to zero time indicates that the [3-i4C]serine 
accumulates to an intracellular concentration of between 3-4mM (see 
Fig. 3.4). This is the concentration of serine resulting from the concentrative 
uptake of extracellular serine and does not include intracellular serine derived 
from endogenous sources such as glucose.
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3.2.2.2. Characterization of serine influx
A number of distinct neutral amino acid transport systems have been 
described with the capacity to transport serine. In many cases selective 
inhibitors of individual components of total transport have been employed to 
characterize the systems which operate in particular tissues and the extent to 
which these systems contribute to total transport of an amino acid. In this 
study, system L activity has been assigned to that inhibited by 
2-aminobicyclo-[2.2.1]heptane-2-carboxylic acid (BOH; see Fig. 3.1) 
(Christensen etal., 1969) and system A to that inhibited by 2-(methylamino)- 
isobutyric acid (MeAlB; see Fig. 3.1) (Christensen et a/., 1965) or by 
2-aminoisobutyric acid (AIB) since this compound showed exactly the same 
inhibition profile for serine uptake as did MeAIB. BCH inhibited serine uptake 
into MOLT-4 cells by 20% and MeAIB by 55%, both at saturating 
concentrations of inhibitor and in the absence of other amino acids (Fig. 3.5). 
In an attempt to identify the remaining component of transport a number of 
other amino acids and amino acid analogues were tested as inhibitors of this 
component of serine uptake. Those which exhibited less than 50% inhibition 
are shown in Table 3.3. Total absence of inhibition by lysine dismisses the 
Ly+ (White et al., 1982; White & Christensen, 1982) and the more recently 
characterized B°,+ system (Van Winkle et a!., 1985) as potential candidates 
for this component of serine transport. Likewise poor inhibition by L-histidine 
and L-phenylalanine precludes any role by system N (Kilberg et a!., 1980) or 
by system T (Rosenberg et a!., 1980) respectively. An alternative 
N-methylated amino acid to MeAIB, namely N-methyl-L-alanine did not inhibit 
this system nor did serine where the a-proton had been replaced by a methyl 
group. The intermediate inhibitory effects of ' :, proline and glycine may
be due to iow affinity of these compounds for the transport system but is also 
suggestive of the existence of more than one system.
It has been suggested that the transport of alanine across the apical 
membrane of confluent kidney cells measured under conditbns for ASC 
transport occurs through two distinct systems (Boerner et ah, 1986). During 
growth of these cells, transport activity supposedly attributable to system ASC 
increased; this was in fact because of the induction of a second transport 
system as evidenced by distinct inhibition profiles of alanine transport 
between subconfluent and fully confluent cells. One transport component 
was assigned to system ASC and the other to a novel system, termed
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system G, with affinity for basic and neutral amino acids. The inability of 
lysine to inhibit the unidentified component of serine uptake in MOLT-4 cells 
rules out system G as a potential candidate.
Compounds inhibiting the uptake of serine by more than 50% are 
shown in Table 3.4. Inhibition by excess unlabelled serine indicates that a 
saturable process is responsible for greater than 90% of the uptake and 
eliminates any major role for passive diffusion. Alanine, asparagine and 
threonine exhibited over 80% inhibition and are all recognised as common 
ASC substrates. The system is able to accommodate side chains containing 
hydroxyl, amido, chloro, thiol and thioester groups as well as aliphatic carbon 
chains. Preferred side chains contain at least one carbqn atom and affinity 
for the system tends to decrease with increasing carbon chain length and 
with the introduction of branching. The overall inhibition profile is very similar 
to those observed by other workers for transport activity attributable to 
system ASC in other cell types (Table 3.5). The most notable difference lies 
in the inhibition by hydroxyproline but this may be accounted for by the use of 
different isomers. The studies with HTC cells used frans-4-hydroxyproline 
which gave 94% inhibition of ASC transport whereas the lack of inhibition 
observed in MOLT-4 cells involved the use of c/s-4-hydroxyproline. This 
result is in agreement with observations that only the trans isomer has good 
affinity for the ASC system (Thomas & Christensen, 1970). Unfortunately, 
this isomer was not tested in the present study. The other two groups which 
used hydroxyproline (see Table 3.5) did not state which isomer was 
employed.
Another major difference in Table 3.5 lies in the extent of inhibition by 
glutamine, a much lower value being seen for Inhibition of serine uptake by 
system ASC in HTC cells. The possible presence of system N In these cells 
may be responsible for the decrease in the extent of inhibition of the ASC 
component by glutamine. The extent of inhibition of system ASC by 
asparagine and histidine, the other substrates for system N, was however 
similar to that observed for MOLT-4 cells. Consistent with this result is 
evidence for a system in HTC cells, similar to system N of the hepatocyte, 
that is more specific for glutamine (Handlogten et al., 1981). If the 
component of serine transport is indeed attributable to system ASC, then 
cysteine would be expected to strongly inhibit the serine uptake. This was 
indeed the case in human erythrocytes but not in the MOLT-4 cells. Inclusion 
of 1 mM-dithiothreitol did not increase the extent of inhibition by cysteine.
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This observation may be explained by division of this component of serine 
transport into two further components one of which is system ASC and the 
other a system which does not support cysteine transport.
Characterization of the ASC system is difficult due to the absence of a 
selective inhibitor. In isolated rat hepatocytes, 2-aminoisobutyric acid (AIB) 
was transported by system A and ASC whereas its N-methylated analogue 
MeAIB was selective for system A (Le Cam & Freychet, 1977; Kilberg et al., 
1979). This observation therefore presented a possible way to distinguish 
between these two systems in this cell type. However, some workers have 
shown that AIB is transported only by system A in isolated rat hepatocytes 
(Edmondson etal., 1979) and also in human liver plasma membrane vesicles 
(Mailliard & Kilberg, 1990). AIB was also not considered to be a substrate for 
the ASC system as originally described for the Ehrlich cell (Christensen et al., 
1967) nor for that defined in Chinese Hamster ovary cells (Shotwell et al.,
1981). The inhibition of the unidentified component of serine uptake in 
MOLT-4 cells by AIB was exactly the same as that by MeAIB using identical 
concentrations suggesting that AIB only interacts with the A system in these 
cells, as is the case for the Ehrlich cell, the Chinese Hamster Ovary cell and 
the human liver.
Other criteria which have been used to characterize the ASC system 
are its Na+-dependence, kinetic parameters, greater stereospecifity and pH 
sensitivity than system A and lack of adaptive regulation. The unidentified 
component of serine transport in MOLT-4 cells was indeed Na+-dependent 
(Fig. 3.6). Radioactivity recovered from [3-i4C]serine uptake over 20min, In 
the presence of 20mM-BCH and lOmM-AlB, and in EBSS in which choline 
had replaced sodium was not significantly different from that recovered at 
zero-time. This shows that the unidentified component of serine transport 
into MOLT-4 cells is therefore totally dependent on Na+ and also that any 
uptake of serine by a non-saturable process (passive diffusion) cannot be 
measured under these conditions. Since the discovery of the Na+-dependent 
ASC system by Christensen in 1967, a Na+-independent variant has been 
demonstrated in sheep and horse erythrocytes (Young etal., 1975; Fincham 
& Young, 1983). Young has proposed that Na+-dependence has been 
specifically lost from the ASC system upon maturation of the erythrocyte but 
other workers argue that the Na+-independent system is a distinct system in 
its own right, at least in the pigeon erythrocyte, already present in less mature 
cells (Vadgama & Christensen, 1985). The system was therefore designated
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asc in accordance with the convention for using lower case letters for 
Na+-independent systems and upper case letters for Na+-dependent systems 
(Bannai etal., 1984). This leads to obvious complications when considering 
the previously characterized L and T systems which are Na+-independent.
Na+-dependence cannot therefore be used to help discriminate the 
ASC system from the other possible systems but rather is necessary to 
characterize which of the two possibilities (ASC or asc) is present in particular 
tissues. With regard to the Na+-dependent ASC system, Edmondson has 
suggested that Li+ is able to substitute for Na+ for ASC transport but not for 
transport by system A in isolated rat hepatocytes (Edmondson et al., 1979). 
This is not the case for the proposed ASC transport of serine in MOLT-4 
cells. At low time points, no significant rate of serine transport was observed 
when Li+ was substituted for Na+. However, incubations for 20min suggested 
that Li+ could partially substitute for Na+ whereas choline would still not 
support any serine transport (Table 3.6).
The dependence of the initial rate of serine uptake in the presence of 
lOmM-MeAIB and 20mM-BCH on the extracellular concentration of serine 
(0.25-1 OmM) was investigated in MOLT-4 cells. A computer fit of the data to 
the Michaelis-Menten equation yields a of 11.8mM and V^ax of 1390nmol
serine transported/h per 10® cells. However the shape of the curve shows 
distinct similarities to that obtained by workers studying the uptake of serine 
by rabbit ileal mucosa where a non-saturable component of serine uptake 
was found at higher serine concentrations (16-50mM) (Sepulveda & Smith,
1978). It is therefore possible that in MOLT-4 cells the unidentified 
component of serine transport may be resolved into one saturable and one 
non-saturable component. A fit of the data to the Michaelis-Menten equation 
with an additional non-saturable component of transport included (Fig. 3.7) 
gave values for of 0.8mM and V^ax of 142nmoI serine/h per 10® cells, 
strikingly different from the values above. This value is however in good
agreement with that of 1 .OmM for the ASC system as originally described for 
the Ehrlich cell (Christensen et al., 1967). In the human erythrocyte, a for
serine of 0.3mM was determined for a Na+-dependent transport system not 
inhibited by MeAIB and with many ASC characteristics (Al-Saleh & Wheeler,
1982). A value of 3.2mM was published for an ASC-like component of serine 
transport in the rabbit ileal mucosa (Sepulveda & Smith, 1978) and 0.16mM 
for cultured human fibroblasts (Franchi-Gazzola et al., 1982). These values 
therefore differ by at least an order of magnitude depending on the source of
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the ASC system and may indicate further tissue-specific subdivision of this 
component of transport.
The non-saturable rate can also be calculated at any serine 
concentration using the diffusion rate constant of 0.25 obtained from Fig. 3.7. 
At an extracellular serine concentration of 0.25mM, the non-saturable rate is 
equal to 13.1 nmol serine/h per 10® cells whereas the saturable rate was 32.9 
nmol serine/h per 10® cells. The total rate of serine uptake into MOLT-4 cells 
not inhibited by 20mM-BCH and lOmM-AlB is therefore 46.0nmol serine/h 
per 10® cells. This is in excellent agreement with initial rates measured in 
separate experiments of 44.5 ± 2.92nmol serine/h per 10® cells 
(mean ± S.E.M.; n=15). However the apparent proportion of the non­
saturable rate (30%) of the total transport rate is not consistent with the 
observation that 10mM-serine inhibited more than 90% of its own uptake by 
the proposed ASC component at 0.25mM-serine. This result suggests that 
only 8% of the rate can be accounted for by a non-saturable process. This 
discrepancy may be because of over-estimation of the non-saturable rate and 
higher serine concentrations should be used for a more accurate 
determination of this linear component.
Determination of stereospecificity, pH sensitivity and adaptive 
regulation relative to system A could also have been used to help 
characterize this unidentified component of serine transport but were not 
studied in this report. The system was indeed stereospecific in so much as 
20mM D-serine only inhibited the uptake of 0.25mM-L-serine by 33% (Table 
3.3). However, on the strength of the structure-activity relationships and 
kinetic analysis of the component of serine uptake in MOLT-4 cells not 
inhibited by MeAIB or BCH, at least 70%, and maybe as much as 92%, of this 
uptake may be accounted for by system ASC. Thus the serine uptake into 
MOLT-4 cells suspended in EBSS at an extracellular serine concentration of 
0.25mM comprises 55% system A, 20% system L, at least 17.5% system 
ASC and a probably small non-saturable component. On the basis of similar 
Km and K; values for interactions between AIB, serine and alanine, a single
common system for these amino acids was suggested in mouse lymphocytic 
cells (Finkelstein & Adelberg, 1977). However, these workers did not use 
MeAIB as a possible means of discriminating system A from system ASC and 
their results may therefore be consistent with the operation of both systems if 
the kinetic parameters for each substrate in question were similar for the two 
systems. Furthermore, activities of systems L, ASC and A were detected in
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human lymphocytes but serine was not studied as a substrate in that report 
(Segel et al., 1983). The relative contribution of the transport systems 
involved in the uptake of serine in certain other cell types is shown in Table
3.7. All characterizations were made in amino acid-free medium and using 
concentrations of serine in the physiological range. It is interesting that the 
two tumour cell types (MOLT-4 and Ehrlich ascites) both exhibit high 
percentages for the transport of serine by system A. This transport system 
has been implicated as being important for cell proliferation and neoplastic 
transformation (see section 3.1.3.3; p. 62). In Table 3.7, no clear-cut pattern 
for the relative contributions of each system to serine uptake is evident for the 
different cell types, apart from the fact that the same transport systems are 
involved in each case. To emphasize this diverse pattern further, detailed 
studies on the uptake of O.OSmM-serine into mouse peritoneal macrophages 
revealed that 90% of the total uptake was Na+-independent and attributable 
to system L (Sato etal., 1987).
Each of these characterizations was carried out in amino acid-free 
medium and therefore represents a non-physiological environment. The 
uptake of serine into MOLT-4 cells was therefore also partially characterized 
in Hepes-buffered medium, which contains other amino acids. Under these 
conditions, contribution by system A to serine uptake (52%) was similar to 
that in EBSS (55%) but no significant contribution by system L was measured 
(Fig. 3.8). It is not unlikely that the larger neutral amino acids, the 
"preferred" system L substrates, totally compete out the serine uptake by 
system L seen in EBSS . No further characterization in Hepes-buffered 
medium was undertaken and it is therefore not possible unequivocally to 
characterize the remaining 48% of transport as system ASC.
3.2.3 Serine efflux from MOLT-4 cells
3.2.3.1 Determination of the specific activity of intracellular serine
Measurement of amino acid efflux from cells has not been studied to 
the extent of amino acid influx presumably due to the greater ease of 
measuring extracellular specific activities for influx measurements in 
comparison with the measurement of intracellular specific activities for efflux 
measurements. Determination of the intracellular specific activity of serine for
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these experiments requires determination of the radioactivity associated with 
intracellular serine together with a measurement of the intracellular serine 
concentration.
The radioactivity associated with intracellular serine at steady-state 
was calculated by measurement of the accumulation of radiolabel after 20, 40 
and 60min incubations and correction of the values obtained for any 
radioactivity associated with purine (Table 3.8). The corrected values 
indicate that after subtraction of the radiolabel incorporated into purine, no 
further metabolism is demonstrable and that a steady-state has been 
achieved. This is surprising because a linear incorporation of radiolabel from 
[3-i^C]serine into soluble pyrimidine would be expected and it would 
therefore appear that such incorporation is minor relative to that into soluble 
purine. Assuming that no metabolite of [3-’l4C]serine containing significant 
radioactivity has accumulated at steady-state, the corrected values for 
intracellular radioactivity can be considered to be associated with serine. 
Using the mean corrected value over all the time points (2799 ±160 dpm per 
|il ICW; mean ± S.D. from four separate experiments) and the mean specific 
activity of extracellular serine (941 ± 57 dpm per nmol serine; mean ± S.D. 
from four separate experiments), the intracellular serine concentration which 
results from the concentrative uptake of serine from the extracellular medium 
was calculated as 2.98mM. This value is consistent with that calculated from 
Fig. 3.4 (3-4mM).
The potential for endogenous serine synthesis requires that the total 
intracellular serine concentration be measured by an alternative method. 
Samples preincubated for 20min followed by further incubation for 20, 40 or 
60min but containing no radioactivity were treated in the same way as for the 
transport experiments and the amino acids present in the PGA layer beneath 
the oil measured using an amino acid analyser. Parallel samples served for 
intracellular and extracellular space determinations. The amount of serine 
was determined, and the knowledge of the extracellular volume centrifuged 
through the oil used to calculate the amount of serine arising through 
contamination by extracellular fluid. Only 1% of the total serine measured in 
the PGA layer was due to extracellular contamination and this correction was 
therefore ignored. The intracellular volume for individual experiments can 
then be used to calculate the nmol serine per p,l IGW which is equivalent to 
the concentration of intracellular serine expressed in millimolar terms. The 
final serine concentrations measured at each time point are shown in Table
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3.8. Although the mean data suggest that the intracellular concentration of 
serine is still rising up to 60min, differences between the values for the three 
time points are not significant {P>0.3). However, because the efflux 
measurements involved the accumulation of radiolabel over 20min only, it 
would be theoretically correct to take the value for the serine concentration at 
this time point (3.76 ± 0.44mM) for the purposes of efflux calculations. 
Therefore the specific activity of the intracellular serine can now be 
determined and was calculated as 744 dpm per nmol serine.
High intracellular concentrations of serine have been measured in 
other cell types. In the hepatocyte a value of 6.5mM was measured and 
11.1mM for the hepatoma HTC (White & Christensen, 1982). A value of 
9.2mM-serine was found for human skin fibroblasts (White et a/., 1982). The 
lower concentration of 0.3mM in mouse macrophages is consistent with the 
absence of concentrative transport of serine in these cells (Sato etal., 1987).
3.2.3.2 Measurement of serine efflux
The basis of the efflux measurements was to preincubate the cells in 
Hepes-buffered medium with [3-l^C]serine to steady-state and then to initiate 
efflux of the radiolabel by replacing the medium with that containing 
0.25mM- serine but in which the [3-i4C]serine was omitted. Total immediate 
removal of the extracellular radioactivity is not possible but adequate dilution 
of the radiolabel should minimize influx of radiolabeled serine at the point of 
initiation of efflux. In any case a correction for this influx can be made from 
the knowledge of the previously measured influx rate and the resulting 
specific activity of extracellular serine after dilution and immediately prior to 
measuring efflux. Thus the measured radioactivity which effiuxes from the 
cell is given by equation (3.1).
Measured dpm efflux = actual dpm efflux - dpm influx (3.1)
The dpm influx was calculated as 2550 dpm/h per 10® cells using an 
extracellular specific activity of 86.7 ±5.1 dpm per nmol serine (mean ± S.D. 
from four experiments) and an initial rate of serine influx of 29.4nmol serine/h 
per 10® cells (from Fig. 3.4). The measured dpm efflux was determined by 
subtracting the radioactivity remaining in the cells after appropriate times of
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efflux from the radioactivity in the cells at the initiation of efflux. This method 
assumes that all the radiolabel which effluxes from the cell is associated with 
serine. Other metabolites which will be labelled are the one-carbon 
tetrahydrofolate cofactors but these are unlikely to leave from the cell 
because they are usually polyglutamylated. Other possible metabolites, such 
as labelled purines, could not be detected in the extracellular medium; this 
supports the assumption that all radiolabel which leaves the cells is in serine. 
Incorporation of radiolabel into soluble pyrimidines seemed likely to be minor 
as compared to that into purine as mentioned earlier (section 3.2.3.1; p. 73) 
and therefore efflux of pyrimidines should not significantly affect the results if 
indeed it does actually occur. The results for the efflux of radiolabel can be 
plotted against time to determine the initial rate of measured efflux (Fig. 3.9) 
and the actual initial rate of efflux calculated from equation (3.1) as shown in 
equation (3.2).
Actual dpm efflux/h per 10® cells = 19800 + 2550 (3.2)
Thus the initial rate of efflux is 22350 dpm/h per 10® cells. Using the 
previously calculated value for the specific activity of intracellular serine (744 
dpm per nmol serine) the rate of efflux was calculated as 30.0nmol serine/h 
per 10® cells. This value is so close to the influx rate that it is possible that an 
overestimation has occurred because of efflux of radiolabel not associated 
with serine. However, the availability of an endogenous supply of serine 
sufficient to supply the requirements of the cell is an alternative explanation 
for this unexpected result. This is consistent with the higher intracellular 
serine concentration measured by amino acid analysis (3.76-4.40mM) 
compared to that measured by radiochemical uptake (2.98mM) (see Table 
3.8) although only the difference between the results for the 60min incubation 
was actually statistically significant (P<0.05).
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3.3 Conclusions
Serine infiux in MOLT-4 cells, in the absence of other amino acids, is 
accomplished via transport systems A, L and ASC. At an extracellular serine 
concentration of 0.25mM, systems A and L account for 55% and 20% of total 
transport respectively. The Na+-dependent ASC system accounts for at least 
17.5% of total transport and the remaining proportion of uptake is by a 
non-saturable process. In the presence of other amino acids (at 
concentrations present in RPMI 1640 medium; see Table 2.1; p. 45), system 
L does not participate in serine influx whereas system A activity accounts for 
52% of total transport. The remaining transport activity (48%) is presumably 
accomplished via system ASC but was not characterized further.
The fact that serine efflux is of the same magnitude as serine influx 
implies that an intracellular source of serine is also available and this 
proposal has been investigated in Chapter 5 and discussed in Chapter 7. 
Furthermore, the availability of an endogenous supply of serine may mean 
that serine transport into the MOLT-4 cell is not an important step in the 
provision of one-carbon units for nucleotide synthesis de novo. This 
possibility was addressed by the application of metabolic control analysis to 
total serine transport with respect to the pathway of purine synthesis de novo 
(Chapter 6).
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Fig. 3.1 Structures of potential model substrates for amino acid transport systems. 
The system for which the compound has been proposed as a model substrate Is shown In 
parentheses beneath the structure. For references, see text (section 3.1.1.1 ; p. 50).
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Saturable + Non­
saturable
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Nonsaturable
only
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[Substrate]
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Fig. 3.2 Theoretical plots to determine the kinetic parameters for one saturable 
component of uptake in the presence of a nonsaturable component. A. A Michaelis 
Menten plot of uptake rate (v) versus [substrate (S)] but using substrate concentrations high 
enough such that a linear portion of nonsaturable uptake can be observed. Assuming that 
only a single component of saturable uptake is present, the line can then be fitted to the 
equation v ■ ((Vmax[^])/(Km+[^l)) + (Ko[S]) where Kq is the rate constant for the 
nonsaturable uptake. B. A Hanes plot used to calculate the for a saturable component
of uptake regardless of the presence of a nonsaturable component. To create this plot, 
increasing concentrations of nonradiolabelled substrate (Sp) are regarded as inhibiting the 
uptake of that same substrate (radiolabelled) at a fixed concentration (S )^. Values (Z) 
calculated from the [Sp] divided by the portion of transport inhibited by that particular [Sp], 
are plotted versus the [Sp]. For competitive inhibition, the x-intercept, (Xj) « -Kj(1+[Sj-]/Km). 
However, for this special case, K; can be taken as being equal to Kp^  and this means that 
Kpp= - (x j  + [Sf]). The reciprocal of the slope of the line gives the saturable component of 
uptake at that particular substrate concentration and thus the Vp^ x^ can be calculated from
the Michaelis Menten equation. For an example of the use of this method, see Sepulveda & 
Smith (1978).
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Fig. 3.3. Time course for serine uptake into MOLT-4 cells suspended in EBSS. Cells 
from the late-logarithmic phase were resuspended at 1.5 x 10® cells/ml in EBSS and 4pCi 
[®H]H20 added per ml of suspension. Aliquots of 245pl were transferred to incubation tubes
and gassed with carbogen. The tubes were capped and preincubated at 37°C. Zero-time 
samples were placed on ice. Serine uptake was initiated by the addition of [3-1^C]serine 
(0.45|iCi/pmole for time points up to Imin and O.ISpCi/pmole for time points greater than 
1 min) to a final concentration of 0.25mM. Incubations were carried out for the appropriate 
time after regassing and capping as necessary. Assays were terminated by centrifugation of 
200pl cell suspension through oil. Rates are expressed as the mean ± S.E.M. from 3 
experiments and were initially measured as nmol serine transported per pi ICW. These
values were then subsequently converted to nmol serine transported per 10® cells using a 
value of 1.16pl IGW/10® cells (mean from 26 experiments; see section 3.2.1 ; p. 65).
80
‘03
03 <o“iII
C
7
6
5
4
3
2
1
0
Extrapolation  
to zero -tim e
10 20 30 400
Time (min)
â  0.5 q% ;
«<0 0.4; 
.5 o
È5 5  0.3! 
•5 t  0.2!
i  l o . i ;
ÇÜ n
0.2 0.40 0.6 0.8 1
Time (min)
Fig. 3.4 Time course for serine uptake into MOLT-4 celis suspended in Hepes- 
buffered medium. Cells from the late-logarithmic phase were resuspended in Hepes- 
buffered medium either containing 0.25mM-serine (for steady-state rate measurements) or
without serine (for zero-trans measurements) at a concentration of 2 x 10® cells/ml. To the 
suspension was added 4pCi [®H]H20 per ml and 430jil aliquots of the cell suspension were 
transferred to incubation tubes. The tubes were capped with rubber seals and lOpI 
135mM-NaHC0g added using a Hamilton syringe. Samples were preincubated at 37®C for 
20min. Steady-state measurements of serine uptake ( ■ ) were initiated by the addition of 
0.15pCi (for time points up to Imin) or O.OSpCi (for time points greater than Imin) of
[3-^^C]serine per 450pl of assay incubation. For zero-trans measurements (a ), assays were
initiated by the addition of O.ISpCi of [3-^ ^C]serine (1.3pCi/pmole). incubations at 37^0 
were carried out for the appropriate time and terminated by centrifugation of 400pl cell 
suspension through oil. Rates of uptake shown are the mean ± S.E.M. from 3 experiments 
and were initially measured as nmol serine transported per pi iCW. These were
subsequently converted to nmol serine transported per 10® cells using a value of 1.36pl ICW
per 10® cells (mean from 13 experiments; see section 3.2.1 ; p. 65).
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FIg. 3.5 Characterization of serine transport into MOLT-4 cells 
suspended in EBSS. Cells from the late-logarithmic phase were suspended
at 4 X 10® cells/ml in EBSS and 2\iC\ [®H]H20 added per ml of cell 
suspension. The suspension was gassed with carbogen and preincubated at 
370c. The transport assay was initiated by transfer of 125|il cell suspension 
to tubes (at 37OG) containing 120p.l EBSS plus appropriate concentration of 
inhibitor and 5p.l 12.5mM-[3-’*^C]serine (5.4|xCi/ml). Incubations were carried 
out for 10s and terminated by centrifugation of 200jxl cell suspension through
oil. Zero-time samples were carried out on ice instead of at 37^0. Rates 
were calculated as nmol serine transported/h per |xl ICW. These values were
subsequently converted to nmol serine transported/h per 10® cells using a 
value of 1.16|xl ICW per 10® cells (see section 3.2.1; p. 65). Results are the 
mean ± S.E.M. from 3 experiments.
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Fig. 3.6 Sodium dependence of the proposed ASC system in MOLT-4 
cells. Cells from the late-logarithmic phase were resuspended at a
concentration of 4 x 10® cells/ml in EBSS (■), or in EBSS in which choline
had replaced sodium ( a ), and 6|xCi [3h ]H20 added per ml cell suspension.
The suspension was gassed with carbogen and preincubated at 37°C. The 
transport assay was initiated by transfer of 125 i^l cell suspension to tubes (at 
37°C) containing 120^1 EBSS plus BCH and AIB and Sjxl 
12.5mM-[3-"*4c]serine (18.9jxCi/ml) for incubation times up to Imin or 5p.l
12.5mM-[3-"^4c]serine (6.3^iCi/ml) for incubation times over Imin. The final 
concentrations of BCH, AIB and serine were 20,10 and 0.25mM respectively. 
Samples were gassed with carbogen as necessary and incubated at 37^0 for 
the appropriate time. Assays were terminated by centrifugation of 200p,l cell 
suspension through oil. Values shown are the mean ± S.D. from a single 
experiment and were initially expressed as nmol serine transported per |xl 
ICW. These were then subsequently converted to nmol serine transported 
per 10^ cells using the value of 1.16p.l ICW per 10^ cells (see section 
3.2.1; p. 65).
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Fig. 3.7 Kinetic analysis of a component of serine transport into 
MOLT-4 cells not inhibited by BCH or AIB. Cells from the late-logarithmic
phase were resuspended in EBSS at a concentration of 4 x 10® cells/ml and
BjxCi [®H]H20 added per ml cell suspension. The suspension was gassed
with carbogen and preincubated at 37^C. Transport assays were Initiated by 
transfer of 125|xl cell suspension to tubes (at 370C) containing 120[xl EBSS
plus BCH and AIB and Sjxl of [3-**^C]serine (40p,Ci/ml) with varying amounts 
of non-radiolabelled serine. The final concentrations of BCH and AIB were 
lOmM and 20mM respectively. The assay was terminated after 20s by 
centrifugation of 200|xl cell suspension through oil. Rates were originally 
calculated as nmol serine transported/h per pi IGW (mean ± S.E.M. from 3 
experiments). These values were then converted to nmol serine 
transported/h per 10® cells using a vaiue of 1.16pl ICW per 10® cells (see 
section 3.2.1; p. 65). The initial rate measurement at 0.25mM-serine is the 
mean ± S.E.M. from 14 separate experiments.
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Fig. 3.8 Inhibition of serine transport by BCH and MeAIB in cells 
resuspended in Hepes-buffered medium. Cells from the logarithmic phase
were resuspended in Hepes-buffered medium at a concentration of 2.6 x 10® 
ceils/ml. To the suspension was added 2|xCi [3h ]H20 per ml and aliquots of 
420|xl transferred to incubation tubes which were then capped with a rubber 
seal. Using a Hamilton syringe, 10|xl of 135mM-NaHC03 was added through
the seal. The cell suspension was preincubated at 37°C for 20min and the 
transport assay initiated by the addition of 170|xl of solution containing the 
appropriate concentration of inhibitor. (This solution was prepared previously 
using 480^il of Hepes-buffered medium (containing appropriate 
concentration of inhibitor) to which was added 32p,l [3-'*^C]serlne 
(15|xCi/ml). The tube was sealed and 32\i\ of 50mM-NaHCO3 added using a
Hamilton syringe. This solution was prewarmed to 37%). Incubations were 
carried out for Imin and the transport terminated by centrifugation of 550\i\ 
ceil suspension through oil. Measurements were originally calculated as 
nmol serine transported/h per |xl ICW and were subsequently converted to
nmol serine transported/h per 10® ceils using a value of 1.36 pi ICW per 10® 
celis (see section 3.2.1; p. 65). Values shown are the mean ± S.E.M. from 3 
experiments.
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Fig. 3.9 Time course for serine efflux from MOLT-4 cells. Cells from the 
logarithmic phase were resuspended in Hepes-buffered medium at a
concentration of 2 x 10® cells/ml. Aliquots of 480|xl were transferred to 
incubation tubes which were then capped with rubber seals. Using a 
Hamilton syringe, lOjxl of SOOmlVI-NaHCOg (prepared in Hepes-buffered
medium) were added and the samples preincubated at 37^0 for 20min. After
this time, 10|xl of [3-^^C]serine (6jLiCi/ml) were added and tubes incubated at
37^0 for a further 20min. Next, 450^il of cell suspension were removed 
to an Eppendorf tube and centrifuged (12000 g, 5s). From the supernatant 
were removed 405jxl for determination of radioactivity. The remaining 45pil
were mixed to resuspend the cells and incubated at 37^0 for 4min. To 
initiate measurement of efflux, 405|xl of Hepes-buffered medium containing
3mM-NaHC03 and [^HjHgO (4|iOi/ml) were added and the contents 
transferred to another incubation tube which was then capped. Incubations 
at 37°C were carried out for the appropriate time and terminated by 
centrifugation of 400jil cell suspension through oil. Modifications of this 
procedure were made for measurement of steady-state radiolabel and 
cellular spaces (see section 2.5.3; p. 38). Values were originally calculated 
as dpm released per |il ICW and subsequently converted to dpm released
per 10® cells using a value of 1.36 i^l ICW per 10® cells (see section 
3.2.1; p. 65). Values shown are the mean ± S.E.M. from at least 3 
experiments.
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Table 3.1 Summary of the neutral amino acid transport systems characterized to date
Transport
System
Model
Substrate
Sodium
Dependent?
Cell type in which 
first defined (Ref.)
Preferred substrates, occurence 
and other notes
L BCH No Ehrlich cell 
(Oxender & 
Christensen, 1963)
Large, neutral amino acids with 
branched, hydrophobic or aromatic 
side chains. Ubiquitous. Shows 
minimal pH sensitivity, strong 
exchanging properties and trans­
stimulation and may now actually 
be subdivided into LI and L2.
A MeAIB Yes Ehrlich cell 
(Oxender & 
Christensen, 1963)
Small, neutral amino acids. Most cell 
types but conspicuously absent in 
erythrocytes. High pH sensitivity, 
scarcely detectable at pH5, weak 
exchanging properties and trans­
inhibition.
Gly None Yes Pigeon erythrocyte Glycine and sarcosine only. Also 
(Vidaver etal., 1964) present in rabbit reticuloc\4e and HTC 
cells. No pH sensitivity or exchanging 
properties have been demonstrated.
ASC None Yes Ehrlich cell 
(Christensen et a!., 
1967)
Small amino acids with aliphatic or 
hydroxyaliphatic side chains with 1 or 2 
carbon atoms, cysteine, asparagine 
and cysteine. Ubiquitous?
Intermediate pH sensitivity, but less 
sensitive than system A and has weak 
exchanging properties and does 
exhibit trans-stimulation.
P taurine Yes Ehrlich cell 
(Christensen, 1964)
Taurine, p-alanine and sulphonic 
groups accepted. Rabbit reticulocyte, 
avian erythrocyte, rat hepatocyte and 
kidney.
N None Yes Rat hepatocyte Glutamine, asparagine and histidine.
(Kilberg et ai, 1980) Similar system termed N^ found
recently in skeletal muscle. High pH 
sensitivity.
T 4-azido- No 
phenylalanine
Human erythrocyte 
(Rosenberg et ai, 
1980)
Aromatic amino acids including their 
D-isomers. Also found in rat 
hepatocyte.
asc None No Pigeon erythrocyte 
(Vadgama & 
Christensen, 1985)
Same as for system ASC. Greater 
pH sensitivity than ASC.
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Table 3.2. Cell volume determined by a variety of methods for several different cell types
The various different methods are described In the text. Cell volumes are reported as pi of 
intracellular water normalized as shown In the table. N.D. : Not determined.
Cell type Method used Cell volume/ 
10® cells
Cell volume/ 
mg protein
Reference
Human lymphoblastic pH]water 
leukaemia (MOLT-4) [^ ^CJsucrose
1.16 3.9 Present study
Mouse leukaemia 
(L1210)
Wet - Dry weight 
P^C]inulin
0.62 N.D. Jackson & Harrap, 1973
Mouse leukaemia 
(L1210)
Wet - Dry weight 
[i4C]inulin
0.54 N.D. Matherly etal., 1987
Mouse lymphocyte 
(GF-14)
Wet - Dry weight 
pHJinulin
0.64 N.D. Finkelstein & Adelberg, 1977
Mouse peritoneal 
macrophage
3-0-methyl-D-
glucose
N.D. 5.0 Sato etal., 1987
Human skin 
fibroblast
3-0-methyl-D-
glucose
N.D. 4.0 White ef a/., 1982
Human erythrocyte Not given 0.05 N.D. Rosenberg etal., 1980
Rat hepatocyte 
(suspension)
pHJwater
[i^ CjPEG®
3.35 N.D. Le Cam & Freychet, 1976
Rat hepatocyte 
(suspension)
pH]water
p4C]PEG®
2.57 N.D. Fehlmann etal., 1979b
Rat hepatocyte 
(primary culture)
3-0-methyl-D-
glucose
N.D. 2.5 Kletzien e/a/., 1975
Rat hepatocyte 
(primary culture)
3-O-methyl-D-
glucose
N.D. 2.5 White & Christensen, 1982
Rat hepatocyte 
(primary culture)
Not given N.D. 1.8 Weissbach e/a/., 1982
Rat hepatoma 
(HTC)
3-0-methyl-D-
glucose
N.D. 4.6 White & Christensen, 1982
® Polyethyleneglycol
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Table 3.3. Inhibition of a component of serine transport into MOLT-4 cells not
inhibited by BCH or AIB by amino acids and various analogues.
Compounds inhibiting transport by less than 50% are shown in this table. The procedure was 
exactly as described for Table 3.4. Results are expressed as % inhibition (mean ± s .e .m . for 3 
experiments) of the control rate in the absence of test compound which was measured as 
44.5 ± 2.92 nmol serine transported/h per 10® cells (mean ± s .e m . from 15 separate 
experiments).
Test Compound Side Chain % inhibition
Proline
(Whole structure)
Glycine
Isoleucine
D-serine
Phenylalanine
Citrulline
Histidine
2-methyl-DL-serine
N-methylalanine
Lysine
Aspartic acid 
Glutamic acid 
Cycloserine
(Whole structure)
c/s-4-hydroxyproline 
(Whole structure)
J —.COOH
NH
-H
-CH(CH3)CH2CH3
-CHgOH
-CH2-C6H5
-(CH2)3NHC0NH2
-CH2 —
HN NV
-CH20H
-CH3
.(CH2)4NH2
-CH2COOH
-CH2CH2COOH
46.7 ±4.2
45.3 ±5.9
42.0 ± 5.4
33.0 ± 3.5
30.0 ±4.0
24.7 ± 3.8
20.0 ±5.0
9.3 ±6.2 
4.0 ±5.9
3.7 ±3.3
2.7 ±4.1 
0.7 ±8.5
NH 14.5 ± 3.6
NH
8.0 ±7.6HO
COOH
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Table 3.4 inhibition of a component of serine transport into MOLT-4 cells not
inhibited by BCH or AIB by amino acids and various analogues.
Compounds inhibiting transport by more than 50% are shown in this table. Cells from the 
late-logarithmic phase were resuspended in EBSS at a concentration of 4 x 10® cells/ml and 
2|iCi pH]H20 added per ml cell suspension. This was gassed with carbogen and 
preincubated at 37®C. A portion (400pl) was placed on ice for zero-time samples. The 
transport assay was initiated by transfer of 125pl cell suspension to tubes (at 37®C) 
containing 120jil EBSS plus BCH, AIB and appropriate test compound and 5pl 
12.5mM-[3-‘‘^ C]serine (18.6pCi/ml; 1.49pCi/pmol). The final concentrations of BCH, AIB and 
test compound were 20, 10 and 20mM respectively. Assays were carried out for 20s and 
terminated by centrifugation of 200pl cell suspension through oil. Results are expressed as 
% inhibition (mean ± s .e m . for 3 experiments) of the control rate measured in the absence of 
test compound which was 44.5 ± 2.92 nmol serine transported/h per 10® cells (mean ± s .e m . 
from 15 separate experiments).
Test Compound Side Chain % inhibition
Alanine -CHa 95.5 ± 2.0
Serine -CHgOH 92.0 ± 4.0
Asparagine -CH2CONH2 89.7 ± 6.7
2-amino-n-butyric acid -CH2CH3 86.1 ± 3.6
Homoserine -CH2 CH2OH 84.3 ±3.2
S-methylcysteine -CH2SCH3 83.0 ± 4.0
Threonine -CHOHCH3 81.4 ±8.5
Allothreonine -CHOHCH3 78.0 ± 6.0
2-aminopentanoic add -CH2CH2CH3 72.2 ± 6.8
Glutamine -CH2CH2CONH2 76.7 ±4.9
3-chloroalanine -CH2CI 76.3 ±2.9
Methionine -CH2CH2SCH3 73.7 ±4.7
Cysteine -CH2SH 73.3 ±6.1
0-methyl-DL-serine -CH2OCH3 72.0 ±2.9
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Table 3.5. inhibition of system ASC by a variety of physiological amino acids and some 
other amino acid analogues in a number of different cell types.
Activity of system ASC was measured as follows for the various different cell types: as the 
component of 0.25mM-[3-‘*^C]serine uptake not inhibited by BCH or AIB for MOLT-4 cells; as the 
Na+-dependent uptake of 0.1mM-pH]alanine at pH6.0 (a condition under which system A was 
inactive with respect to alanine uptake) in MDCK cells (Boerner et al., 1986); as the Na+- 
dependent uptake of 0.2mM-[^ '*C]serine in the human (Al-Saleh & Wheeler, 1982) and the pigeon 
(Eavenson & Christensen, 1967) erythrocyte; as the Na+-dependent uptake of 0.1 mM- 
[i4c]cysteine in the rat hepatocyte (Kilberg et a!., 1981); as the Na+-dependent uptake of 
0.05mM-[G-®H]threonine in the HTC cell (Handlogten etal., 1981); as the Na+-dependent uptake 
of 0.1mM-[i4c]alanine in the presence of 10mM-MeAlB in the pig lymphocyte (Borghetti et al., 
1981). The concentration of test compound used in each study is shown in brackets directly 
below the cell type. Results are expressed as percentage inhibition of control uptake. ND : Not 
determined.
% Inhibition
Test MOLT-4 MDCK Human Pigeon
Compound erythrocyte erythrocyte
(20mM) (lOmM) (lOmM) (4mM)
Rat HTC Pig 
hepatocyte lymphocyte
(25mM) (2mM) (lOmM)
Alanine 96 95 97 92 84 89 ND
N-methylalanine 4 ND 2 ND ND 7 ND
3-chloroalanine 77 ND 97 ND ND ND ND
Norvaline 77 ND 83 ND ND ND ND
Norleucine 63 ND 91 ND ND ND ND
Serine 92 95 97 92 94 89 93
Homoserine 84 ND 95 ND ND 95 ND
Threonine 81 93 94 ND 67 ND 95
Cysteine 83 ND 98 91 100 99 94
S-methylcysteine 83 ND ND ND 100 84 ND
Methionine 74 86 78 72 ND ND 86
Asparagine 90 93 ND ND ND 89 ND
Glutamine 77 95 ND ND ND 25 ND
Histidine 20 45 15 ND ND 14 33
Valine 56 63 66 57 43 32 62
Leucine 55 83 78 64 61 51 ND
Isoleucine 42 74 62 70 36 48 ND
Glycine 45 66 48 30 ND 24 68
Proline 47 40 61 43 46 32 55
Hydroxyproline 8 ND 87 ND 40 94 ND
D-serine 33 ND 36 ' ND ND 27 ND
Phenylalanine 30 56 48 30 26 22 51
Lysine 4 14 ND 0 ND ND 11
Arginine 3 13 ND ND ND 0 20
Aspartic acid 3 8 ND ND ND ND ND
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Table 3.6. Effect of replacing sodium with either lithium or choline on serine uptake 
into MOLT-4 ceils suspended in BBSS.
Cells from the iate-iogarithmic phase were resuspended in BBSS, or in BBSS in which either 
lithium or choline had replaced the sodium, at a concentration of 4 x 10® ceils/mi. To the 
suspension was added 6pCi PI-OH2O per ml. The suspension was then gassed with 
carbogen and preincubated at 37®G. Transport assays were initiated by the transfer of 125pi 
cell suspension to tubes (at 37®G) containing 120pi of appropriate BBSS with BGH and AIB 
and 5|il 12.5mM-[3-‘'^ G]serine (I.SpGi/pmol for the 20s incubation and O.SpGi/pmole for the 
20min incubation). The final concentrations of BGH, AIB and serine were 20,10 and 0.25mM 
respectively. For the 20min incubation, samples were regassed, recapped and incubated at 
37°G. The transport assay was terminated by centrifugation of 200jil cell suspension through 
oil. Values were calculated as nmol serine transported/pl IGW and are expressed as the 
means ± s .d . from a single experiment.
Ion Assay time nmol serine transported /pi IGW
Sodium 20 s 0.209 ±0.039
20 min 2.070 ±0.160
Gholine 20 s 0.018 ±0.004
20 min 0.052 ±0.004
Lithium 20 s 0.033 ±0.007
20 min 0.655 ±0.037
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Table 3.7. Distribution of serine transport among the various neutral amino acid 
transport systems In a variety of cell types.
System A activity was measured as the Na+-dependent uptake inhibited by excess MeAlB and 
system ASC activity as the Na+-dependent uptake not inhibited by MeAIB. System L activity was 
assigned to that inhibited by excess BGH. Serine uptake by each system is expressed as a 
percentage of the total uptake. N.D. : Not determined.
Gell type
Extracellular 
[serine] (mM)
Distribution of serine transport 
(% of total)
ASG
Reference
other
MOLT-4 0.25 55 23 20 ®2 Present study
Rat hepatocyte 0.10 45 30 N.D. b24 Kilberg etal., 1981
Rat brain 
capillaries
0.10 21 40 31 ®8 Tayarani etal., 1987
Chinese Hamster 
ovary cell
0.20 21 75 3 ®1 Shotwell etal., 1981
Ehrlich cell 1.00 85 10 5 0 Christensen etal., 1969
Human fibroblast 0.11 3 94 3 0 Franchi-Gazzola etal., 1982
Pig lymphocyte 0.20 6 73 N.D. b2i Borghetti etal., 1981
Pig lymphocyte 
(lectin-stimulated)
0.20 1 81 N.D. M8 Borghetti etal., 1981
® Non-saturable uptake
 ^ This value represents total Na+-independent uptake and may therefore be accounted for 
partially or totally by the L system.
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Table 3.8. Determination of radiolabel associated with Intracellular serine and of the 
intracellular serine concentration.
Cells from the logarithmic phase were resuspended in Hepes-buffered medium at a 
concentration of 2 x 10® cells/ml. To a portion of cell suspension was added 4pCi PI-QH2O 
per ml. Aliquots of 440pl were transferred to incubation tubes which were capped with rubber 
seals and 4.5pl OOOmM-NaHCOg added. All samples were preincubated at 37®C for 20min. 
Radiochemical assays were initiated by the addition of 4.5pl [3-‘*^C]serine (12pCi/ml) and 
tubes incubated at 37°C for 20, 40 or SOmin. The assays were terminated by centrifugation 
of 400pl cell suspension through oil. For the measurement of radiolabel in purine, 40pl of 
2.5M-PCA was below the oil to which was added 360pl of water. The isolation of purines was 
then carried out as desribed in section 2.4.4 (p. 35) but decreasing all amounts by a factor of 
2.5. For the purine samples, pHJwater was omitted and the mean value for the total space 
centrifuged through the oil in the incubations where pH]H20 was included used for 
calculation of the radiolabel in purine per pi ICW. Samples prepared for amino acid analysis 
were carried out in the same way but with the omission of all radiolabel.
Time
(min)
dpm/pl ICW dpm in purine/ 
pi ICW
Corrected 
dpm/pl ICW
Accumulated 
[serine] (mM)®
Intracellular 
[serine] (mM)^
20 3737 ± 121 758± 71 2979 ±140 3.17° ±0.15 3.76° ±0.44
40 4815±110 2071 ±270 2744 ±292 2.92° ±0.31 4.02° ±0.37
60 5373 ±147 2700 ±386 2673 ±413 2.84° ±0.44 4.45° ±0.32
® Measured by uptake of radiolabelled serine; mean ± s .e .m . from four experiments.
 ^Measured by amino acid analysis; mean ± s .e m . from three experiments.
® The difference between these values for the individual incubation times is only statistically 
significant for the 60min incubation (P<0.05). For the 40min incubation, P<0.1 and for the 
20min incubation P<0.3.
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CHAPTER 4
SHMT ACTIVITY IN MOLT-4 CELLS
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Chapter 4: SHMT activity in MOLT-4 ceiis
4.1 Introduction
One of the aims of the present work is to apply metabolic control 
analysis to SHMT with respect to the pathway of purine synthesis de novo. 
For this purpose, an inhibitor specific for SHMT is required together with a 
suitable assay for the enzyme. A number of inhibitors and assays are 
available and the advantages and disadvantages of each are detailed below. 
The possible presence of a cytosolic and a mitochondrial Isozyme of SHMT in 
MOLT-4 cells also needs to be considered.
4.1.1 Assay techniques for SHMT
The ability of SHMT to catalyse a variety of different reactions has led 
to the development of a number of alternative assays each with its own 
advantages and disadvantages (Schirch, 1982). The simplest assay involves 
the SHMT-catalysed conversion of 3-phenylserine to glycine and 
benzaldehyde and detection of the latter product by its absorption at 279nm 
(Ulevitch & Kallen, 1977). This assay does not work well however in tissue 
extracts where the enzyme activity is low because product formation 
monitored by absorbance at 279nm is obscured by protein absorption. 
Others workers have measured absorbance at an alternative wavelength of 
252nm presumably to overcome this problem (Schirch & Dlller, 1971). A 
further disadvantage of this assay is the low solubility of 3-phenylserine such 
that saturating concentrations of the substrate cannot always be attained 
(Schirch, 1982).
Utilizing allothreonine as a substrate, SHMT catalyses the formation of 
glycine and acetaldehyde. Excess NADH and alcohol dehydrogenase reduce 
the acetaldehyde to ethanol and enzyme activity can therefore be monitored 
by the decrease in absorbance at 340nm (Schirch & Oilier, 1971). A major 
disadvantage of both this assay and the 3-phenylserine assay is that no 
features associated with the folate binding site can be studied because THF 
is not required as a cofactor in either reaction.
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Two further assays based on the physiological reaction of SHMT have 
been developed. One is a radiochemical end-point assay which utilizes 
[3-l^C]serine as substrate and therefore radiolabelled 5,10-CH2THF is
formed as a product. Added formaldehyde readily exchanges with the 
radiolabelled one-carbon units and the resulting radiolabelled formaldehyde 
forms a complex with dimedone which can be extracted into toluene (Taylor & 
Weissbach, 1965). The assay is sensitive with good specificity and is 
therefore often chosen for measurement of SHMT activity in unpurified tissue 
extracts. One disadvantage of this assay is that significant degradation of the 
THF can occur over the relatively long incubation time. This means that high 
concentrations of THF should be used to ensure saturating conditions are 
maintained throughout the assay period. This assay is therefore also 
inadequate for kinetic studies with THF. This fact was overlooked by 
workers who used the assay to show a positive homotropic effect of THF on 
SHMT purified from pig kidney (Kumar et ai, 1976) and from monkey liver 
(Ramesh & Appaji Rao, 1978). The use of an alternative assay which did not 
use long incubation times and which monitored enzyme activity continuously 
(so that deviations from linearity would be detected) showed that the 
apparent homotropic effect was in fact only an artefact (Schirch & 
Quashnock, 1981). The basis of this alternative assay is the conversion of 
the product S.IO-CHaTHF to 5,10-CHTHF using NADP+ and 5,10-CH2THF
dehydrogenase. Both the products NADPH and 5,10-CHTHF absorb at 
340nm and so the reaction can be followed spectrophotometrically. The 
disadvantage of this assay is that the 5,10-CH2THF dehydrogenase is difficult
to purify from either bacterial or mammalian sources (Schirch, 1982).
More recently a new radiochemical assay has been described based 
upon the ability of folates to bind to DEAE-cellulose paper (Geller & Kotb, 
1989). Incubations of enzyme extracts with radiolabelled serine and other 
necessary components are streaked onto the paper followed by washing to 
remove un reacted serine. The radioactivity associated with the dried paper is 
then determined. Although of similar sensitivity to the widely used 
radiochemical assay mentioned above, this new assay is simpler and more 
rapid to complete.
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4.1.2 Inhibitors of SHMT
Metabolic control analysis of an enzyme within a defined pathway may 
be accomplished by use of a specific inhibitor of that enzyme (see Chapter 
6). Types of compounds which may show inhibitory action against SHMT 
would include serine antimetabolites, antifolate analogues and also vitamin 
Bq antagonists because the enzyme necessarily requires pyridoxal
phosphate as a bound cofactor for its function. D-cycloserine (Fig. 4.1), a 
vitamin Bg antagonist, inhibited SHMT in mouse spleen in vivo, the inhibition 
being potentiated by 4-vinylpyridoxal (Fig. 4.1), one of the most powerful Bg 
antagonists (Bukin et a!., 1979). Purified cSHMT from monkey liver was 
competitively inhibited by D-cycloserine with respect to serine (Ramesh & 
Appaji Rao, 1980). D-cycloserine also inhibited cSHMT in crude extracts 
from rat lenses (Geller et a/., 1990). The aminooxy compounds 
aminooxyacetate, hydroxylamine and L-canaline (Fig. 4.1), inhibited sheep 
liver cSHMT much more rapidly than D-cycloserine and acted by breaking the 
enzyme-Schiff base to form oxime-type complexes (Baskaran et a!., 1989b). 
The problem with using Bg antagonists is that they are unlikely to be very
specific for SHMT due to the large number of PLP-requiring enzymes within a 
cell. The mechanism of inactivation of SHMT by D-cycloserine is however 
different to the usual way in which PLP-dependent enzymes are inactivated 
and this could confer a degree of selectivity to the inhibition of SHMT by this 
compound (Manohar et a/., 1984). Furthermore another aminooxy 
compound, O-amino-D-serine, may have a higher specificity for SHMT than 
the other aminooxy compounds because of its closer structural similarity to 
serine (Baskaran ef a/., 1989a).
Antifolate analogues may also not show specificity for SHMT because 
of the large number of folate-requiring enzymes. One of the triazine 
antifolates, NSC127755 (Fig. 4.1), was shown to inhibit SHMT in crude 
extracts prepared from mouse myeloma X63 cells with an iCgg in the order of
50nM (Snell & Riches, 1989). However, lack of specificity Is again likely 
because NSC127755 was designed and shown to be an irreversible inhibitor 
of chicken liver dihydrofolate reductase (Baker & Vermeulen, 1970). These 
results do not necessarily dictate which or whether both of the enzymes 
would be inhibited In vivo. However, the fact that the iCgg for inhibition of
chicken liver DHFR by NSC127755 (Kumar et a/., 1981) was one order of 
magnitude lower than that measured for SHMT in crude myeloma extracts
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(Snell & Riches, 1989) suggests that DHFR would be inhibited to a greater 
extent than SHMT. This proposal is however made with the reservation that 
the two IC50 values quoted are for enzymes from different tissues. A second
antifolate compound, tetrahydrohomofolate (NSC89473; Fig. 4.1), inhibited 
SHMT from L1210 cells with an IC50 of 62.5p,M (Scanlon et al., 1981).
However, this compound substituted for THF in its ability to act as a substrate 
for the enzymes 5,10-CH2THF dehydrogenase, 5,10-CH2THF reductase,
thymidylate synthetase and 10-CHOTHF synthetase and could therefore 
perturb the metabolic environment to an extent unsuitable for metabolic 
control analysis.
Serine antimetabolites have not been extensively studied with regard 
to inhibition of SHMT activity. Cyclohexylserine (Fig. 4.1) was shown to 
inhibit nucleic acid synthesis with minimal effects on protein synthesis In 
leukaemic cells with a presumed action on SHMT (Pazmino et al., 1973). A 
short series of 2-substituted serines were tested as potential suicide inhibitors 
of SHMT but of those tested only 2-vinylserine (Fig. 4.1) had an inhibitory 
effect (Tendler ef a/., 1987).
One of the other reactions which SHMT is capable of catalysing is the 
transamination of its bound PLP by D-alanine with the concomitant 
production of pyruvate (Schirch & Diller, 1971). The release of free 
pyridoxamine phosphate makes this a useful reaction for formation of the 
apoenzyme for further study (Schirch, 1982). Substitution of a fluoride group 
at the carbon 3 position of D-alanine generated a compound which caused 
irreversible inhibition of SHMT by alkylation of the enzyme at its active site; in 
addition, SHMT also catalysed the hydrolysis of this compound 
(3-fluoro-D-alanine (3FDA); see Fig. 4.1), to pyruvate and hydrogen fluoride, 
which does not result in inhibition of the enzyme: (Wang et al., 1981). 
Although 3FDA has a very low affinity for SHMT, it is likely to be virtually 
specific because metabolism of D-amino acids is rare. D-amino acid oxidase 
purified from pig kidney has however been shown to catalyse the oxidation of 
3FDA to fluoropyruvate (Dang et al., 1976). None of the inhibitors described 
have been shown to be totally specific for SHMT and 3FDA was chosen for 
use in metabolic control analysis in the present work.
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4.1.3. Cytosolic and mitochondrial isozymes of SHMT
Cytosolic and mitochondrial forms of SHMT have only been purified to 
homogeneity from rat (Nakano et al., 1968) and rabbit (Fujioka, 1969) liver. 
Initial purifications involved prior separation of mitochondria followed by 
various combinations of heat treatment, ammonium sulphate precipitation 
and brushite and DEAE-cellulose chromatography. The isozymes from rat 
liver showed differing patterns of pH dependence and the cSHMT was more 
anionic than mSHMT evident from its greater affinity for DEAE-cellulose and 
its electrophoretic mobility (Nakano et a!., 1968). In contrast, the isozymes 
from rabbit liver showed similar pH dependence and electrophoretic mobility 
(Fujioka, 1969). Both isozymes from both sources had similar kinetic 
constants for their substrates. More recent purification procedures have 
dispensed with the need for prior separation of mitochondria on the basis that 
the two isozymes can be separated by virtue of their differing affinities for 
DEAE-cellulose (Schirch & Peterson, 1980; Ogawa & Fujioka, 1981). A good 
separation of SHMT activity was achieved for the rat liver isozymes (Ogawa & 
Fujioka, 1981). The mSHMT was eluted first from the DEAE-cellulose 
column, consistent with its previously reported greater cationic nature relative 
to cSHMT (Nakano et a!., 1968). The proposed fractions of SHMT activity 
for the rabbit liver enzyme were less well distinguished and indeed the order 
of elution was reversed (Schirch & Peterson, 1980) with respect to the rat 
liver isozymes. This observation is consistent with the more similar charge of 
the two isozymes (based on electrophoretic mobility) reported for purifications 
from rabbit liver (Fujioka, 1969). The similarity of the kinetic constants for the 
rabbit isozymes were confirmed except that glycine showed a four-fold 
greater affinity for the mSHMT (Schirch & Peterson, 1980). Analysis of 
peptides from a tryptic digest of mSHMT and study of the reactivity of 
sulphydryl reagents with this isozyme compared to cSHMT suggested that 
the two isozymes are encoded by distinct genes (Gavilanes et al., 1983). 
Furthermore, the two isozymes from rabbit liver have different primary 
sequences (Martini et a!., 1989) and the isozymes from both rabbit liver 
(Fujioka, 1969) and rat liver (Ogawa & Fujioka, 1981) show distinct 
immunochemical properties.
The availability of a number of assays for SHMT may provide a simple 
means for distinguishing between the two isozymes should their capacity for 
the utilization of alternative substrates be different. This possibility was first
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realised in studies on the rat liver enzyme for which the allothreonine aldolase 
and aminomalonate decarboxylase activities of cSHMT could not be 
demonstrated for the mitochondrial enzyme (Palekar et al., 1973). Neither 
enzyme catalysed the aldol cleavage of threonine. Both isozymes purified 
from rabbit liver however catalysed the allothreonine and threonine aldolase 
activities (Akhtar et a!., 1975; Schirch & Peterson, 1980). Further 
experiments with rat liver mSHMT confirmed a lack of threonine aldolase 
activity but a small aldol cleavage of allothreonine was demonstrated (Ogawa 
& Fujioka, 1981). Assays which utilize more physiological substrates have 
not been shown to be useful as a means of distinguishing between the two 
isozymes.
One further method for the characterization of the cytosolic and 
mitochondrial forms of SHMT would be the use of inhibitors specific to one or 
the other. Chloroacetaldehyde, lodoacetamide, bromopyruvate and 
glycidaldehyde (Fig. 4.2) inhibited the cytosolic form but not the mitochondrial 
isozyme (Akhtar et ah, 1975). Although both enzymes are capable of 
carrying out the transamination of D-alanine (Schirch & Peterson, 1980), 
3FDA did not inhibit mSHMT from rabbit liver; this lack of inhibition was 
thought to be due to the absence of a cysteine residue in the mitochondrial 
enzyme which is involved in the irreversible alkylation of cSHMT (Gavilanes 
etal., 1983).
4.1.4 Studies In MOLT-4 cells
The experiments reported in this chapter were designed to study the 
characteristics of inhibition by 3-fluoro-D-alanine of SHMT In MOLT-4 cells. 
This was with a view to using inhibition of the enzyme for metabolic control 
analysis of SHMT in relation to purine synthesis de novo. For this purpose. It 
was also important to know which or whether both of the isozymes of SHMT 
were present in these cells. In addition, if both Isozymes were present. It was 
necessary to know if both were inhibited by 3-fluoro-D-alanine or if only one 
of the enzyme forms was affected.
The enzyme has not previously been assayed in this cell line, although 
assays have been performed in other normal and neoplastic lymphoid cells 
(Thorndike et al., 1979; Eichler etal., 1981; Strong etal., 1990). The assay 
of choice for the present study was the radiochemical assay originated by
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Taylor & Weissbach (1965) because it is sensitive with good specificity and is 
therefore a good choice for use with crude enzyme extracts (Schirch, 1982). 
The instability of THF, which is a disadvantage of this assay. Is not a problem 
for these studies because saturating concentrations of THF were always 
used.
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4.2 Results and Discussion
4.2.1 Modification of the SHMT assay
< Measurement of the SHMT activity In a sonicate prepared from a 
suspension of MOLT-4 cells at a concentration of 1 x 10® cells per ml under 
conditions described previously for rat liver (Snell, 1980) resulted in the 
recovery of only 250-300 cpm for control samples. Furthermore, the recovery 
of radioactivity for the blanks in which enzyme protein was omitted was 55% 
of the control values. Such high blanks relative to control recoveries can 
result in large errors on only small differences between control and blank 
activities. In addition, quantitative inhibition analyses on samples starting with 
control activities giving only 150 cpm would not be possible. Modifications of 
the assay previously described were therefore carried out to try to overcome 
these difficulties.
4.2.1.1 Reduction of the assay blank
high
The nature of the^assay blank is not known. One possibility Is that 
small quantities of the radiolabelled serine can actually leak Into the toluene 
layer. However, if this is the case, one might expect a higher blank if 
extractions are made into a greater volume of toluene but this was not 
observed. Furthermore, repeat extractions with fresh toluene would result in 
continued recovery of radiolabel if the [3-f4C]serine were responsible for the 
blank value but this did not occur either. These results point to the presence 
of a small, finite quantity of a component which can be readily extracted into 
toluene as a cause of the blank cpm values.
Mixing the [3-i4c]serine assay stock solution with toluene did not 
result in the recovery of any radioactivity in the toluene layer unless the assay 
components were also present. No incubation at 37^0 was required for the 
extraction. To determine which assay components were responsible for the 
recovery of the contaminating radioactivity, toluene was added to mixtures of 
the assay components in which individual components were omitted. 
Radioactivity was recovered in the toluene layer in every case except for that 
in which the dimedone had been omitted. Addition of dimedone to the
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mixture followed by shaking with fresh toluene resulted in recovery of 
radiolabel in the toluene layer. Dimedone is present in the assay because it 
forms a complex with formaldehyde which can be readily extracted into 
toluene. The blank radioactivity may therefore be caused by 
[i4C]formaldehyde present as a contaminant of the [3-i4C]serine. Effective 
removal of such a contaminant ought to be possible by lyophilization due to 
the volatility of formaldehyde. The amount of radiolabel extracted into 
toluene from previously lyophilized [3-’*^C]serine was decreased by 70% 
relative to that from the untreated [3-l4C]serine stock. The [3-‘*4C]serine 
was therefore routinely lyophilized, dissolved in water and stored at -20°C 
prior to assay.
Workers carrying out this assay for SHMT rarely refer to the assay 
blank. One report noted a 75% reduction of the blank if the commercial 
[3-"(4C]serine was purified using a column of AG1 x 8, OH- form (Daly & 
Aprison, 1974). In another study a Dowex 50-H+ column was used to remove 
impurities from the commercially supplied [3-l4c]serine (Thorndike et a/.,
1979).
4.2.1.2 Improvement of assay sensitivity by increased recovery of radiolabel
To assay the enzyme at low activity, it would be desirable to enhance 
the sensitivity of the assay, for example by an increase in the recovery of the 
radiolabelled product. An increase in the radiolabel recovered could simply 
be accomplished by the addition of more [3-i4C]serine but this would be too 
expensive for routine use. However, a five-fold increase in specific activity 
was accomplished by using the same amount of radiolabel but reducing the 
total assay volume from 0.5ml to 0.1ml. The cell sonicate was prepared from 
a cell suspension containing 5x10® cells per ml, a five-fold increase over 
that previously used, to account for this reduction in assay volume. The 
SHMT activity was found to be linear with protein concentration using 
sonicates prepared from cell suspensions containing up to 50 x 10® cells per 
ml. However, to prepare such cell suspensions would have involved growing 
up large numbers of cells, which would be undesirable for routine use 
because of the cost of the tissue culture requirements.
Increased recovery of radiolabel could also be accomplished by 
carrying out the assay incubation for longer time periods. However, the
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assay was only linear up to 20min using the sonicate prepared from a cell 
suspension containing 5x10® cells per ml. The non-linearity probably arises 
from instability of the THF or of the enzyme itself.
The final way in which the recovery of radiolabel could be improved is 
to increase the specific activity by decreasing the serine concentration. 
Measurement of SHMT activity at saturating concentrations of serine was not 
intended in the assay as originally described by Taylor and Weissbach 
(1965). These workers used a serine concentration of 0.25mM and this was 
chosen for routine studies in this report.
The effect of Triton X-100 on the measurement of SHMT activity is 
also worthy of mention. Inclusion of Triton X-100 in the sonicate to a final 
concentration of 0.1% (v/v) resulted in an 80% increase in assayable SHMT. 
Complete cell breakage by sonication in the absence of Triton X-100 was 
observed by microscopic analysis but the presence of intact mitochondria 
could result in inaccessibility of certain assay components to mSHMT. The 
formation of vesicles after sonication could also account for the increased 
SHMT activity liberated by Triton X-100 treatment. Centrifugation (12000 g, 
lOmin) of the sonicate prepared without Triton X-100 and assay of the 
supernatant in the presence and absence of the detergent did not result in 
any difference in assayable SHMT. This therefore shows that, if it is the 
presence of intact mitochondria which causes some SHMT to be unavailable 
to the assay components, these organelles must be pelleted by this 
centrifugation step. Vesicles obviously cannot be responsible because these 
would not be pelleted under these low g-force centrifugation conditions. 
Addition of Triton X-100 at the same time as the addition of the dimedone did 
not result in increased recovery of radiolabel; this result therefore showed 
that the higher SHMT activity measured in the presence of the detergent was 
not because of a promoting effect on the formation of, or extraction of, the 
formaldehyde-dimedone complex. Explanation of the effects of Triton X-100 
by an increase in the release of a mitochondrial isozyme would imply that at 
least 45% of the total SHMT is located in the mitochondria.
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4.2.1.3 Effect of Ionic strength on SHMT activity
For many studies which have used this radioassay for SHMT the 
buffer of choice has been potassium phosphate, pH7.4. In the present work 
however, SHMT activity in MOLT-4 cells was measured In Hepes buffer as 
well as phosphate buffer because inorganic phosphate has been shown to 
inhibit the enzyme from rabbit liver (Schirch & Diller, 1971). The activity 
measured in 60mM-phosphate was six-fold higher than that measured in 
25mM-Hepes. Increasing the phosphate concentration in the presence of 
25mM-Hepes resulted in a concentration-dependent stimulation of SHMT 
activity (Fig. 4.3). However, in the total absence of phosphate, an increase in 
the concentration of Hepes gave a similar result, although higher 
concentrations of Hepes were required to give similar activities. This 
suggested that the observed increase may be due to an ionic strength effect 
because concentrations of Hepes and phosphate giving similar ionic 
strengths (see Appendix C) supported the same SHMT activity (Fig. 4.4).
Inclusion of various ions with 25mM-Hepes buffer was also used to 
vary the ionic strength. Addition of ions to give a comparable ionic strength to 
that of 60mM-phosphate resulted in significantly lower SHMT activity. 
Inclusion of 150mM-KCI or 150mM-NaCI showed the same reduction in 
activity whereas ISOmM-potassium acetate and 150mM-KCI decreased the 
activity to different extents (Table 4.1). The activity is therefore more likely to 
be reduced due to an effect of the anions rather than the cations. 
Furthermore, the effect was also dependent on the concentration of the 
anions. This inhibition of SHMT by certain anions is in agreement with that 
observed for rabbit liver (Schirch & Diller, 1971). Consequently inclusion of 
these components to achieve an ionic strength equivalent to that of 
60mM-phosphate is not possible without loss of SHMT activity.
Studies involving metabolic control analysis require conditions as close 
as possible to physiological and therefore 310mM-Hepes was chosen for 
routine assay because it gave approximate physiological ionic strength 
without the need for high phosphate concentrations. A summary of the 
conditions chosen for routine assay is given in Table 4.2.
Direct comparison between the results obtained for 60mM-Hepes and 
60mM-phosphate shows a four-fold higher SHMT activity measured using the 
phosphate buffer. This result is in total contrast to that observed in rat liver 
where the activity measured in 60mM-Hepes, pH7.4 was approximately 40%
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higher than that measured in 60mM-phosphate, pH7.4 (Geller & Kotb, 1989). 
These workers had developed an alternative assay for SHMT based on the 
ability of 5,10-CH2THF to bind to DEAE-cellulose papers. The discrepancy
between their results and those reported here could therefore be due to an 
effect of the ions in the buffer on the binding of the 5,10-CH2THF to the
DEAE-cellulose. If increased ionic strength were to cause decreased 
binding, then the presence of 60mM-phosphate would prevent binding to a 
greater extent than the 60mM-Hepes.
4.2.2. Inhibition of SHMT by 3-fiuoro-D-alanine
The inhibition of SHMT by 3-fluoro-D-alanine (3FDA) was investigated 
because this compound has good specificity for SHMT and may therefore be 
useful for metabolic control analysis. These inhibition studies were therefore 
carried out as preliminary investigations to establish conditions which could 
be utilized for such control analyses.
4.2.2.1. Inhibition of SHMT by 3FDA in crude cell extracts
Studies on the inhibition of SHMT by 3FDA in crude cell extracts 
involved a prior incubation of a crude sonicate from MOLT-4 cells with the 
inhibitor for varying time periods before the SHMT assay itself. No attempt 
was made to try to separate the 3FDA from the enzyme extract after this 
incubation and prior to the assay, and the inhibitor was therefore also present 
throughout the assay period itself. The concentration of 3FDA in the original 
incubation was diluted four-fold into the assay preincubation and five-fold 
overall after addition of the radiolabelled serine. Over the concentration 
range 0-25mM 3FDA (and therefore 0-5mM 3FDA in the assay itself) a plot of 
SHMT activity versus concentration of 3FDA was used to estimate an IC50 of
approximately 9mM (Fig. 4.5). Plotting percentage inhibition relative to the 
control versus concentration of 3FDA resulted in a curve reminiscent of a 
hyperbolic function which seemed to tend towards 100% inhibition (Fig. 4.6). 
Representation of this data as a reciprocal plot and calculation of the 
reciprocal of the y-intercept indicated that the inhibition was tending towards
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a value of 100% (Fig. 4.7). In addition, an IC50 of lOmM was calculated from 
the reciprocal of the x-intercept of this plot.
The length of time of prior incubation of the sonicate with 3FDA did not 
affect the extent of inhibition achieved. This may be because the inhibition 
occurred oniy during the assay period itself, in which case the IC50 would be
approximately five-fold lower. One explanation for this observation would be 
a necessity for the presence of high concentrations of THF to achieve 
measureable inhibition. The instability of THF together with its low 
endogenous concentration could mean that amounts of THF required to 
influence the inhibition of SHMT by 3FDA may not be maintained without 
supplementation with exogenous THF. Dramatic effects of THF on the 
inhibition of SHMT by 3FDA have been observed on the enzyme purified from 
lamb liver (Wang et al., 1981). To test this hypothesis, assay preincubations 
were carried out with different combinations of 3FDA , THF and PLP over two 
different time periods prior to addition of radiolabelled serine plus any 
component previously omitted. The results (Table 4.3) show that the 
omission of THF from the 6min preincubation resulted in only 42% inhibition 
compared to 70% for controls where THF was present. Furthermore, no 
further inhibition is achieved upon increasing the preincubation time from 
6min to 24min in the absence of THF whereas in its presence the 70% 
inhibition achieved at 6min was increased to 93% after a 24min 
preincubation (Table 4.3). This again suggests that inhibition occurs only 
during an incubation when THF is present as an assay component. The 
presence or absence of added PLP did not affect the extent of inhibition. 
This possible effect of THF may be of importance for the interpretation of 
results on the inhibition of SHMT in vivo because different concentrations of 
THF in the cytosolic and mitochondrial compartments could affect the extent 
of inhibition of each of the two isozymes.
4.2.2.2. Inhibition of SHMT by 3FDA in cells in culture
Incubation of MOLT-4 cells in complete growth medium with 
0-25mM-3FDA for 2h and subsequent assay for SHMT suggested that 50% 
inhibition was the maximum effect that could be achieved. Incubations with 
G-10mM-3FDA overnight did not improve this inhibition (Fig. 4.8). One 
possible reason for this observation would be that the rate of synthesis of
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SHMT balances the rate of Inactivation by 3FDA so as to give 50% activity. 
Alternatively, the concentration of endogenous THF may limit the extent of 
inhibition which can be achieved. A further explanation of this result is that a 
proportion of the total SHMT cannot be inhibited by 3FDA. This is not an 
unreasonable suggestion on the basis that two isozymes of SHMT exist in 
different subcellular compartments. Lack of inhibition of a mitochondrial 
isoform relative to cSHMT could result from impermeability of the inner 
mitochondrial membrane to 3FDA, from lower concentrations of THF in the 
mitochondria than in the cytosol or from a structural difference at the active 
site. Studies on purified SHMT from rabbit liver claimed that 3FDA only 
inactivated the cytosolic form (Gavilanes et al., 1983). The studies in the 
following section were designed to discover whether or not two isozymes of 
SHMT exist in MOLT-4 cells, and if so, whether they are both inhibited by 
3FDA.
4.2.3. Digitonin fractionation of cytosolic and mitochondrial SHMT
Digitonin permeabilizes membranes by interaction with cholesterol 
molecules. The plasma membrane has a greater percentage composition of 
cholesterol than the intracellular membranes and therefore digitonin can be 
used to achieve selective permeabilization of the plasma membrane. 
Treatment with digitonin can result in the formation of holes in the plasma 
membrane through which cytosolic components can escape whilst the 
organelles are retained within the cells. Separation of cytosolic components 
from those present in the organelles can then be achieved by centrifugation.
Successful fractionation of cytosolic and mitochondrial components 
using digitonin requires the correct ratio of digitonin to amount of cellular 
material. For these experiments with MOLT-4 cells, the use of 0.16mg 
digitonin per 10® cells resulted in the release of a mass of gelatinous material 
(assumed to be DNA) after 10s incubations and this observation was taken 
as an indicator that the digitonin concentration was too high. Serial dilution of 
the digitonin stock showed that the mass of gelatinous material was no longer 
released after 10s when the concentration of digitonin in the assay was 
decreased to 0.025mg/ml equivalent to 0.004mg digitonin per 10® cells. 
These preliminary observations were used to design a time course for the 
release of LDH from the cells for which O.OOGmg digitonin per 10® cells were
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used (Fig. 4.9). Total release of LDH occurred after a 2min incubation as 
shown by comparison of the measured supernatant activity with the total 
activity and by the absence of LDH activity in the pellet at this time. An 
attempt was made to measure the mitochondrial marker glutamate 
dehydrogenase but this was unsuccessful because of the low total activity 
measured and of variations in the background rate. Incubations were 
therefore carried out using a much larger concentration of cells and with only 
two time points (2min and 5min) over which total release of LDH was 
expected with hopefully minimal release of a mitochondrial marker. The 
concentration of digitonin used was adjusted in accordance with the increase 
in total cellular protein so that the ratio of mg digitonin to 10® cells was kept at 
approximately 0.006 to 1. The results of two experiments are shown in Table
4.4. Total release of LDH was observed as expected after incubation for both 
2min and 5min. Measurement of citrate synthase activity as a
mitochondrial marker indicated that between 5-30% of the total enzyme 
activity was released in these experiments. The greater leakage of the 
mitochondrial marker in Experiment 2 presumably arose because of the 
unintended use of 0.012mg digitonin per 10® cells compared to O.OOSmg 
digitonin per 10® cells in Experiment 1.
Regardless of this difference, the results can still be used to calculate 
the percentage of SHMT located in the cytosolic and In the mitochondrial 
subcellular compartments. The calculation used was that described by 
Janski & Cornell (1980) shown below:
y = (lOOa-c)Z(a-b)
In this equation, 'a' is the fraction of total LDH, and 'b' the fraction of total OS, 
released into the supernatant or retained in the pellet at a given time. The 
parameter ’c’ is the percentage of SHMT released into the supernatant or 
retained in the pellet at a given time. All these parameters have been 
measured experimentally and thus the only unknown value is Y  which Is 
equal to the percentage of total SHMT located in the mitochondria. For the 
purposes of the calculation, LDH release was taken to be exactly 100% 
(Table 4.4). Thus the percentage of SHMT located in the mitochondria can 
be calculated from values obtained for both supernatant and pellet activities 
and for the two different time points. The mean values obtained for the two 
experiments were 90.2 ± 1.93 and 90.7 ± 6.45 (means ± S.D.; n=4) and this
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result indicates that a much higher proportion of SHMT is located in the 
mitochondria of MOLT-4 cells compared to the liver. The percentage of 
SHMT shown to be mitochondrial by purifying the two Isozymes from rabbit 
liver was only 25% (Fujioka, 1969). The same value was calculated for rat 
liver (Ogawa & Fujioka, 1981) although at least 35% had been measured 
previously in the same tissue (Nakano et al., 1968). For monkey liver, at 
least 75% of the total SHMT was shown to be the cytosolic isozyme 
(Ramesh & Appaji Rao, 1980). Partial subcellular distribution of SHMT in rat 
kidney cortex homogenates indicated 48% in the soluble fraction (Lowry et 
a!., 1986). It should be noted at this point that the calculated percentage 
distributions of SHMT from the digitonin experiments assume that the kinetic 
properties of the two isozymes are identical. The advantage of the cited 
experiments with liver is that the actual purification of the two isozymes was 
accomplished and therefore similar kinetic parameters for the two isoforms of 
SHMT could actually be demonstrated.
A high percentage localization of SHMT in the mitochondria may be 
associated with rapid cellular proliferation or even more specifically with 
neoplastic transformation. The possibility for a unique association of this 
nature is opposed by two pieces of evidence. Firstly, only 1-4% of total 
SHMT is thought to be cytosolic in the central nervous system of the rat, the 
rest being associated with particulate structures (Daly & Aprison, 1974). 
Cells of the ONS do not undergo rapid proliferation. Secondly, recent studies 
with LI 210 cells, a mouse leukaemic cell line, suggested indirectly that only 
one-third of the total SHMT was located in the mitochondria (Strong et a!., 
1990). These results however were only based upon the observation that 
during the purification of SHMT from L1210 cells approximately one third of 
the total enzyme did not bind to GM-sephadex columns. A predominantly 
mitochondrial localization of SHMT, as observed in the present work, would 
be consistent with recent reports that point to an important role of mSHMT in 
the provision of one-carbon precursors for nucleotide synthesis de novo (see 
Appling, 1991, for review). This possibilty is discussed further in Chapters 5 
and 7.
The effect of 3FDA on the mitochondrial and cytosolic SHMT activity 
was also investigated in the same experiments as those reported in Table
4.4. Cells were incubated with 10mM-3FDA overnight and the digitonin 
fractionation carried out exactly as for the control cells. The results are given 
in Table 4.5 and show that inhibition of total SHMT activity was 44% and 60%
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for the two experiments. With respect to the large amount of mSHMT, this 
extent of inhibition necessarily implies that 3FDA inhibits mSHMT. This is in 
contrast to the suggestion that 3FDA does not inhibit mSHMT purified from 
rabbit liver (Gavilanes et al., 1983). What is not clear in the present study is 
whether the cSHMT component is in fact inhibited; this is difficult to ascertain 
because of its low control activity which is contaminated by mSHMT released 
into the supernatant fractions. However, the errors on the values for the 
percentage localization of SHMT in the mitochondria of control (90.2 ± 1.93% 
and 90.7 ± 6.45%; mean ± S.D. from four determinations in experiments 1 
and 2 respectively in Table 4.4) and inhibitor-treated (86.2 ± 3.2% and 82.7 ± 
13.4%; mean ± S.D. from four determinations in experiments 1 and 2 
respectively in Table 4.5) cells do not indicate a difference between the two 
sets of data. This would be consistent with inhibition of the two isoforms by 
3FDA to equal extents.
4.2.4. Kinetic analysis of SHMT
The kinetics of SHMT with respect to serine were investigated. The 
enzyme, which is principally mitochondrial on the basis of the digitonin 
experiments, displayed Michaelis-Menten kinetics for serine giving a K^ of
0.5mM and a V^ax of 112 nmol serine/h per 10® cells (Fig. 4.10). The K^ is
very similar to values reported for the cytosolic enzyme purified from a 
number of different sources (Table 4.6). The kinetic parameters for the 
mitochondrial enzyme were only determined for rat liver (Nakano et al., 1968) 
and rabbit liver (Fujioka, 1969) preparations and were very similar to values 
for the cytosolic form. The intracellular serine concentration of 4.4mM 
measured by amino acid analysis means that under physiological conditions 
SHMT should be saturated with respect to serine. Whether or not this is the 
case depends upon the actual serine concentrations in the cytosolic and 
mitochondrial compartments of these cells.
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4.3 Conclusions
The compound 3FDA has been shown to Inhibit SHMT in MOLT-4 
cells and may therefore be a useful tool for metabolic control analysis. This 
possibility was investigated by studying the effects of 3FDA on purine 
synthesis de novo in these cells (Chapter 5). Any effect observed could be a 
consequence of inhibition of the mitochondrial isozyme which accounts for 
90% of the total assayable SHMT.
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Fig. 4.1 Structures of proposed Inhibitors of SHMT.
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Fig. 4.2 Compounds proposed to inhibit the cytosolic and not the 
mitochondrial isozyme of SHMT purified from rabbit liver (Akhtar et ai, 
1975).
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Fig. 4.3 Effect of Inorganic phosphate concentration on SHMT activity 
In crude cell extracts. Cells from the late-logarithmic phase, resuspended
in sucrose buffer at a concentration of 5 x 10® cells per ml, were sonicated 
and triton X-100 added to a final concentration of 0.1% (v/v). SHMT was 
assayed using 25mM-Hepes buffer, pH7.4 with added phosphate to give the 
final concentrations shown. The pH was readjusted to 7.4 if necessary.
SHMT activity is expressed as nmol formaldehyde formed/h per 10® cells and 
values are means ± S.D. of 3 determinations in a single experiment. 
Measurements were initially normalized per mg total protein and were then
converted to per 10® cells using a value of 0.3mg total protein per 10® cells 
(see section 2.2.4, p. 31).
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Fig. 4.4 Effect of ionic strength on SHMT activity in crude cell extracts.
Ceils from the late-logarithmic phase, resuspended In sucrose buffer at a
concentration of 5 x 10® cells per ml, were sonicated and triton X-100 added 
to a final concentration of 0.1% (v/v). SHMT activity was assayed using 
Hepes buffer, pH7.4 using increasing concentrations to vary the ionic 
strength. The actual concentrations of Hepes used and calculations of ionic 
strengths are shown in Appendix 0  (pp. 225-228). The SHMT activity 
measured in the same experiment using 27mM-Hepes plus 
60mM-phosphate, pH7.4, in the assay is shown as a single point (•). Values
are expressed as nmol formaldehyde formed/h per 10® cells and are the 
means ± S.D. from 3 determinations in a single experiment. Values were 
originally normalized per mg total protein and were subsequently converted
to per 10® cells using a value of 0.3mg total protein per 10® cells (see section 
2.2.4, p. 31).
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Fig. 4.5 Effect of 3FDA on SHMT activity in crude cell extracts. Cells 
from the late-logarithmic phase, resuspended in sucrose buffer at a
concentration of 5 x 10^ cells per ml, were sonicated and triton X-100 added 
to a final concentration of 0.1% (v/v). The sonicate was incubated with 3FDA
at 37°C for lOmin ( a ) or 60min (■) prior to assay for SHMT. Results are
expressed as nmol formaldehyde formed/h per 10^ cells and values are 
means ± S.D. from 3 determinations in a single experiment.
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Fig. 4.6 Inhibition of SHMT activity by 3FDA In crude cell extracts. Cells 
from the late-logarithmic phase, resuspended in sucrose buffer at a
concentration of 5 x 10^ cells per ml, were sonicated and triton X-100 added 
to a final concentration of 0.1% (v/v). The sonicate was incubated with 3FDA
at 37^0 for lOmin ( a ) or 60min (■) prior to assay for SHMT. Results are 
expressed as percentage inhibition relative to the control and values are 
means from 3 determinations in a single experiment.
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Fig. 4.7 Reciprocal plot of percentage inhibition versus 3FDA 
concentration. The data used are from Fig. 4.6 for which a iOmin 
incubation with 3FDA was carried out. The reciprocal of the y-intercept is the 
maximum possible inhibition at infinite inhibitor concentration. The negative 
reciprocal of the x-intercept is equivalent to the ICgQ-
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Fig. 4.8 Effect of 3FDA on SHMT activity in cells In culture. Cells from 
the late-logarithmic phase, resuspended in NaMCOg-buffered medium at a
concentration of 5 x 10^ cells per ml, were incubated at 37^0 in a humidified 
incubator in an atmosphere of 5% CO2 in air. After 24h, the cells were finally
resuspended in sucrose buffer at a concentration of approximately 10^ cells 
per ml. This suspension was sonicated and SHMT activity assayed. Enzyme
activity is expressed as nmol formaldehyde formed/h per 10® cells and 
values are means ± S.D. from 3 determinations in a single experiment. The 
lower control SHMT activity measured in this experiment is due to the lack of 
addition of triton X-100.
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Fig. 4.9 Effect of digitonin on the release of LDH from MOLT-4 cells.
Cells from the late-logarithmic phase, resuspended in sucrose buffer at a
concentration of 5 x 10® cells per ml, were cooled on ice. Aliquots of 600pl 
were transferred to separate tubes on ice containing ISOpI of digitonin 
(0.125mg/ml) made up in sucrose buffer. Incubations were carried out on ice 
for the appropriate time and terminated by centrifugation (12000 g, 80s) 
followed by the immediate removal of 700|xl of supernatant to an alternative 
tube. The pellet (including 50|xl residual supernatant) was resuspended in 
700jxl sucrose buffer containing 0.025mg digitonin per ml. Samples for 
measurement of total enzyme activity were prepared by addition of 600|xl cell 
suspension to ISOjxl digitonin (0.125mg/ml) with no centrifugation. All 
samples were then sonicated and triton X-100 added to a final concentration 
of 0.1% (v/v). Lactate dehydrogenase (LDH) activity is expressed as ^imol 
NADH utilized/min per mg protein (mean ± S.E.M. from 3 experiments). The 
total LDH activity was 2.40 ±0.17 |xmol NADH utilized/min per mg protein.
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Fig. 4.10 Kinetics of SHMT for serine. Cells from the late-logarithmic 
phase were resuspended in phosphate-buffered saline at a concentration of
1.5 X 10® cells per ml. The suspension was sonicated and SHMT assayed 
using 60mM-potassium phosphate buffer, pH7.4 in the assay instead of
Hepes. The assay was initiated by the addition of O.IjxCi of [3-*^40]serine per 
0.5ml total assay volume. SHMT activity is expressed as nmol formaldehyde
formed/h per 10® cells and values are the means ± S.D. from 3 
determinations in a single experiment. A. Michaelis-Menten plot. B.
Lineweaver-Burk plot. The kinetic parameters were calculated from a 
computer fit of plot A to the Michaelis-Menten equation.
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Table 4.1 Effect of certain ions on SHMT activity in crude ceil extracts.
Cells from the late-logarithmic phase resuspended in sucrose buffer at a 
concentration of 4 x 10® cells per ml were sonicated and triton X-100 added 
to a final concentration of 0.1% (v/v). SHMT was assayed using 
25mM-Hepes, pH7.4, as the assay buffer with various ions Included as 
shown. Enzyme activity is expressed as nmol formaldehyde formed/h per 
10® cells and values are means ± S.D. from 3 determinations in a single 
experiment. Activities were initially normalized per mg total protein and were 
subsequently converted to per 10® cells using a value of 0.3mg total protein 
per 10® cells (see section 2.2.4, p. 31).
Ions present in assay buffer^ SHMT Activity
25mM-Hepes 8.4 ± 0.59
60mM-Hepes 12.8 ±0.51
60mM-Potassium phosphate 48.2 ±1.46
25mM-Hepes + 60mM-Potassium phosphate 51.2 ±1.05
25mM-Hepes + 150mM-Sodium chloride 23.6 ±1.16
25mM-Hepes + ISOmM-Potassium chloride 26.9 ± 0.57
25mM-Hepes + 300mM-Potassium chloride 16.8 ±0.50
25mM-Hepes + ISOmM-Potassium acetate 35.5 ± 0.50
25mM-Hepes + 300mM-Potassium acetate 28.7 ±0.11
® Concentrations given are the final concentrations in the assay.
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Table 4.2 Summary of the conditions for the routine SHMT assay used
in the present work.
Solution added Volume (p,l) Final concentration
1M-Hepes (KOH), pH7.4 30 300mM-Hepes
lOmM-THF in 50mM-Hepes, pH7.4 
containing 60mM-2-Mercaptoethanol
20 2mM-THF 
lOmM-Hepes 
12mM-2-Mercaptoethanol
2mM-PLP 10 0.2mM-PLP
1.25mM-Serine 20 0.25mM-Serine
Crude cell extract in 0.32M-sucrose, 
10mM-Hepes and 1 mM-EDTA
20 64mM-sucrose
2mM-Hepes
0.2mM-EDTA
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Table 4.3 Effect of THF and PLP on the inhibition of SHMT in crude cell 
extracts by 3FDA.
Cells from the late-logarithmic phase, resuspended In sucrose buffer at a 
concentration of 3x10® cells/ml, were sonicated and triton X-100 added to 
a final concentration of 0.1% (v/v). The sonicate was preincubated at 37°C 
for the appropriate time with various combinations of THF, PLP and 3FDA. 
Assays were then initiated by the addition of [3-i4C]serine as normal plus any 
components previously omitted. Incubations were then carried out at 37^C 
for 20min. SHMT activities are expressed as nmol formaldehyde formed/h 
per 10® cells and values are the means ± S.D. from 3 determinations in a 
single experiment. Each % inhibition has been calculated relative to the 
appropriate control value. Concentrations of components when present 
during the preincubation were 2.5mM-THF, 0.25mM-PLP and 2.5mM-3FDA. 
During the 20min assay period itself, concentrations were 1.7mM-THF, 
0.17mM-PLP, 1.7mM-3FDA and 0.21 mM-serine.
Preincubation THF PLP 3FDA SHMT %
time (min) Activity inhibition
6 + + - 49.6 ±2.02 0
6 + + + 14.7 ±1.13 70
6 - + - 55.9 ±0.81 0
6 - + + 32.4 ±0.29 42
6 + - - 51.5 ±1.36 0
6 + - + 14.6 ±1.18 72
24 + + - 26.9 ±1.49 0
24 + + + 1.9 ±0.21 93
24 + - 63.4 ±0.14 0
24 - + + 35.5 ±2.05 44
24 + - - 29.4 ±0.18 0
24 + - + 2.6 ±0.33 91
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Table 4.4 Digitonin fractionation of the cytosolic and mitochondrial
isozymes of SHMT.
Cells from the late-logarithmic phase were resuspended in sucrose buffer at a 
concentration of 15 x 10® cells per ml and cooled on ice. Aliquots of 400|xl 
were transferred to separate tubes containing IOOp.1 of digitonin (0.5mg/ml) 
dissolved in sucrose buffer. Incubations were carried out on ice for 2min or 
5min and terminated by centrifugation (12000 g, 30s) followed by immediate 
removal of 350jxl of supernatant to an alternative tube. To the pellet (plus 
residual 150|xl supernatant) were added 350|xl of sucrose buffer containing 
0.1 mg digitonin per ml. Total enzyme activity samples were prepared without 
centrifugation. All samples were sonicated and triton X-100 added to a final 
concentration of 2% (v/v). Lactate dehydrogenase (LDH) activity was 
measured as a cytosolic marker and is expressed as pmol NADH utilized/min 
per mg protein. Citrate synthase (CS) activity was measured as a 
mitochondrial marker and is expressed as nmol CoA formed/min per mg 
protein. SHMT is expressed as nmol formaldehyde formed/h per 10® cells. 
All values are means ± S.D. from 3 determinations in a single experiment. 
The percentage of SHMT in the mitochondria was calculated as previously 
described (Janski & Cornell, 1980). N.A.: Not applicable
Incubation Fraction LDH CS SHMT % 0f SHMT
time (min) activity activity activity in mitochondria
Experiment 1
0 Total 2.26 ±0.16 97.6 ±2.49 53.4 ± 2.79 N.A.
2 Supn* 2.38 ±0.13 7.4 ±0.59 9.1 ± 0.95 89.8
2 Pellet -0.20 ±0.12 97.4 ±2.49 49.2 ± 2.69 92.9
5 Supn* 2.48 ±0.15 5.8 ± 0.34 8.8 ± 0.47 88.3
5 Pellet -0.22 ±0.08 95.6 ±3.99 46.8 ± 1.77 89.8
Experiment 2
0 Total 2.47 ±0.09 100.8 ±11.30 58.4 ± 3.03 N.A.
2 Supn* 2.56 ±0.29 22.6 ±2.07 18.1 ± 3.15 88.6
2 Pellet -0.08 ±0.11 83.4 ±8.70 43.3 ± 8.07 89.2
5 Supn* 2.68 ±0.20 11.7 ±0.94 14.8 ± 1.54 84.9
5 Pellet -0.16 ±0.08 96.8 ± 3.67 53.1 ± 4.08 99.9
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Table 4.5 Digitonin fractionation of the cytosoiic and mitochondrial
isozymes of SHMT from cells treated with 3FDA.
Cells from the late-logarithmic phase were resuspended in complete growth 
medium at a concentration of 5 x 10® cells/ml and incubated at 37°C for 24h 
in the presence of 1DmM-3FDA. They were then resuspended in sucrose 
buffer at a concentration of 15 x 10® cells per ml and cooled on ice. Aliquots 
of 400|xl were transferred to separate tubes containing lOOjil of digitonin 
(0.5mg/ml) dissolved in sucrose buffer. Incubations were carried out on Ice 
for 2min or 5min and terminated by centrifugation (12000 g, 30s) followed by 
immediate removal of 350jxl of supernatant to an alternative tube. To the 
pellet (plus residual 150}xl supernatant) were added 350|xl of sucrose buffer 
containing 0.1 mg digitonin per ml. Total enzyme activity samples were 
prepared without centrifugation. All samples were sonicated and triton X-100 
added to a final concentration of 2% (v/v). Lactate dehydrogenase (LDH) 
activity was measured as a cytosolic marker and is expressed as pmol NADH 
utilized/min per mg protein. Citrate synthase (CS) activity was measured as 
a mitochondrial marker and is expressed as nmol CoA formed/min per mg 
protein. SHMT is expressed as nmol formaldehyde formed/h per 10® cells. 
All values are means ± S.D. from 3 determinations in a single experiment. 
The results presented are for two individual experiments and are directly 
comparable with those shown in Table 4.4. The percentage of SHMT in the 
mitochondria was calculated as previously described (Janski & Cornell,
1980). N.A.; Not applicable.
Incubation Fraction LDH CS SHMT %  Of SHMT
time (min) activity activity activity in mitochondria
Experiment 1
0 Total 2.37 ±0.21 110.1 ±19.70 30.3 ± 0.74 N.A.
2 Supn^ 2.69 ±0.13 7.4 ± 0.50 7.1 ± 0.71 82.5
2 Pellet -0.06 ±0.13 105.9 ±16.50 26.2 ± 1.04 89.6
5 Supn^ 2.62 ±0.17 6.0 ± 0.54 6.1 ± 0.59 84.6
5 Pellet -0.07 ±0.13 101.4 ± 8.27 24.7 ± 1.45 88.0
Experiment 2
0 Total 2.31 ±0.17 89.0 ±12.50 23.4 ± 2.42 N.A.
2 Supn^ 2.42 ±0.18 30.8 ± 1.84 8.9 ± 0.34 91.3
2 Pellet -0.06 ±0.11 53.8 ± 5.67 12.1 ± 1.20 91.6
5 Supn' 2.38 ±0.20 23.1 ± 1.26 8.4 ± 0.31 84.9
5 Pellet -0.08 ±0.08 68.9 ± 6.09 10.7 ± 0.73 63.1
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Table 4.6 Values for the for serine of SHMT from a number of 
different sources.
Source Km (mM) Reference
Rat liver^ 0.54 Nakano étal., 1968
Rat liver^ 0.45 Palekar étal., 1973
Rabbit liver^ 0.8 Schirch & Diller, 1971
Rabbit liver^ 1.3 Fujioka, 1969
Monkey liver^ 0.7 Ramesh & Appaji Rao, 1978
Pig kidneys 0.9 Kumar ef a/., 1976
L1210cellsa 0.5-0.6 Strong et al., 1990
Rat lensb 0.25 Geller et al., 1990
Human CLLc cells^ 0.6 Thorndike et al., 1979
MOLT-4 cells 0.5 Present study
a Purified cytosolic enzyme 
h Cell homogenate 
c Chronic lymphocytic leukaemia
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Chapter 5: Serine as a source of one-carbon units for purine synthesis 
de novo
5.1 Introduction
The pathway of purine synthesis de novo consists of a sequence of 
ten distinct reactions which convert 5-phosphoribosyl-1-pyrophosphate 
(PRPP) to inosinate (IMP) (Fig. 5.1). A branch point at IMP distributes flux 
between the synthesis of adenylate and guanylate (Fig. 5.2). The PRPP is 
synthesized from ribose-5-phosphate generated by the pentose phosphate 
pathway. The atoms of the purine ring are derived from glutamine, glycine, 
10-CHOTHF, CO2 and aspartate (Fig. 5.3). Both glycine and the one-carbon
unit of 10-CHOTHF can be derived from serine. This is accomplished 
through the reaction catalysed by SHMT which converts serine and THF into 
glycine and 5,10-CH2THF. This latter folate cofactor is converted to
10-CHOTHF by the action of two folate-dependent enzymes which form part 
of the C-j-THF synthase complex. An understanding of one-carbon folate
metabolism is therefore an integral part of a study of serine metabolism in 
relation to purine synthesis de novo.
5.1.1 Polyglutamylatlon of folates
Folic acid is made up of three functional groups; a pterin, 
p-aminobenzoic acid and glutamate (Fig. 5.4). The active cofactor for 
one-carbon metabolism is 5,6,7,8-tetrahydrofolate (THF) which bonds to 
different one-carbon groups at its N® or Nf® nitrogen atom or both. The most 
reduced one-carbon group carried by THF is a methyl group forming 
5-CH3THF; this is the principle form of reduced THF found both in the plasma
and in the cytosol of the rat hepatocyte (Wang et al., 1967; Horne et al., 
1989). The transport of folate compounds into L I210 cells involves at least 
two distinct systems, one for folic acid itself and the other for reduced folates 
such as 5-CH3THF (Huennekens et al., 1978). The reduced folates are
transported by a high-affinity, concentrative system whereas folic acid is 
transported by a non-concentrative system for which the principle substrate is 
adenine (Suresh et ai, 1979). More recently, folic acid and 5-CH3THF have
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been shown to bind to a membrane receptor which, in a monkey kidney 
epithelial cell line, is internalized (Kamen et al., 1988). Once inside the cell, 
folic acid is converted into DHF and subsequently to THF by the enzyme 
dihydrofolate reductase (DHFR). The 5-CHgTHF which is transported into
the cell must be utilized for methionine biosynthesis in order to generate THF 
for use in other cytoplasmic processes.
Intracellular THF cofactors often exist in a polyglutamylated form due 
to the addition of more glutamate residues by the enzyme folylpolyglutamate 
synthetase (McGuire & Bertino, 1981). Chinese hamster ovary cell mutants 
deficient in polyglutamylation require thymidine, adenosine and glycine for 
growth and exhibit lower overall cellular concentrations of folate (McBurney & 
Whitmore, 1974). These workers suggested that the physiological role of 
polyglutamylation might be for the intracellular retention of the transported 
monoglutamates. Polyglutamylation also has striking effects on the kinetic 
parameters of some folate-requiring enzymes, often associated with an 
increase in V^ax and a decrease in the (McGuire & Bertino, 1981). The
extent of polyglutamylation may also be responsible for determining the flux 
of one-carbon units through competing metabolic pathways or the efficiency 
of channeling through multienzyme complexes. The number of glutamate 
residues added depends on the tissue and on the cofactor form, and addition 
of up to six glutamates to the monoglutamate has been demonstrated. The 
same enzyme is responsible for each glutamate addition and the most 
preferred substrate is THF whilst the least preferred is S-CHgTHF, at least in
Chinese hamster ovary cells (Taylor & Hanna, 1977). Pentaglutamate and 
hexaglutamate derivatives are the principle forms found in rat liver and LI 210 
cells (Schirch & Strong, 1989).
5.1.2 The Ci-THF synthase complex
The C-j-THF synthase complex is a trifunctional protein which 
catalyses 5,10-CH2THF dehydrogenase, 5,10-CHTHF cyclohydrolase and 
10-CHOTHF synthetase enzyme activities (Fig. 5.5). This protein has been 
purified from porcine (MacKenzie, 1973), ovine (Paukert et al., 1976) and 
chicken (Wasserman et al, 1983) liver and more recently from LI 210 cells 
(Strong et ai, 1990). Tissue distribution studies in the rat showed that the 
highest activity of the C-j-THF synthase complex was detected in the kidney.
132
followed closely by the liver (Cheek & Appling, 1989). Studies with 
Saccharomvces cerevisiae have indicated the presence of a mitochondrial 
isozyme of the C-j-THF synthase (Shannon & Rabinowitz, 1986). This
isozyme is dispensable, however, because mutant strains which lack a 
functional gene encoding the mitochondrial enzyme complex are viable and 
their growth is unaffected relative to wild-type strains.
The 5,10-CH2THF dehydrogenase activity of the C-j-THF synthase 
requires NADP+ as a cofactor for the conversion of 5,10-CH2THF to
5,10-CHTHF. An NAD+-dependent activity originally discovered in the Ehrlich 
ascites tumour cell (Scrimgeour & Huennekens, 1960) has been 
demonstrated in a number of tissues and cell types which include bone 
marrow, spleen and thymus of the adult animal, tissues of embryonic origin, 
and also transformed cells (Mejia & MacKenzie, 1985). The prevalence of 
this enzyme activity therefore appears to be associated with rapidly dividing 
cells although it is not present in regenerating liver or cultured fibroblasts. 
The NAD+-dependent 5,10-CH2THF dehydrogenase activity is part of a
bifunctional protein which also catalyses the cyclohydrolase activity (Mejia et 
al., 1986). The 10-CHOTHF activity is absent from the complex, however, in 
contrast to the activities of the C-j-THF synthase. In further contrast, the
bifunctional protein has been detected principally in the mitochondria, at least 
in the three transformed murine cell types studied (Mejia & MacKenzie, 
1988). The presence of a mitochondrial pre-sequence in the mRNA for the 
bifunctional protein further supports its mitochondrial localization (Bélanger & 
MacKenzie, 1989).
5.1.3 Other fates of 5,10-CH2THF
The conversion of 5,10-CH2THF to 10-CHOTHF for purine synthesis 
de novo is not the only metabolic fate of this one-carbon cofactor (Fig. 5.6). 
Méthylation of dUMP to dTMP by thymidylate synthetase utilizes
5.10-CH2THF directly with the concomitant formation of DHF. Alternatively,
5.10-CH2THF can be reduced to 5-CH3THF by 5,10-CH2THF reductase. 
The 5-CH3THF is then used as a methyl donor for methionine biosynthesis 
from homocysteine; this is a vitamin B-j2-dependent reaction catalysed by
methionine synthetase. It is widely believed that this is the only metabolic 
route which utilizes 5-CH3THF and that the reductase does not function in the
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reverse direction. Therefore any deficiency in methionine synthetase activity 
could lead to an accumulation of 5-CHgTHF, a phenomenon often referred to
as the "methyl trap". Inhibition of methionine synthetase by nitrous oxide in 
rat liver resulted in a build up of 5-CH3THF at the expense of 10-CHOTHF
and THF (Horne et al., 1989). Furthermore, these alterations in folate 
distribution occurred in the cytosol but not in the mitochondria; because 
reduced folates cannot cross the mitochondrial inner membrane (see section 
5.1.4, p. 135) this indicated that methionine biosynthesis occurs in the cytosol 
(Horne et al., 1989). A methyltransferase activity has, however, been 
detected in mitochondria, but differs from the cytosolic form in that it does not 
require vitamin B12 for its activity (Wang et ai, 1967).
Other workers have provided evidence that oxidation of 5-CH3THF to 
formate and CO2 can occur in rat liver in vivo after administration of 
methionine (Lumb et al., 1989). The loss of 5-CH3THF also corresponded
with a rise in THF and 10-CHOTHF concentrations (Lumb et al., 1988). The 
observed N-methylation of biogenic amines by 5-CH3THF has been attributed
to the formation of a condensation product between the amine and 
formaldehyde. This would require a reversal of the 5-CH3THF reductase 
activity for the synthesis of 5,10-CH2THF (Taylor & Hanna, 1975). It is not 
clear however whether this particular reductase activity Is physiologically 
important (Pearson & Turner, 1975).
The possibility that one-carbon units can be trapped as 5-CH3THF
means that fluxes through the reductase enzyme and through thymidylate 
synthetase and the C-j-THF synthase need to be carefully regulated. A 
decrease in the ratio of 5,10-CH2THF to DHF has been proposed as a 
physiological mechanism to inhibit the reductase activity and thereby direct 
one-carbon units towards utilization for purine and pyrimidine biosynthesis 
(Matthews & Baugh, 1980). The actual concentration of 5,10-CH2THF may
potentially increase the utilization of one-carbon units for nucleotide 
biosynthesis because thymidylate synthetase and 5,10-CH2THF 
dehydrogenase are not saturated with 5,10-CH2THF at physiological 
concentrations whereas the 5,10-CH2THF reductase is saturated (Green et 
al., 1988). Inhibition of the reductase by an increase in the ratio of the 
concentration of S-adenosylmethionine to that of S-adenosylhomocysteine 
would be one mechanism by which the concentration of 5,10-CH2THF could 
be elevated. Furthermore, 5-CH3THF inhibits SHMT in vitro and a decrease 
in the concentration of this cofactor in vivo could therefore relieve inhibition of
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SHMT and thereby increase the production of 5,10-CH2THF from serine
(Matthews et al., 1982). There are reports, however, that the concentration 
of 5,10-CH2THF and other reduced folates are maintained within a narrow 
range at the expense of 5-CH3THF and 10-CHOTHF in L1210 cells (Bunni et 
al., 1988).
5.1.4 Serine and one-carbon metabolism In mitochondria
The existence of a mitochondrial isozyme of SHMT and certain other 
folate-dependent enzymes together with the presence of folate derivatives in 
mitochondria imply a role of these organelles in one-carbon metabolism. 
Supply of folate coenzymes to the mitochondrial matrix is accomplished by 
the transport of folic acid and DHF across the inner mitochondrial membrane; 
transport of the more reduced folate compounds has not been demonstrated 
(Cybulski & Fisher, 1981). Provision of reduced folate cofactors for 
mitochondrial processes must therefore rely on the presence of a 
mitochondrial DHFR to convert DHF to THF. This enzyme has been detected 
in mitochondria from Saccharomyces cerevisiae (Zelikson & Luzzati, 1977) 
but a ubiquitous distribution of this mitochondrial enzyme has not been 
demonstrated. One-carbon units required for the formation of 5,10-CH2THF
may then be derived from serine by the action of mSHMT or alternatively 
from glycine by the glycine cleavage system (see Fig. 5.16). Uptake of serine 
and glycine across the mitochondrial Inner membrane has been 
demonstrated and occurs by a facilitated transport process (Cybulski & 
Fisher, 1976). More detailed work indicated that the L-isomer of several 
neutral amino acids may be transported by the same stereospecific transport 
protein (Cybulski & Fisher, 1977). Another potential source of one-carbon 
units is from choline catabolism which is known to occur in mitochondria (Fig.
5.7). Conversion of choline into glycine results in the formation of two 
molecules of formaldehyde which can be converted to 5,10-CH2THF and a
third one-carbon unit is used to methylate homocysteine to form methionine.
Various physiological roles of mSHMT have been proposed. In 
combination with cSHMT, the mitochondrial enzyme has been postulated to 
provide a shuttle system for one-carbon units (in the form of the 
hydroxymethyl group of serine) across the mitochondrial membrane (Cybulski 
& Fisher, 1976). In experiments with rat liver, mSHMT was thought to initiate
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the catabolism of serine, the resulting glycine being further catabolized by the 
glycine cleavage system and the 5,10-CH2THF by the sequential action of
5.10-CH2THF dehydrogenase, 5,10-CHTHF cyclohydrolase and 10-CHOTHF 
: NADP+ oxidoreductase (Yoshida & Kikuchi, 1970). However, the 
stoichiometry of glycine disappearance in isolated rat liver mitochondria does 
not support this proposal. Instead, evidence supports a glycine oxidation 
system catalysing serine synthesis through the coupled reactions of the 
glycine cleavage system and mSHMT (Snell, 1984) (see Fig. 5.16). This 
coupling has also been proposed to occur in rat kidney cortex slices, the 
serine produced being thought in vivo to enter the blood stream and be 
utilized as a gluconeogenic substrate by the liver (Rowsell et a!., 1982). One 
other possible role of mSHMT is in carnitine biosynthesis because crystalline 
mSHMT has been shown to convert 3-hydroxy-8-N-trimethyllysine to
4-butyrobetaine aldehyde, one of the reactions in the formation of carnitine 
from lysine (Hulse eta!., 1978).
Chinese hamster ovary cell mutants have been used to show that 
mSHMT is important in satisfying the metabolic needs of these cells for 
glycine. One mutant which lacked mSHMT had a requirement for glycine and 
reversion to glycine independence was associated with the reappearance of 
mSHMT activity (Chasin et al., 1974). Furthermore, the amount of mSHMT 
generally correlated with the intracellular glycine concentration and also with 
the extent to which exogenous serine increased the glycine pool (Pfendner & 
Pizer, 1980). Two other glycine-requiring auxotrophs had impaired mSHMT 
activity due possibly to a deficiency in mitochondrial recycling of the THF 
cofactors rather than in the mSHMT itself (Taylor & Hanna, 1982).
In the absence of mitochondrial transport of reduced folates, the ability 
of mitochondria to convert 5,10-CH2THF to 10-CHOTHF Is of Importance In
providing the precursor for the formation of formylmethionyl tRNA for the 
initiation of mitochondrial protein synthesis. Recently, one-carbon units 
derived from serine have been shown to exit intact rat liver mitochondria as 
formate (Barlowe & Appling, 1988). This would require the conversion of
5.10-GH2THF to 10-CHOTHF and subsequent release of formate by a
reversal of the 10-CHOTHF synthetase reaction. Thus one-carbon 
metabolism in mitochondria may be capable of supplying one-carbon units for 
cytoplasmic processes. The formate which exits the mitochondria can be 
converted to 10-CHOTHF by the cytoplasmic ATP-dependent 10-CHOTHF 
synthetase. Interestingly, mutants of Saccharomyces cerevisiae. which lack
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this enzyme activity, are impaired in their ability to synthesize purines utilizing 
serine as a one-carbon source (McKenzie & Jones, 1977). Furthermore, a 
yeast mutant which lacks mSHMT has a general requirement for dTMP, 
methionine, adenine and histidine for cell growth (Zelikson & Luzzati, 1976). 
In addition, the supply of one-carbon units by mSHMT for cytoplasmic 
processes would easily explain the dispensability of cytoplasmic
5,10-CH2THF dehydrogenase and 5,10-CHTHF cyclohydrolase in other yeast
mutants (McKenzie & Jones, 1977).
5.1.5 Serine as a supply of one-carbon units in MOLT-4 cells
The experiments reported in this chapter were designed to determine 
whether extracellular serine is the only significant source of one-carbon units 
for purine synthesis de novo in MOLT-4 cells. The possibility for other 
sources of one-carbon units or for an endogenous source of serine were 
investigated. An unexpected effect of 3FDA on purine synthesis de novo, 
together with the knowledge that SHMT is principally located in the 
mitochondria, led to a study on the potential role of mSHMT in the 
resynthesis of serine from surplus glycine.
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5.2 Results and Discussion
5.2.1 HPLC and spectrophotometric analysis of purines
Hypoxanthine, guanine and adenine standards were easily separated 
by the HPLC method described (section 2.4.5, p. 36) with retention times of 
9min, 19min and 22min respectively. In all samples chromatographed, only 
peaks for adenine and guanine were observed; a peak for hypoxanthine was 
never detected.
The absorbance spectra for adenine and guanine are different (Fig.
5.8). The calculation of the individual amounts of each purine in a mixture of 
the two is therefore possible by measurement of the absorbance of such a 
mixture at two wavelengths at which adenine and guanine show differential 
absorption. Since the eluate from the Bond Elut columns contained only 
adenine and guanine (as demonstrated by HPLC), measurement of its 
absorbance at 248.5nm and 262.5nm (the absorbance maxima of guanine 
and adenine respectively) was used to calculate the amounts of adenine and 
guanine without the need for HPLC. In order to achieve this, absorption 
coefficents for adenine and guanine at both wavelengths need to be known. 
Two of these values are published (Dawson ef a/.,1969).
£262.5nm (adenine) = 13.15mM-‘icm^
G248.5nm (guanine) = 11.40mM-icni^
To calculate the remaining two coefficients, standard solutions of 
0.06mM-adenine and 0.06mM-guanine were prepared and the concentration 
verified using the published absorption coefficients and the measured 
absorbances at the appropriate wavelength. Use of the calculated 
concentration of the standard solutions and values for the absorbance of the 
guanine solution at 262.5nm and the adenine solution at 248.5nm enabled 
the following absorption coefficients to be calculated:
£248.5nm (adenine) = 9.43mM-icm‘1
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£262.5nm (guanine) = 7.49mM”'icrn^
Concentrations of adenine and guanine in samples can now be 
calculated by measurement of the absorbance at 248.5nm and 262.5nm by 
use of the simultaneous equations (5.1) and (5.2).
Absorbance at 248.5nm = (9.43 x [A]) + (11.40 x [G]) (5.1 )
Absorbance at 262.5nm = (13.15 x [A]) + (7.49 x [G]) (5.2)
Rearrangement of equation (5.1) gives equation (5.3).
[A] = (AbS248.5 - (11.4 X [G]))/9.43 (5.3)
Substitution of this expression for [A] into equation (5.2) results in 
equation (5.4).
[G] = ((13.15 X AbS248.5) - (9.43 x Abspa? i;))/79.27 (5.4)
Thus the concentration of guanine can be calculated and substitution 
of this value into equation (5.3) enables determination of the concentration of 
adenine. The concentrations obtained will have the units of millimolar. For 
spectrophotometric measurements, IOOp.1 of the eluate was diluted five-fold 
with 0.1M-HCI and these concentrations can therefore be converted to 
amount of purine per ml of original hydrolysate using equation (5.5).
nmol purine/ml hydrolysate = Concentration (mM) x 5 x 1500 (5.5)
recovery x 0.9
In order to verify this method, the amounts of adenine and guanine 
present in eluates from three separate experiments were measured using 
HPLC and the spectrophotometric method just described. Good agreement 
was obtained between the two sets of data (Table 5.1) and the 
spectrophotometric method was therefore considered to be a reliable 
alternative to HPLC.
For normalization of purine synthesis data, absorbance at 260nm was 
measured for samples from the first hydrolysate in the purine isolation
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procedure. The values obtained are indicative of the total amount of purine 
present and therefore of the amount of cellular material present. By 
measurement of the absorbance at 260nm together with the actual amount 
of total purine present by HPLC, an experimental absorption coefficient can 
be calculated to convert all absorbance measurements at 260nm into 
concentrations of total purine. The results of an experiment in which cells 
from the late-logarithmic phase were incubated at 37°C for Oh or 4h, in the 
presence or absence of 3FDA, and two further experiments in which cells 
from the logarithmic phase were incubated at 37°C for 1h are shown in Table
5.2. The results of the third experiment shown in this Table demonstrate that 
neither the incubation at 37°C nor the presence of 3FDA affected the 
calciilated absorption coefficient. The first experiment, however, did give a 
lower value than the other two experiments and the reason for this is not 
clear unless the greater amount of cellular material used in this experiment 
affected the final value.
The results also show that, in the first two experiments, a 20% higher 
concentration of adenine relative to guanine was apparent whereas 
concentrations were equal in the third experiment. The method of using the 
absorbance at 260nm to calculate the amount of total purine is only valid if 
the ratio of adenine to guanine in the samples remains constant because 
these two purines do not absorb to the same extent at 260nm (see Fig. 5.8). 
However, the fact that the absorption coefficient was not affected in the 
second experiment suggested that this might not be a problem. The only 
apparent reason for the discrepancy in the adenine to guanine ratio is that 
cells taken from the logarithmic phase had high concentrations of adenine 
relative to guanine whereas cells from the late-logarithmic phase had equal 
amounts of the two purines. As the rate of purine synthesis de novo is higher 
during the logarithmic phase than during the late-logarithmic phase (see Fig.
6.3, p. 199), increased AMP synthesis might be associated with a higher rate 
of purine formation. This hypothesis is, however, in total contrast to results 
from experiments with a hepatoma cell line in which an increase in the 
synthesis of GMP relative to AMP was observed upon transition from the 
plateau to the logarithmic phase of growth (Natsumeda etal., 1988).
With no conclusive evidence that the phase of cell growth affected the 
value of the absorption coefficient, a mean value from the three experiments 
was calculated (11.8 ± 0.4mM-^mean ± S.E.M. from three experiments). This 
value was used in all experiments to calculate the concentration of total
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purine present in each hydrolysate from the absorbance measurements at 
260nm. Knowledge of the cell concentration then enables calculation of nmol 
purine/10® cells. The values calculated for cells taken from three different 
parts of the growth curve show that there is a decrease in the amount of total 
purine/10® cells as the cells progress from the logarithmic phase of growth to 
the plateau phase (Table 5.3). : The difference between the values for the
cells from the logarithmic and f is no i statistically significant
(P<0.T7). All purine synthesis data was originally calculated as nmol purine 
synthesized/h as a percentage of total purine (unless otherwise indicated); 
these values were converted to nmol purine synthesized/h per 10® cells using 
the appropriate values from Table 5.3.
5.2.2. Effect of 3-fiuoro-D-alanine on the incorporation of radioiabei 
from [3-i4c]serine into purine
Incorporation of radiolabel from extracellular [3-l4C]serine into total 
purine was linear up to at least 2h (Fig. 5.9). incubation of cells with various 
concentrations of 3FDA overnight and subsequent assay for purine synthesis 
revealed a dose-dependent stimulation of the incorporation of radiolabel from 
[3-i4c]serine into purine (Fig. 5.10). in this experiment, assay of SHMT was 
not performed but a separate experiment had already shown that these 
incubation conditions with 3FDA did result in significant inhibition of SHMT 
(see Fig. 4.8, p. 121). Further experiments with only the highest 
concentration of inhibitor confirmed this unexpected stimulation. Incubation 
of cells for 24h with 1GmM-3FDA inhibited SHMT activity by 24% and purine 
synthesis was increased from 2.38 ± 0.19 to 4.07 ± 0.12nmol purine 
synthesized/h per 10® cells, an increase of 71^1^'^ The difference between 
these values is statistically significant (F<0.001). T’Rese results were 
calculated using data for the 2h incubation, but longer incubations were also 
carried out in an attempt to show whether the effect was a real stimulation of 
purine synthesis de novo or whether the stimulation was only apparent due to 
an effect on the intracellular specific activity of the serine. By use of longer 
incubations, purine synthesis can be measured by calculation of the 
difference between the total amount of purine present after Incubation from 
that present at zero time. These total amounts can be determined from the 
absorbances measured at 262.5nm and 248.5nm as described in section
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5.2.1 (p. 138). Unfortunately, the errors on these determinations were too 
iarge to conclude that the effect of 3FDA on purine synthesis was indeed a 
stimulation of the actual rate but the results did show that the rate measured 
from [3-i4C]serine was approximately half of the total rate (Fig. 5.11). This 
therefore implies that either an intracellular source of serine or possibly of 
one-carbon units dilutes the radiolabei from extracellular serine within the 
cells. This possibility is discussed further in the following sections.
The incorporation of radiolabel from [3-*i4C]serine into adenine and 
guanine bases was compared in 3FDA-treated and control cells using HPLC. 
An effect of 3FDA on the specific activity of the intracellular serine or one- 
carbon pool would be expected to affect incorporation of radiolabel into 
adenine and guanine to equal extents. This is however not the case in that in 
the presence of 3FDA incorporation of radiolabel from [3-i4C]serine into 
adenine is stimulated to a greater extent than that into guanine (Table 5.4). 
This observation means that 3FDA must exert its stimulatory effect on purine 
synthesis de novo at a position after the branch point from IMP (see Fig. 5.2). 
The 3FDA may exert a direct stimulatory effect on adenylosuccinate 
synthetase or adenylosuccinate lyase or may influence the concentration of 
an effector of one of these enzymes. The concentration of aspartate, one of 
the substrates for adenylosuccinate synthetase (see Fig. 5.2), has been 
shown to be limiting for adenylate synthesis in Ehriich ascites tumour cells 
(Crabtree & Henderson, 1971) . Thus if treatment with 3FDA caused an 
increase in the concentration of aspartate, increased flux to adenine relative 
to that to guanine could occur. Another possible explanation for this result 
might be increased activity of the purine nucleotide cycle in inhibitor-treated 
ceils. The 3FDA may have a toxic effect on these cells, may be by virtue of 
the hydrogen fluoride which is released as a result of the metabolism of this 
inhibitor. If toxicity resulted in a decrease in ATP concentration, the 
conversion of AMP to IMP by AMP deaminase could be activated to maintain 
the ATP/ADP ratio (Kovacevic et al., 1988; also see section 1.2, p. 13). The 
consequent decrease in the concentration of AMP could reduce the inhibition 
of adenylosuccinate synthetase and result in increased flux through the 
adenylate branch from IMP.
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5.2.3 Measurement of the incorporation of radioiabei from [‘i^CJNaHCOs 
into purine
5.2.3.1 Theoretical calculation of the extracellular concentration of
bicarbonate
RPMi 1640 medium is often buffered using a NaHC03/C02 buffering 
system. The presence of 5% CO2 in the gas phase above the medium 
maintains a pH of 7.4 when the concentration of NaHCOg in the medium is 
23.8mM. Removal of the 5% CO2 disturbs the equilibrium of the
interconversion of NaHCOg and carbonic acid (see Fig. 5.12) and results in 
the release of CO2. In the absence of large quantities of NaHCOg, the RPMI 
1640 can alternatively be buffered with Hepes at a concentration of 25mM so 
that the osmotic strength is similar to that in the presence of the usual 
concentration of NaHCOg. The RPMi 1640 pius 25mM-Hepes can be
adjusted to pH7.4 with NaOH. The resultant medium has been termed 
Hepes-buffered RPMI 1640 and this medium supplemented with 10% (v/v) 
dialysed PCS and lOnM-ieucovorin termed Hepes-buffered medium.
In the total absence of added NaHCOg, some bicarbonate wili be 
present in the medium as a result of an equilibrium with the CO2 in the 
atmosphere. At any one pH value, the concentration of CO2 in the gas phase 
will be proportional to the concentration of NaHCOg in the medium. 
Therefore, if 5% COg maintains a NaHCOg concentration of 23.8mM at 
pH7.4, then at this same pH the 0.04% CO2 in the atmosphere (Cantarow &
Trumper, 1975) will result in a bicarbonate concentration of 0.19mM.
When NaHCOg is now added to the medium in a closed vessel, CO2
will be released into the gas phase and the concentration of bicarbonate will 
simultaneously decrease until an equilibrium is attained. For the experiments 
reported here, the total volume of the assay vessel was 22.6 ± 0.13ml (mean 
± S.D. from six determinations) and the volume of cell suspension used was 
1.3ml. Thus the total gas volume above the cell suspension was 21.3mi. At 
37°C and 1 atmosphere pressure, one mole of air occupies a volume of 25.4 
litres. Therefore there will be 0.00084mol of air in 21.3ml of gas space 
containing 340nmol of COg (using a value of 0.04% COg in air). As
previously shown, the concentration of bicarbonate present in the medium at 
pH7.4 is 0.19mM. Therefore 1.3ml of medium contains 250nmol of 
bicarbonate and the percentage of total carbon in bicarbonate/COg present in
143
the aqueous phase is 42% with 58% present as COg in the gas phase. On 
the assumption that NaHCOg added to the same closed system will distribute 
itself in the same ratio between aqueous and gas phases, the final aqueous 
concentration of bicarbonate once equilibrium has been attained can be 
calculated. This calculation is illustrated using an experiment in which 
[i4C]NaHCOg was added to a concentration of 2mM to 1.3ml of
Hepes-buffered medium in the closed system described above. The 
immediate resulting concentration of aqueous bicarbonate is therefore 
2.19mM equivalent to 2.85}xmol per 1.3ml of medium. Thus the total amount 
of bicarbonate pius COg present in the closed system is 3.19|imol (2.85^imol 
in aqueous phase + 0.34p.moi COg in gas phase). If this distributes at
equilibrium such that 42% of the carbon is in the aqueous phase, there will be 
1.34p,mol bicarbonate in the aqueous phase at equilibrium. The final 
concentration of bicarbonate is therefore 1.03mM.
In order to verify that the distribution ratio between the gas phase and 
the aqueous phase under these conditions is valid, [l4C]NaHCOg was used
and the loss of radiolabel from the medium in the same closed system 
monitored after various times. The results indicate that radiolabei is indeed 
lost from the medium and that equilibrium is attained after 20min of shaking 
at 37°C (Fig. 5.13). The theoretical amount of radiolabei in the medium at
equilibrium can be calculated. The specific activity of the added 
[i4c]NaHCOg was 1365dpm/nmol and 2.6|xmol of NaHCOg are added per 
1.3ml of medium. The total amount of carbon present as COg or bicarbonate
in the gas and aqueous phase is 3.19}xmol (calculated earlier). Thus the final 
specific activity calculated after consideration of the bicarbonate and COg
already present is 1112dpm/nmol. If 1.34|xmol of bicarbonate are present in 
the 1.3mi of medium at equilibrium (calculated earlier), then the theoretical 
radioactivity in the aqueous phase will be 1.49 x 10^dpm. This value can also 
be measured experimentally from the results depicted in Fig. 5.13. The 
measured '•4c dpm in the medium at equilibrium (30min incubation time) was 
1.51 ± 0.096 X 10^dpm (mean ± S.D. from triplicate measurements) per 1.3mi 
which is very close to the theoretically calculated value of 1.49 x lO^dpm.
To test these calculations further a second concentration of NaHCOg 
was used. This time NaHCOg at the same specific activity as before 
(1365dpm/nmol) was added to a concentration of 3mM and the radiolabei in 
the medium measured after a 1h incubation at 37®C. The final concentration 
of bicarbonate at equilibrium was calculated as 1.45mM. The new specific
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activity is 1188dpm/nmol bicarbonate. The theoretical radioactivity in the 
medium is therefore 2.24 x 10® dpm per 1.3ml. The measured i^Cdpm 
remaining in the medium after 1h was 2.69 ± 0.14 x 10® dpm (mean ± S.D. 
from 5 experiments), which is 51% of that originally added. The theoretical 
and measured results are therefore not totally consistent presumably 
because the distribution of carbon into the aqueous phase and the gas phase 
is not exactly as that assumed for the theoretical calculation.
5.2.S.2 Determination of saturating concentrations of bicarbonate for purine 
synthesis
The high concentration of NaHCOg (23.8mM) normally used in RPMI 
1640 medium necessitates the use of expensive amounts of [14C]NaHCOg to
achieve a useful specific activity. Measurement of purine synthesis from 
[3-**4C]serine was therefore used to determine the effects of lowering the 
NaHCOg concentration on this process and to choose a concentration of 
NaHCOg for future use. The range of NaHCOg concentrations which could
be tested was restricted because 0.19mM was the lowest theoretical 
concentration possible (due to the equilibrium between bicarbonate and COg
in the air) and final concentrations of 2.3mM or higher caused changes in the 
pH of the Hepes-buffered RPMi 1640. The effect of this range of NaHCOg
concentrations on purine synthesis from [3-i^C]serine is shown in Fig. 5.14. 
The calculated Km from a computer fit of the data is 0.19 ± 0.038mM and the 
Vmax was 2.44 ± 0.14nmol purine synthesized/h per 10® cells. This Vmax 
value is comparable to the rate obtained using NaHCOg-buffered medium
(2.01 ± 0.14nmol purine synthesized/h per 10® cells). A final concentration of 
1.45mM-bicarbonate (equivalent to the addition of NaHCOg to 3mM) was
chosen for routine use, a value 8.5 times the proposed Km which should 
therefore be close to saturating conditions and a concentration which does 
not affect the pH of the assay medium.
The stock solution of [i^CJNaHCOg had an activity of 0.8mCi/mi
(8.6mCi/mmole) and that prepared immediately prior to use consisted of 3 
volumes of this radiolabelied stock to 10 volumes of 350mM-NaHCOg.
Addition of 13|xl of this solution to 1.3ml of assay medium results in an 
immediate initial concentration of 3.19mM-NaHCOg and specific activity of
1285dpm/nmol bicarbonate. After equilibration the theoretical bicarbonate
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concentration is 1.45mM and specific activity is 1188dpm/nmol bicarbonate. 
Thus, after the addition of [i^CjNaHCOg to initiate the assay, the specific
activity decreases by only 8% during the equilibration of the carbon in the gas 
and aqueous phases. The concentration of bicarbonate in the medium will 
initially be high and will subsequently decrease until equilibrium is attained 
but this should not be a problem as the bicarbonate concentration is 
saturating for purine synthesis. The specific activity of bicarbonate has 
therefore been taken as 1188dpm/nmol for all future calculations which 
involve the measurement of purine synthesis rates from [i^CjNaHCOg under
these conditions.
Incorporation of radiolabei from [i4C]NaHCOg into total purine under 
the conditions described was linear up to 3h of incubation at 37°C (Fig. 
5.15a) and up to cell concentrations of 7 x 10® celis/mi (Fig. 5.15b). 
Conditions which included a 1 h incubation time and a cell concentration of 
2 x 10® cells/ml were employed for routine use. Samples of eluate from the 
Bond Elut columns were chromatographed by HPLC to check that all the 
radioactivity which eluted from the columns could be accounted for in the 
adenine and guanine peaks. This was in fact the case (Table 5.5) and 
71 ± 1.5% (mean ± S.e .m . from three experiments) of the total radiolabei 
incorporated into purine was associated with adenine. Although incorporation 
of [3-i4c]serine into purine was not measured in these experiments, previous 
results (Table 5.4) suggested that this percentage was only 58 ± 2.9% (mean 
±  S.E.M. from three experiments) when radiolabelied serine is the precursor. 
The difference between these values is statisticaliy significant (P<0.02). The 
greater incorporation of radiolabei from p4C]NaHC03 into adenine relative to
guanine may however be because the cells were taken from the logarithmic 
phase in the p4c]NaHCOg experiments but from the late-logarithmic phase in
the [3-i4C]serine experiments. This would be consistent with earlier 
observations that the adenine concentration is higher than the guanine 
concentration during the logarithmic phase (see section 5.2.1, p. 138). To 
account for the difference on the basis that different radiolabelied precursors 
were used would have to mean that the non-radiolabelled one-carbon source 
dilutes radiolabei from [3-i4c]serine into adenine to a greater extent than that 
into guanine. This is unlikely because incorporation of radiolabei into purine 
via the one-carbon pool occurs before the IMP branch point (see Figs. 5.1 
and 5.2).
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Another surprising result shown in Table 5.5 is that 89 ± 2.9% (mean ± 
S.E.M. from three experiments) of the total radiolabei present in the 
hydroiysate after the first boiiing step is associated with purine. This means 
that the rate of incorporation of p^CjNaHCOg into total pyrimidines can at
most be only one ninth of that into total purine. Much higher rates of 
incorporation of radioiabei from serine and from formate into purine relative to 
thymine have been measured in lectin-stimuiated human lymphocytes (Rowe 
et al., 1985). However, in total contrast, rates of pyrimidine biosynthesis from 
p4c]NaHCOg were consistently higher than those of purine synthesis in the
lymphoblast cell line WI-L2 (Huisman et a!., 1979).
5.2.4 Possibility of the formation of one-carbon units for purine 
synthesis de novo from an alternative source to extracellular serine
5.2.4.1 Evidence for an endogenous source of serine or an alternative 
source of one-carbon units
The results from eight separate experiments which compared rates of 
purine synthesis from [i4C]NaHCOg and [3-‘>4C]serine are shown in Table
5.6. The difference between the rates measured from these precursors is 
statistically significant (P<0.01). The rate of 3.90nmol purine synthesized/h 
per 10® cells measured from p4C]NaHC0g was not significantly different from
the total rate calculated from spectrophotometric measurements 
(3.78 ± 0.53nmol purine synthesized/h per 10® cells; mean ± S.E.M. from three 
experiments) (Fig. 5.11). The theoretical rate of purine synthesis can also be 
calculated from the cell doubling time. Exponential ceil growth can be 
described by equation (5.6) where Cq is the number of cells at zero-time, C*
the number of cells at time T and % the fractional change in cell number over 
that time.
Ct/Co = e^t (5.6)
At the cell doubling time (tg), equation (5.7) holds.
Ct2 = 2Cq (5.7)
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Substitution of Ct by 2Cq into equation (5.6) resuits in equation (5.8).
X = \n2/\2 (5.8)
The doubling time for MOLT-4 cells has been measured as 17h (see 
Fig. 2.2, p. 44) and therefore X = 0.041. The percentage increase in cell 
number, and presumably therefore the percentage increase in the amount of 
purine, is 4.1% per hour. Using the previously calculated value of 112.5nmol 
purines per 10® cells (Table 5.3) for cells from the logarithmic phase, this rate 
is equivalent to 4.61 nmol purine synthesized/h per 10® cells. This theoretical 
rate is therefore 18% higher than that calculated from [i40]NaHCOg
incorporation into purine (3.90 ± 0.39) which could be due to a slight dilution 
of the radiolabelied bicarbonate by endogenously-derived COg. For cells
taken from the late-logarithmic phase, the nmol purine per 10® ceils was
103.5 and therefore the theoretical purine synthesis rate Is 4.24nmol purine 
synthesized/h per 10® cells. This value is 12% higher than that calculated for 
late-logarithmic cells from spectrophotometric measurements which was 
3.78nmol purines synthesized/h per 10® cells (Fig. 5.11). This discrepancy 
could be accounted for by the fact that the cell doubling time at the 
late-logarithmic phase could be higher than 17h. In fact, a cell doubling time 
of 19h at this stage of growth would make these rates compare exactly.
The fact that three independent calculations of the total purine 
synthesis rate all compare favourably and are all higher than the purine 
synthesis rate measured from [3-i4C]serine is good evidence for a 
non-radiolabelled source of either serine or one-carbon units. The rate of 
purine synthesis measured from [3-i4C]serine is 63% of that measured from 
[ i4C]NaHC03 (Table 5.6), 53% of the theoretical rate calculated from the cell
doubling time of logarithmic cells and 54% of the total rate measured by 
spectrophotometry in iate-iogarithmic cells (Fig. 5.11).
5.2.4.2 Extracellular glycine as a possible source of one-carbon units
One hypothesis for the source of non-radiolabelled one-carbon units is 
that serine is synthesized from glycine by mSHMT. The synthesis of one 
purine molecule requires two one-carbon units but only one glycine molecule 
(see Figs. 5.1 and 5.3). Furthermore, pyrimidine synthesis utilizes a
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one-carbon unit and no glycine. The supply of one-carbon units from serine 
for nucieotide biosynthesis therefore results in the concomitant formation of 
glycine surplus to the requirements for purine synthesis de novo. In theory 
this glycine could enter the mitochondria where two molecules may be 
converted into one molecule of serine via the coupled reactions of mSHMT 
and the glycine cleavage system (Fig. 5.16). This coupling has been 
demonstrated for serine production in isolated rat liver mitochondria (see 
Snell, 1984) and in rat kidney cortex slices (Rowsell et al., 1982). 
Furthermore, in avian liver mitochondria, 5,10-CH2THF formed by glycine
oxidation has been shown to provide one-carbon units for purine synthesis de 
novo (Yoshida & Kikuchi, 1971; 1973). This hypothesis would also neatly 
explain the stimulation of purine synthesis upon treatment with 3FDA 
because inhibition of mSHMT (which has been demonstrated in these ceils) 
would decrease the supply of endogenously-derived serine to the cytosol 
which would increase the specific activity of the cytosolic serine pool. To test 
this hypothesis, rates of purine synthesis from [1-i4C]glycine and 
[2-i4C]glycine were compared. Under the proposed scheme, radiolabei from 
[2-i4C]glycine but not from [1-’>4C]glycine would become incorporated into 
the one-carbon pool. Therefore although radiolabei from both precursors will 
become incorporated into purine as glycine per se, an apparent greater 
incorporation should occur from [2-i4C]glycine if the proposed mitochondrial 
scheme is operating. The results showed, however, that there was no 
significant difference (P>0.3) between the rates of purine synthesis from 
[1-i4c]glycine or [2-i4C]glycine (Table 5.6) which means that the extracellular 
glycine would not be responsible for dilution of the one-carbon pool formed 
from extracellular radiolabelied serine. This result is consistent with 
experiments involved with one-carbon metabolism in lectin-stimulated human 
lymphocytes (Rowe et a!., 1985). The measured purine synthesis rate from 
P^Cjglycine (0.68nmol purine synthesized/h per 10® cells) was similar to that 
measured in another lymphoblastic leukaemia cell line, MOLT-3 (1.04nmol 
glycine utilized/h per 10® cells) (Marijnen et a!., 1989). In the present study, 
the rate of purine synthesis measured from [i4C]glycine was approximately 
one-sixth of that measured from [i^CJNaHCOs. This result suggests that
SHMT plus any other endogenous source of glycine supply this amino acid 
for purine synthesis at five times the rate of supply from the uptake of 
extracellular glycine.
149
Measurements of purine synthesis from p^CjNaHCOs, [3-i4C]serine, 
[1“i4c]glycine and [2-‘*4C]gIycine were also made in the presence and 
absence of 3FDA. The extent of inhibition of SHMT by 3FDA seemed to vary 
for an unknown reason but these differences have been used to try to 
correlate stimulation of purine synthesis with the extent of inhibition of SHMT 
(Table 5.7). The stimulation of purine synthesis from [l4C]glycine upon 3FDA 
treatment did correlate with the extent of inhibition of SHMT which implied 
that this effect is mediated through SHMT. This observation would be 
expected because inhibition of SHMT will reduce the supply of endogenously- 
derived glycine which therefore increases the specific activity of the 
intracelluiar glycine pool. The stimulation of purine synthesis from 
p4C]NaHC03 [3-i^C]serine correlated with each other but not with the
extent of inhibition of SHMT. These results therefore suggest that the 
stimulation of purine synthesis sometimes observed upon treatment with 
3FDA is due to an effect of this inhibitor other than its interaction with SHMT. 
This inference is consistent with the greater stimulation of adenine synthesis 
relative to guanine which wouid not be expected from an effect on SHMT.
5.2.4.3 Other possible sources of serine or one-carbon units for purine 
synthesis de novo
The availability of an RPMi 1640 medium with a number of 
components absent enabled a study to test the effect of omission of these 
compounds on purine synthesis de novo. Measurements of incorporation of 
radioiabei from [3-'l4C]serine into purine shouid increase if an alternative 
supply of one-carbon units is removed. Omission of leucovorin, glycine, 
tryptophan or histidine from the extracellular medium (which are all potential 
sources of one-carbon units) had no effect on purine synthesis from 
[3-i4C]serine, or indeed from p4c]NaHC03, either in the presence or
absence of extracellular serine (Table 5.8). The incorporation of radiolabei 
from [3-i4c]serine (285jiM) into purine was 100 times greater than that from 
5-p4C]CHOTHF (radiolabelied leucovorin) (5 i^M) in L1210 ceils (Matheriy 
et al., 1987). This result indicates that, at an extracellular concentration of 
10nM-ieucovorin as used in the present work, this folate cofactor is not likely 
to be a significant source of one-carbon units in the presence of normal 
medium concentrations of serine. Radiolabei from [2-l4C]glycine or
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p4C]histidine did not contribute to the one-carbon pool in lectin-activated 
human lymphocytes but that from p^Cjtryptophan did account for 2.5% of the 
total purines synthesized (Rowe etal., 1985).
Foetal calf serum was omitted to test whether serine derived from 
serum proteins contributes to the intracellular serine pool. The absence of 
FCS resulted in a 22% decrease in purine synthesis measured from 
p^CjNaHCOg, and a 33% decrease from [3-i4C]serine, relative to controls in
which FCS was present. These decreases were not observed, however, 
when FCS was omitted together with serine (Table 5.8). These results 
indicate that FCS is necessary to support maximum purine synthesis but 
does not effect the rate maintained by the alternative one-carbon supply to 
serine. The fact that omission of FCS did not cause an apparent stimulation 
of the rate of purine synthesis from [3-‘*^C]senne dismisses this medium 
component as the alternative source of one-carbon units.
Omission of glutamine from the assay medium had significant effects 
on purine synthesis measured from both [l^cjNaHCOg and [3-i4C]serine. A 
reduction in the rate of purine synthesis (measured from p^CJNaHCOs) of 
approximately 80% resulted from a lack of glutamine in the medium in 
accordance with its important role as a substrate for two of the synthetic 
reactions and as a nitrogen donor for the conversion of IMP to GMP. The 
fact that any purine synthesis occurred at all indicated the presence of an 
endogenously-derived supply of glutamine unless the low rate was 
maintained by glutamine which remained in the ceils after the wash 
procedure. Omission of glutamate together with glutamine did not result in 
any further reduction in the rate of purine synthesis which showed that the 
low rate observed in the absence of glutamine was not accounted for by 
synthesis of glutamine from extracellular glutamate. This observation might 
have been explained by a lack of glutamine synthetase activity in these cells, 
except that the presence of this enzyme has been reported in MOLT-4 cells 
(Kitoh etal., 1990). However, the result may also be explained by an inability 
of the cells to transport glutamate. Glutamate itself could also be 
endogenously synthesized from ammonia and 2-ketoglutarate in a reaction 
catalysed by glutamate dehydrogenase.
The omission of glucose from the extracellular medium also had a 
significant effect on the rate of purine synthesis from both [3-l4C]serine and 
['i4C]NaHC03. The rate from [ i4C]NaHC03 was reduced by 68.7 ± 1.8%
(mean ± S.E.M. from three experiments) in the absence of glucose. This
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result is not surprising because giucose is a precursor of the PRPP required 
for nucleotide synthesis. The fact that purine synthesis does occur in the 
absence of glucose could be due to turnover of the purine nucleotide pool to 
regenerate PRPP in the absence of net nucleotide synthesis, or couid 
alternatively be accounted for by residual glucose remaining in the ceiis after 
washing. Glucose is in fact a potential source of one-carbon units as well by 
virtue of its conversion to serine via the glycolytic intermediate, 
3-phosphoglycerate, and the subsequent action of the phosphorylated 
pathway of serine biosynthesis (Snell, 1986). In order to show any operation 
of this pathway, an attempt was made to measure incorporation of radiolabei 
from [i4C]glucose into purine bases.
5.2.4.4 Glucose as a potential supplier of one-carbon units
The high concentration of glucose in the RPMI 1640 medium
(11.ImM) would necessitate the use of an expensive quantity of radiolabei to
achieve a useful specific activity. A preliminary experiment suggested that a
decrease in the glucose concentration from lOmM to 0.25mM maintained a 
maximal purine synthetic rate from [i4c]NaHC0g, This concentration was
therefore chosen for routine use for measurement of purine synthesis from 
[i4C]glucose. Cell viability at lower glucose concentrations was assessed by 
measurement of ATP concentrations after a 1.5h incubation at 37^C. The 
results showed that, in the total absence of extracellular glucose, the ATP 
concentration was decreased by 13% relative to that measured at 
lOmM-glucose. Maximal ATP concentrations were achieved at 2mM-giucose 
(Fig. 5.17). Thus lowering the glucose concentration was not considered to 
have a deleterious effect on cell viability.
A second problem is that glucose can be converted to 
3-phosphoglycerate either by glycolysis or by the pentose phosphate 
pathway. Of the six carbon atoms of glucose, only carbons 1 and 6 can 
potentially enter the one-carbon pool through serine. If the glucose furnishes 
the 3-phosphoglycerate pool by the pentose phosphate pathway however, 
the carbon atom at position 1 is released as carbon dioxide and does not 
appear in the triose phosphate. The final specific activity of the 
3-phosphoglycerate pool when [1-'i4c]glucose or [6-i4C]glucose are used will 
therefore depend on the relative contributions of the pentose phosphate
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pathway and glycolysis. Comparison of the rates of radiolabei incorporation 
into purine from [1-i4c]glucose and [6-'*4c]glucose shouid give an indication 
as to which of the two pathways is dominant. Initial experiments using these 
two radiolabelied precursors resulted in no incorporation of radiolabei into 
purine whatsoever. This result could be because of an absence of the 
phosphorylated pathway in these cells, because of feedback inhibition of 
phosphoserine phosphatase by serine (Fell & Snell, 1988) or because of 
substantial dilution of the radiolabelied giucose by an endogenous source, 
such as glycogen for example. Experiments were also carried out in the 
absence of extracellular serine and rates from p^cjNaHGOs and
[3-i4c]serine were measured to check that purine synthesis de novo was 
actually occurring. The results from these experiments (Table 5.9) confirmed 
that incorporation of radiolabei from [i4C]glucose Into purine only becomes 
apparent when the 0.25mM extracellular serine is removed. Furthermore, the 
insignificant difference between the incorporation from [1-‘•^cjglucose or [6- 
i^C]glucose indicated that any supply of 3-phosphoglycerate by the pentose 
phosphate pathway is insignificant relative to that by glycolysis and that 
therefore the specific activity of the 3-phosphoglycerate pool can be taken as 
half that of the extracellular glucose.
One unexpected result shown in Table 5.9 involves the magnitude of 
the purine synthesis rate from [i^cjNaHCOg at low glucose concentrations in
the absence of serine. The results indicated that in the absence of serine at 
lOmM-glucose a rate of 43% of that in the presence of serine was measured. 
When the glucose concentration was reduced to 0.25mM, the purine 
synthesis rate was measured at 83% of its maximal capacity regardless of 
whether serine was present or not. This result was investigated more fully by 
comparison of rates of purine synthesis from p4C]NaHG03 in the presence
or absence of serine over a range of extracellular glucose concentrations 
(Fig. 5.18). Quite clearly glucose at high yet physiological concentrations 
appears to repress purine synthesis in the absence of extracellular serine. 
This observation is difficult to explain, but would be consistent with inhibition 
of the phosphorylated pathway of serine biosynthesis by a metabolite of 
glucose at high extracellular glucose concentrations. In the presence of 
serine this effect would not be observed because the activity of the 
phosphorylated pathway is low anyway. What advantage such an inhibition 
would have to the cell is not at all obvious. A metabolite of glucose may
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rather inhibit an alternative supply of serine or of one-carbon units. This 
possibility is discussed further in Chapter 7 (p. 212).
The incorporation of radioactivity from [e-l^Cjglucose and 
[3-”i4C]serine into purine showed an inverse correlation with each other as 
the extracellular serine concentration was increased (Fig. 5.19). The 
incorporation of radiolabei from [6-i4C]glucose into purine is decreased in a 
dose-dependent manner by increasing concentrations of extracellular serine, 
but whether this is due simply to a dilution of the radiolabelied one-carbon 
pool by serine, or whether it results from feedback inhibition of serine 
biosynthesis, cannot be inferred from this experiment. What is clear is that 
serine derived from extraceliular glucose does not account for the difference 
observed between the total purine synthesis rate and that measured from 
[3-i4C]serine. Furthermore, the apparent reciprocal regulation of the rates 
measured from [3-‘*4C]serine and from [6-i^C]glucose at different serine 
concentrations, plus the fact that the sum of these rates remains a fairly 
constant proportion of the total rate measured from bicarbonate (Fig. 5.19), 
suggest that the alternative supply of one-carbon units is a source distinct 
from serine and which is not affected by the extracellular serine 
concentration.
5.2.4.5 Serine derived from intracellular protein degradation
Serine derived from the turnover of intracelluiar protein could decrease 
the specific activity of the radiolabelied serine transported into the celi even 
though this process is unlikely to involve a net production of serine. Attempts 
to measure this process involved the culture of cells in complete growth 
medium which contained [r/ng-2-l4c]tryptophan until the cell number had 
increased approximately fifty-fold. On the assumption that tryptophan is 
metabolized only to protein in these cells, and by allowing such a large 
increase in cell number, the intracellular free tryptophan and that associated 
with protein tend to a specific activity equivalent to that of the extracellular 
tryptophan. Thorough washing of the cells in tryptophan-free Hepes-buffered 
medium, followed by transfer of the protein-radiolabelled cells into complete 
Hepes-buffered medium, initiated measurement of the release of radiolabei 
from protein to the cytosol and extracellular space. A time course for protein 
degradation measured in this way was linear for at least 3h (Fig. 5.20) and
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gave an initial rate of 1400dpm released/h per 10® cells equivalent to 
0.53nmol tryptophan released/h per 10® cells.
The percentage of tryptophan in total cell protein can be determined by 
measurement of the protein concentration of a cell sonicate and of the 
radiolabei present in the same sample. The mean percentage of tryptophan 
in total protein was 1.09 ± 0.035% (mean ± S.E.M. from three experiments; 
see Table 5.10). Now 0.53nmol tryptophan released/h is equivalent to 
0.108|xg tryptophan released/h which is therefore equivalent to 9.91 |xg total 
protein degraded/h per 10® cells. The mean mass of protein per 10® cells is 
0.3mg (see section 2.2.4, p. 31) and therefore the rate of protein breakdown 
expressed as the percentage of total protein degraded is 3.3% per hour per 
10® cells. In order to convert this value to nmol serine released from 
protein/h per 10® cells, the percentage of serine in total protein needs to be 
known. This value is not known for these cells but percentage compositions 
of serine in various celluiar proteins have been published. For example, in a 
list of 22 proteins (Dixon & Webb, 1964), the mean percentage of total protein 
by weight which was serine was 6.64 ± 2.76% (mean ± S.D. from 22 
determinations). Using this value, a 3.3% protein degradation rate releases 
6.3nmol serine/h per 10® cells. The rate of uptake of extraceliular serine into 
the cell was 29.4nmol serine/h per 10® cells (see Fig. 3.4, p. 81). Thus 
formation of serine from protein degradation is unlikely to dilute the serine 
pool to the extent required to account for the difference in the purine 
synthesis rate calculated from incorporation of radiolabei from [3-‘*4C]serine 
into purine relative to the total rate.
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5.3 Conclusions
The results presented in this chapter imply that a source of one-carbon 
units distinct from those derived from extraceilular serine is available for 
purine synthesis de novo. This putative source has not been identified but 
contributions by extracellular tryptophan, histidine, leucovorin, serum protein 
and glycine have all been eliminated. The contribution of giucose to the 
one-carbon pool through serine biosynthesis was insignificant relative to that 
by extracellular serine, but the possibility that non-radiolabelled glucose 
(derived from turnover of carbohydrate stores in the cell) diluted the 
radiolabelied glucose cannot be ruled out. The rate of serine production from 
protein degradation is not sufficient to account for dilution of the radiolabelied 
serine to explain the difference between the rates of purine synthesis 
measured from the incorporation of radiolabei from [3-‘*4C]serine into purine 
and the total rate. Possibilities for potential sources of serine or one-carbon 
units are discussed more fully in Chapter 7 with regard to the quantification of 
pathways involved in serine metabolism as measured in experiments in this 
thesis.
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5-PhosphorlbosyI-1-pyrophosphate (PRPP) 
Phosphoribosylpyrophosphate ^  Glutamine
amidotransferase Glutamate
5-Phosphoribosyl-1 -amine
Phosphoribosylglycinamide 1 ^  ATP + Glycine <-------------- Serine
synthetase $^A D P  + Phosphate 
5-Phosphoribosylglycinamide (GAR)
Phosphoribosylglycinamide ^  10-CHOTHF <----------------- Serine
formyitransferase i^ T H F  
5-Phosphoribosyl-A/-formylglycinamide (FGAR) 
Phosphorlbosylformylglyclnamlde ^  Glutamine + ATP
synthetase t^Glutamate + ADP + phosphate
5-Phosphoribosyi-A/-formylgIycinamidine (FGAM) 
Phosphorlbosylamlnolmldazole 1^  ATP
synthetase i^ A D P  + phosphate
5-Phosphoribosyi-5-aminoimidazole (AIR) 
Phosphorlbosylamlnolmldazole CO2 
carboxylase t
5-Phosphoribosyl-4-carboxy-5-aminoimidazole 
Phosphorlbosylamlnolmldazole ^  Aspartate + ATP
suednocarboxamide synthetase ADP + phosphate 
5-Phosphoribosyl-4-(A/-succinocarboxamide)-5-aminolmidazole 
Adenylosuccinate I
lyase ^^Fumarate 
5-Phosphoribosyl-5-amino-4-imidazoiecarboxamide
Phosphorlbosylamlnolmldazole 10-CHOTHF 4 ---------------  Serine
carboxamide formyitransferase f^ T H F
5-Phosphoribosyl-5-formamido-4-imidazolecarboxamide 
Inoslnate I 
cyclohydrolase | ^ H 20 
lriosine-5-phosphate (IMP)
Fig. 5.1 The ten reactions of the purine synthesis de novo pathway 
from PRPP to inoslnate. The substrates which can be formed from serine 
are shown in bold.
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Glutamine Glutamate
ATP AMP + PP,
Xanthylate ^  GMP
NADH + H+ GMP synthetase
NAD+ IMP dehydrogenase
IMP
Aspartate
GTP
GDP + P,
Adenylosuccinate
synthetase
Adenylosuccinate lyase 
Adenylosuccinate —......  ^ ------------- ► AMP
Fumarate
Fig. 5.2 Branch point at IMP for the de novo synthesis of adenine and 
guanine nucleotides.
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C02 Glycine
\  / A
Aspartate . C  ^
N r c
1 I I C-#-10-CHOTHF
,c. Le
10-CHOTHF N N
\
Glutamine Glutamine
Fig. 5.3 The source of atoms in the purine ring.
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Pterin p-amlnobenzoate Glutamate
 ^  ^  ►
OH
I ioNH--------- ( ( ^  \ ----------CONHCHCH2CH2COO-
4 1 N5 /  '---- ' 600-A / \  /
N3 II ,6— 9CH2
/ \  / '
H2N N1 N8
Fig. 5.4 Structure of folic acid. The smaller numbers indicate the way in
which the various atoms are numbered.
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5 ,1 0 - C H 2 T H F
5,10-CH2THF
dehydrogenase
— NADP+ 
^NADPH
5,10-CHTHF
5,10-CHTHF
cyclohydrolase
10-CHOTHF
10-CHOTHF
synthetase
/"^ A D P  + phosphate 
ATP
Formate + THF
Fig. 5.5 Enzyme activities of the C^-THF synthase complex.
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GAR transformylase or 
AlCAR transformylase
10-CHOTHF
THF
FGAR or FAICAR
i
Ci'THF synthase
5 .IO-CH2THF
GAR or AlCAR
NADPH
NADP+
NADPH \  /  
NADP+ /  5,10-CH2THF dUMP
THF <■
Methionine
synthetase
Hoys /  reductase 
5-CH3THF
Thymidylate 
synthetase
dTMP
DHF
NADPH
NADP+
Dihydrofolate
reductase
THF
Fig. 5.6 Metabolic fates of 5,10-CH2THF. The THF formed in each case 
can be converted back to 5,10-CH2THF by SHMT. GAR: 5-phosphoribosyl- 
glycinamide; FGAR: 5-phosphonbosyl-/V-formylglycinamide; AlCAR
5-phosphoribosyl-5-amino-4-imldazole carboxamide; FAICAR
5-phosphoribosyl-5-formamido-4-imidazole carboxamide; Met: methionine 
Hcys: Homocysteine.
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Fig. 5.7 Choiine catabolism in mitochondria.
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Fig. 5.8 Absorption spectra for adenine and guanine. The Individual 
spectra for a solution of 0.06mM-adenine and O.OBmM-guanine are shown. 
These spectra are sufficiently different such that measurements of the 
absorbance of a solution which contains a mixture of adenine and guanine at 
248.5nm and 262.5nm can be used to calculate the Individual concentrations 
of adenine and guanine. These two particular wavelengths were chosen 
because absorption coefficients for adenine at 262.5nm and for guanine at 
248.5nm are published (see text for details of calculation; section 5.2.1, 
p. 138).
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Fig. 5.9 Time course for the incorporation of radiolabei from 
[3-14c]serine into purine. Cells from the late-logarithmic phase were 
resuspended in NaHCOg-buffered medium at a concentration of 1.7 x 10^
cells/ml. The assay was initiated by the addition of O.IjxCi [3-*^4Q]serine per
ml cell suspension, incubations were carried out at 37°C for the appropriate 
time and terminated by centrifugation through silicone oil. Rates are
expressed as nmol purine synthesized per 10® cells and are the mean ± S.D. 
from triplicate measurements.
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Fig. 5.10 Effect of 3FDA on the incorporation of radiolabei from 
[3-14c]serine into purine. Cells suspended in complete growth medium at 
5 X 10^ cells/ml with incubated with the appropriate concentration of 3FDA at 
37°C in a humidified incubator in an atmosphere of 6% CO2 in air. After 24h 
the cells were washed once with NaHCOg-buffered medium and were finally
resuspended in this medium to a concentration of approximately 1.5 x 10® 
cells/ml. The assay for purine synthesis was initiated by the addition of
O.IjxCi [3-"^4C]serine per ml cell suspension and incubations at 37®C carried
out for 1 or 2h. Values are expressed as nmol purine synthesized per 10® 
cells and are the mean ± S.D. from triplicate measurements. The mean rates 
for the 1h incubation in the presence of 5mM or 10mM-3FDA were the same 
and appear as a single point. The error on the rate in the presence of 
10mM-3FDA after a 2h incubation is within the symbol.
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Fig. 5.11 Effect of 3FDA on purine synthesis: Comparison of rates 
calculated from the incorporation of radiolabel from [3-14c]serine into 
purine and from measurements of total purine by spectrophotometry.
Cells from the late-logarithmic phase were resuspended in complete growth
medium at a concentration of 5 x 10^ cells/ml and incubated with 
10mM-SFDA at 37^0 in a humidified incubator in an atmosphere of 5% CO2 
in air. After 24h the cells were washed in NaHCOg-buffered medium and
resuspended in the same medium to a concentration of 2 x 10® cells/ml. The 
radiolabelled assay for purine synthesis was initiated by the addition of
Q.1|xCi [3-‘*4c]serine per ml cell suspension and incubation at 37^C carried 
out for the appropriate time before centrifugation through silicone oil. 
Samples at zero-time (without radiolabel) were also centrifuged through oil 
for measurement of total purine by spectrophotometry (section 5.2.1, p. 138). 
Subtraction of this value from the total purine present after the appropriate 
incubation time determined the total purine synthesis rate. Rates were 
originally calculated as nmol purine synthesized as a percentage of total
purine and were then converted to nmol purine synthesized per 10® cells
using values of 103.5 and 104.2nmol purine/10® cells for control and 
inhibitor-treated cells respectively (see Table 5.3, p. 179). Results are the 
mean ± S.E.M. from three experiments; the lighter coloured bars represent 
values for 3FDA-treated cells and the black bars represent control samples.
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Fig. 5.12 Equilibrium between gaseous CO2 and HCO3- ions In solution.
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Fig. 5.13 Time course for the loss of radiolabel from p^cjNaHCOa from
an aqueous phase to a gas phase. Incubation vials containing 1.3ml of 
Hepes-buffered medium were capped with rubber seals and preincubated at
370c  for 20min. After this time 1.6 i^Ci 200mM-[14c]NaHC03 (0.58|xCi/pmol)
were added through the seal using a Hamilton syringe and the radioactivity 
remaining in the aqueous phase determined after various times. Results are
expressed as the ”^ 4cdpm in 1.3ml of medium and are the mean ± S.D. from 
triplicate determinations in a single experiment.
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Fig. 5.14 Effect of bicarbonate concentration on incorporation of
radiolabel from [3-^^C]serine Into purine. Cells from the late-logarithmic 
phase were resuspended in Hepes-buffered medium at a concentration of
2 x 1 0 ® cells/ml. Appropriate concentrations of NaHCOg were added, the
vials sealed and then preincubated at 37^0 for 20min. The assay for purine 
synthesis was initiated by the addition of G.125^Ci [3-"*4c]serine per 1.3ml 
cell suspension and terminated after 1h by centrifugation of 1ml through 
silicone oil. Results were originally calculated as nmol purine syntheslzed/h 
as a percentage of total purine and were then converted to nmol purine
synthesized/h per 10® cells using a value of 104.8nmol total purine/10® cells 
(see Table 5.3, p. 179). Results are the mean ± S.E.M. from three
experiments apart from the rate measured at 2.29mM-HG03” which is the
mean from two experiments only.
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Fig. 5.15 Incorporation of radioiabel from p^C]NaHC03 Into purine:
Linearity with time and cell concentration. Cells from the logarithmic 
phase were suspended in Hepes-buffered medium at an initial concentration
of 7.2 X 10® cells/ml and diluted appropriately with the same medium. 
Aliquots of 1.3ml of the various dilutions were transferred to vials which were
capped with rubber seals and preincubated at 37°C for 20min. The purine
synthesis assay was initiated by the addition of 2.4|iCi 3G0mM-['*4c]NaHCO3
(0.62|xCi/[imol) to 1.3ml cell suspension and terminated by centrifugation of 
1 ml through silicone oil. A. Time course for incorporation of radiolabel into
purine. The cell concentration was 1.8 x 10® cells/ml. B. Effect of cell 
concentration on the incorporation of radiolabel into purine. The incubation 
time was 1h. All values are the mean ± S.D from triplicate measurements in a 
single experiment.
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Fig. 5.16 Hypothetical scheme for the Involvement of mSHMT In the 
synthesis of serine from glycine.
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Fig. 5.17 The effect of extracellular glucose concentration on the 
intracellular ATP concentration. Cells from the late-logarithmic phase 
were resuspended in Hepes-buffered medium (minus glucose) at a
concentration of 2 x 10® cells/ml. Aliquots of 1.3ml were transferred to vials 
containing ^3\l\ of lOOx strength glucose concentrations. The vials were
capped with rubber seals and preincubated at 37^0 for 30min. To each vial 
was added 13jxl 300mM-NaHC03 and incubations were carried out for a
further 1 h before centrifugation of 1 ml samples through silicone oil into 25p,l 
2.5M-PCA. This procedure was employed to mimic the conditions used for 
the purine synthesis assay. The extracellular medium above the oil was 
removed and the surface of the oil washed with water. Most of the oil was 
removed and 175|xl of water added to the 25|xl PGA. The sample was mixed 
to loosen the pellet, centrifuged and 3|xl of the PGA layer removed for the 
ATP assay as described in section 2.2.5 (p. 32). The results are expressed
as nmol ATP per 10® cells and are the mean ± S.D. from triplicate 
determinations in a single experiment.
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Fig. 5.18 Effect of extracellular glucose concentration on the
Incorporation of radiolabel from [l^cjNaHCOg into purine In the
presence and absence of extracellular serine. Cells from the logarithmic 
phase were resuspended In Hepes-buffered medium (without glucose or
serine) to a concentration of 2 x 10® cells/ml. The suspension was divided 
into two and to one half was added serine to give a final concentration of 
0.25mM. Aliquots of 1.3ml of the appropriate cell suspension were 
transferred to incubation vials containing 13[il of lOOx strength glucose 
concentrations and the vials were capped with rubber seals. The purine 
synthesis assay was Initiated by the addition of 2.4p,Ci 300mM-[1 ^ CjNaHCOg
(0.62|i.Ci/|xmol) and Incubations at 37^C carried out for 1h. The assay was 
terminated by centrifugation of 1ml of cell suspension through oil. Rates 
were originally calculated as nmol purine synthesized/h as a percentage of
total purine and were then converted to nmol purine synthesized/h per 10®
cells using a value of 112.5nmol total purine/10® cells (see Table 5.3, p. 179). 
Values are the mean ± S.D. from triplicate measurements in a single 
experiment.
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Fig. 5.19 Effect of extracellular serine concentration on the rate of 
purine synthesis from radiolabelled NaHCOg, serine and glucose. Cells
from the logarithmic phase were resuspended in Hepes-buffered medium
(without serine or glucose) to a concentration of 2 x 10® cells/ml. Glucose 
was added to a concentration of 0.25mM and 1.3ml aliquots transferred to 
incubation vials containing ISjxl of the appropriate lOOx serine
concentrations. Samples were preincubated at ST^C for 25min and assays 
initiated by the addition of one of the following: 2.4|xCi 300mM-[^ ^ oj^aHCOg
(0.62|xCi/jxmol); [3-^4C]serine such that the specific activity was 0.7pCi/pmol;
0.52pCi [6-1^C]glucose. Incubations at 37^0 were carried out for 65min and 
terminated by centrifugation of 1ml samples through oil. Rates were 
originally calculated as nmol purine synthesized/h as a percentage of total
purine and were then converted to nmol purine synthesized/h per 10® cells
using a value of 112.5nmol total purine/10® cells (see Table 5.3, p. 179). 
Values are the mean ± S.D. from triplicate determinations in a single 
experiment.
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Fig. 5.20 Time Course for release of radiolabel from protein prelabelled 
with [r//7g-2-14c]tryptophan. Cells were cultured in complete growth 
medium containing [r/ng-2-14c]tryptophan (0.001 jxCi/nmoI) such that an 
overall increase in celi number of approximately fifty-fold was achieved. The 
cells in the logarithmic phase were washed three times with Hepes-buffered 
medium (minus tryptophan) and were finally resuspended in complete
Hepes-buffered medium to a concentration of 2 x 10® cells/ml. Aliquots of 
1ml were immediately centrifuged through oil (zero time). Aliquots of 1.3ml
were transferred to incubation vials and were incubated at 37°C for the 
appropriate time before 1ml was centrifuged through oil into lOOjxl 2.5M-PCA. 
A 900}xl sample of the extracellular medium (above the oil layer) was 
removed for determination of radioactivity and the remaining medium 
discarded. The surface of the oil was washed with water and most of the oil 
was discarded. Then 900|xl of water was added to the lOOjxl 2.5M-PCA, the 
sample mixed to loosen the pellet and centrifuged. The radioactivity in 900|il 
of the PCA layer was determined. The sum of the radiolabel associated with 
the extraceliular medium and the PCA-soluble layer was corrected for that 
present at zero time and then taken to represent the radiolabel released
through protein degradation. The results are expressed as 1^0 dpm 
released per 10® cells and are the mean ± S.E.M. from three experiments. 
The rate calculated from the Figure is 1400 dpm released/h per 10® cells.
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Table 5.1 Measurement of the concentrations of adenine and guanine
In eluates from the Bond Elut columns by HPLC and
spectrophotometric measurements.
Samples of cell suspension (approximately 2x10® cells/ml) were incubated 
at 37°C for 1 h and the total purines isolated as described in section 2.4.4 
(p. 35). Samples of eluate from the Bond Elut columns were 
chromatographed or were diluted 5-fold and the absorbance measured at 
248.5nm and 262.5nm. The concentrations of adenine and guanine were 
calculated by reference to a standard curve for the HPLC analysis or as 
described in the text (section 5.2.1, p. 138) for the spectrophotometric 
method. The results from three individual experiments are shown and the 
values expressed as mean ± S.D. from triplicate measurements.
HPLC Spectrophotometric
Experiment
[Adenine] (jiM) [Guanine] (pM) [Adenine] (|xM) [Guanine] (|xM)
1 39.0 ±3.35 30.8 ±2.02 40.9 ±3.84 30.3 ±0.96
2 31.1 ±1.41 24.1 ±0.93 32.4 ±1.63 23.1 ±1.15
3 38.5 ±2.57 31.1 ±2.36 40.3 ±2.21 31.8 ±2.41
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Table 5.2 Measurement of an absorption coefficient at 260nm for total
purines present In the hydrolysate which remains after the first boiling
step.
Absorbance measurements were made at 260nm and the remaining 
hydrolysate processed to isolate purines. The final eluate from the Bond Elut 
columns was chromatographed as described in section 2.4.5 (p. 36) and the 
total concentration of purine (sum of the adenine and guanine 
concentrations) in the hydrolysate calculated. The experimental absorption 
coefficient was calculated by dividing the absorbance at 260nm by the 
concentration of total purine in the hydrolysate. The results are expressed as 
the mean ± S.D. from triplicate determinations. The overall mean 
experimental absorption coefficient is 11.8 ± 0.41 (mean ± S.E.M. from three 
experiments). The three individual experiments are separated in the table by 
horizontal lines.
Incubation +/- [Adenine] [Guanine] Absorbance 2^60 lor
Time (h) 3FDA (mM) (mM) at 260nm total purine
1 - 0.151 ±0.011 0.125 ±0.009 3.03 ±0.12 10.98
1 - 0.116 ±0.003 0.095 ±0.001 2.58 ±0.10 12.23
0 - 0.075 ±0.004 0.077 ±0.004 1.85 ±0.02 12.17
4 - 0.085 ±0.003 0.090 ±0.004 2.08 ±0.04 11.89
0 + 0.060 ±0.001 0.068 ±0.002 1.59 ±0.04 12.42
. 4 + 0.078 ±0.001 0.084 ±0.003 1.97 ±0.10 12.16
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Table 5.3 Amount of total purine per 10® cells.
Cells were resuspended in the appropriate medium at a concentration of 
approximately 2 x 10® cells/ml and counted using a haemocytometer. The 
purine synthesis assay was carried out for up to 2h and the purines Isolated 
as described in section 2.4.4 (p. 35). Total purine was calculated by 
measurement of the absorbance at 260nm of the first hydrolysate using an 
experimentally calculated absorption coefficient of 11.8mM"‘* (see Table 5.2). 
The values given are the mean ± S.E.M. from the number of experiments 
shown. Comparisons are made between cells resuspended in two different 
media, taken from different stages of growth and treated with 3FDA.
Resuspension
medium
+/-
3FDA
Growth
phase (
number of 
experiments
nmoles purine 
per 10® cells
Hepes-buffered - Logarithmic 14 112.5 ± 1.70*#
Hepes-buffered - Late-logarithmic 14 104.8 ± 3.93#$
Hepes-buffered - Plateau 4 94.9 ±2.31*$
NaHCOg-buffered - Late-logarithmic 13 103.5 ±3.50
NaHCOg-buffered + Late-logarithmic 11 104.2 ±2.30
* P<0.001 for the difference between these values. 
$ P<0.05 for the difference between these values.
# P<0.1 for the difference between these values.
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Table 5.4 Incorporation of radiolabel from [3-i4C]serine into adenine
and guanine bases.
Cells from the late-logarlthmio phase were resuspended In NaHCOg-buffered 
medium at 2 x 10® cells/ml and preincubated at 37°C for 20mln. The purine 
synthesis assay was Initiated by the addition of 0.65jxCi of [3-i4C]serine to 
1.3ml of cell suspension and incubations at 37°C carried out for the times 
shown before centrifugation of 1ml samples of cell suspension through 
silicone oil. The radiolabel in some samples from the final Bond Elut column 
eluate was determined immediately whilst other samples were 
chromatographed as described In section 2.4.5 (p. 36) and the radioactivity 
associated with adenine and guanine peaks determined. Values with errors 
are means ± S.D. from triplicate measurements and all other values are single 
determinations. Different experiments are separated by horizontal lines.
I4c dpm in purine/10® cells
Incubation +/- Eluate HPLC analysis Adenine/
time (h) 3FDA Total purine Guanine Adenine Total Purine Guanine
1 - 22422 9922 14941 24863 1.51
1 + 60172 18537 46824 65361 2.53
2 - 45141
±990
16819
±389
26482
±284
43301
±482
1.57
2 + 74075
±1132
21946
±47
50644
±631
72590
±633
2.31
2 - 38608
27538
19304
13452
20684
14378
39988
27830
1.07
2 + 71530
64946
21528
22560
49620
53732
71148
76292
2.34
4 - 53043
±14139
28905
±8088
27537
±6968
56443
±15050
0.95
4 + 135164 
± 39929
50317 95989 
±16196 ±27478
146307 
±  43609
1.91
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Table 5.5 Incorporation of radioiabel from p^cjNaHCOs Into adenine
and guanine bases.
Ceils from the logarithmic phase were resuspended In Hepes-buffered 
medium at 2 x 10® cells/ml and preincubated at 37°C for 20min. The purine 
synthesis assay was initiated by the addition of 0.03mCi of [f^CjNaHCOg to
1.3ml of cell suspension and incubations at 37°C carried out for 1 h. After the 
appropriate time, the assay was terminated by centrifugation of 1 ml samples 
of cell suspension through silicone oil and the purines Isolated as described 
in section 2.4.4 (p. 35). Radioactivity present in the first acid hydrolysate was 
determined as an indication of total ’•^C dpm Incorporated into cell 
constituents during the 1h Incubation. The radioiabel In some samples from 
the final Bond Elut column eluate was determined immediately whilst other 
samples were chromatographed as described in section 2.4.5 (p. 36) and the 
radioactivity associated with adenine and guanine peaks determined. Values 
are shown as single determinations within three different experiments 
separated in the table by horizontal lines.
Total 14c 
dpm in first 
hydrolysate 
per 10® cells
140 dpm in purine/10® ceils (% of total)
Adenine/
Guanine
Eluate HPLC analysis
Total purine Guanine Adenine Total Purine
72892 68518 (94%) 21407 46707 68114 2.18
52752 49059 (93%) 14081 34330 48411 2.44
59612 53055 (89%) 15140 37610 52750 2.48
57032 50758 (89%) 15272 36702 51974 2.40
54610 45872 (84%) 11880 33903 45783 2.85
60905 51160 (84%) 13204 40337 53541 3.05
54959 46715 (85%) 11477 33029 44506 2.88
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Table 5.6 Measurement of purine synthesis de novo from different
radloiabeiied precursors.
Cells from the logarithmic phase, resuspended in Hepes-buffered medium at 
a concentration of 2 x 10® cells/ml, were preincubated at 37°C for 20min. 
The purine synthesis assay was initiated by the addition of one of the 
following to 1.3ml of cell suspension: 2.4|xCi 300mM-NaHC03 
(0.62|xCi/p,mol); 0.125|xCi [3-i4C]serine; 0.25p,Ci [l-i^CJglycine; 0.25p,Ci 
[2-i4c]glycine. Non-radiolabelled NaHCOg was also added to an immediate 
concentration of 3mM to all samples except those containing [i4C]NaHCOg. 
The concentrations of serine and glycine in the medium were 0.25mM and 
0.12mM respectively, incubations were carried out for up to 2h and 
terminated by centrifugation of 1 ml samples through silicone oil. Rates were 
originally calculated as nmol purine syntheslzed/h as a percentage of total 
purine. These were subsequently converted to nmol purine synthesized/h 
per 10® cells using a value of 112.5nmol total purine/10® cells (see Table 5.3) 
and are the mean ± S.E.M. from the number of experiments Indicated in the 
Table.
Radiolabelled Rate of purine Stoichiometry of % of rate Number of 
precursor synthesis precursor : purine from NaHCOg experiments
[l4C]NaHC03 3.90 ±0.390 1 :1 - 8
[3-i4c]serine 2.46 ±0.270 2 :1 63.1 8
[1-i4C]glycine 0.66 ±0.074 1 :1 16.6 6
[2-i4C]glycine 0.70 ±0.088 1 :1 16.8 6
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Table 5.7 Effect of 3FDA on the rate of purine synthesis de novo from
different radloiabeiied precursors.
Cells in complete growth medium resuspended at 5 x 10® cells/ml were 
cultured for 24h in the presence or absence of 10mM-3FDA and were then 
resuspended in Hepes-buffered medium at a concentration of 2 x 10® 
cells/ml. Preincubation at 37^0 was carried out for 20min and the purine 
synthesis assay initiated by addition of one of the following radiolabelled 
precursors to 1.3ml cell suspension: 2.4|xOI 300mM-NaHC03
(0.62|xCi/|xmol); 0.125|xCi [3-14C]serine; 0.25|xCi [1-14C]glycine; 0.25pCi 
[2-i4C]glycine. The concentrations of serine and glycine were 0.25mM and 
0.12mM respectively, incubations were carried out for up to 2h and 
terminated by centrifugation through silicone oil. Rates were originally 
calculated as nmol purine synthesized/h as a percentage of total purine and 
were subsequently converted to nmol purine synthesized/h per 10® celis 
using a value of 112.5nmol total purine per 10® celis (see Table 5.3). The 
rates in the absence of inhibitor were comparable to those shown in Table 
5.6. SHMT activity was assayed in sonicates prepared from the same cell 
suspensions and the rate observed in 3FDA-treated cells calculated as a 
percentage of the control rate.
Percentage Rate of purine synthesis in 3FDA-treated cells relative to control
Inhibition [i4C]NaHC03 [3-i4C]serine [1-i4C]glycine [2-l4C]glycine
26 1.16 0.92 1.00 1.10
37 1.28 1.17 1.49 1.45
46 3.38 2.46 1.82 1.95
59 0.87 1.01 1.78 2.36
72 1.33 1.7 1.90 1.80
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Table 5.8 Effect of omission of various components of RPMI 1640 medium on the 
incorporation of radioiabel from [3-^^C]serine and [^^ClNaHCOg Into purine.
Cells resuspended in Hepes-buffered medium (minus omitted components; PCS was 
replaced by 0.9% NaCI where appropriate) at 2 x 10® cells/ml were preincubated at 37®G for 
20mln. The purine synthesis assay was initiated by the addition of either 2.4pCi 
300mM-NaHG03 (0.62|iGI/pmol) or 0.125|xGI [3-^ "^ G]serine to 1.3ml of cell suspension. 
Incubations were carried out for 1h and terminated by centrifugation of 1ml of suspension 
through silicone oil. Rates were initially expressed as nmol purine syntheslzed/h as a 
percentage of total purine. These were then converted to nmol purine synthesized/h per 10® 
cells using a value of 112.5nmoI total purine per 10® cells (see Table 5.3) and are the mean ± 
S.D. from triplicate determinations. N.D. Not determined.
nmol purine syntheslzed/h per 10® cells
Omission [i^ GjNaHGOg [i^ CjNaHGOg [i^qNaHGOa [i^qNaHGOg [3-^ ^G]serlne
None 5.60 ±0.29 2.53 ±0.10 3.06 ±0.19 2.77 ±0.16 1.63 ± 0.26
FGS ND ND ND 2.17 ±0.08 1.10 ± 0.08
Leucovorin 5.37 ±0.19 ND ND 2.73 ±0.06 1.51 ± 0.06
Glycine ND 2.71 ±0.04 3.46 ±0.32 2.69 ±0.04 1.59 ± 0.03
Tryptophan ND ND ND 2.63 ±0.22 1.72 ± 0.04
Histidine ND ND ND 2.58 ±0.28 1.37 ± 0.04
Glucose ND 0.87 ±0.05 0.86 ±0.07 0.88 ±0.09 0.20 ± 0.04
Glutamine ND 0.60 ± 0.04 0.53 ±0.07 ND ND
Glutamine/
Glutamate
ND 0.59 ±0.04 0.44 ±0.02 ND ND
Serine 1.61 ±0.10 1.81 ±0.11 1.21 ±0.14 1.07 ±0.05 ND
Serine /FGS 1.51 ±0.05 ND ND ND ND
Serine/
leucovorin
1.60 ±0.16 ND ND ND ND
Serlne/tryptophan ND 1.64 ±0.09 1.05 ±0.03 ND ND
Serine/hlstldlne ND 1.72 ±0.10 1.35 ±0.03 ND ND
Serine/glyclne ND 1.59 ±0.11 1.12 ±0.12 ND ND
Serine/glucose! ND 0.72 ±0.02 0.77 ±0.29 ND ND
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Table 5.9 Measurement of the rate of purine synthesis de novo from
different radiolabelled precursors.
Cells from the logarithmic phase, resuspended in Hepes-buffered medium at 
a concentration of 2 x 10® celis/ml, were preincubated at 37°C for 20min. 
The purine synthesis assay was initiated by addition of one of the following to 
1.3ml of cell suspension : 2.4p.Ci 300mM-p4C]NaH003 (0.62|xCi/|xmol); 
0.125pCi [3-i4C]serine; 0.52[iCi [1-*i4C]glucose; Q.52|xCi [6-l4C]glucose. 
Non-radiolabelled NaHC03 was also added to an immediate concentration of 
3mM to all samples except those containing p4C]NaHC03. Incubations were 
carried out for 1h and terminated by centrifugation of 1ml of cell suspension 
through siiicone oil. Rates were originally calculated as nmol purine 
synthesized/h as a percentage of total purine. These were then converted to 
nmol purine synthesized/h per 10® cells using a value of 112.5nmol total 
purine/10® cells (see Table 5.3) and are the mean ± S.E.M. from three 
experiments where errors are shown. Values without errors are the mean 
from two experiments only. The control rate is that measured from 
[ i4c]NaHG03 in the presence of 0.25mM-serine and 10mM-glucose.
[Serine]
(mM)
[Glucose]
(mM)
Radioiabel
used
Rate of purine Rate as percentage 
synthesis of control rate
0.25 10 p4C]NaHC03 3.26 ±0.40 100
0 10 p4C]NaHC03 1.38 ±0.12 43
0.25 0.25 p4C]NaHC03 2.71 ±0.37 84
0 0.25 [i4c]NaHG03 2.67 ±0.14 83
0.25 10 [3-i4C]serine 1.53 47
0.25 0.25 [3-i4c]serine 1.24 38
0.25 0.25 [1-i4G]glucose None detected
0 0.25 [1-i4c]glucose 0.96 ±0.16 30
0.25 0.25 [6-i4G]glucose None detected
0 0.25 [6-i4C]glucose 1.17 ±0.29 37
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Table 5.10 Determination of the percentage of tryptophan in total 
protein.
Cells were cultured in complete growth medium which contained [ring-2- 
i4C]tryptophan (0.001 p.Ci/nmol) such that the overall increase in cell number 
was approximately 50-fold. The cells were washed in Hepes-buffered 
medium (without tryptophan) three times. The cells were finally resuspended 
in Hepes-buffered medium (plus tryptophan) at a concentration of 2 x 10® 
celis/ml. A sonicate was prepared from this suspension using sucrose buffer 
as described in section 2.6 (p. 40). The protein concentration was 
determined by the BCA method (section 2.2.4, p. 31) and samples of the 
sonicate were also taken for determination of the radioactivity. The results 
shown are the percentage tryptophan in total protein by weight (mean ± S.D. 
from triplicate measurements) from three experiments (separated by 
horizontal lines in the Tabie). The overall mean percentage of tryptophan in 
total protein was 1.09 ± 0.035% (mean ± S.E.M. from three experiments.)
14c dpm/ml jig tryptophan/ i^g total protein/ % tryptophan Mean
sonicate® ml sonicate ml sonicate in total protein ±S .D .
136856 10.43 1020 1.02 1.04
143156 10.92 1030 1.06 ±
145216 11.07 1070 1.03 0.02
114100 8.90 760 1.17 1.16
135280 10.56 896 1.18 ±
129020 10.07 896 1.12 0.03
136312 10.70 990 1.08 1.08
142212 11.17 1040 1.07 ±
146952 11.54 1070 1.08 0.01
 ^These values have been corrected for radioiabel associated with the free tryptophan pool by 
virtue of knowledge of the radioactivity associated with the PCA-soluble fraction of separate 
samples. They therefore represent the radioactivity associated with protein. The radiolat)el 
in the free tryptophan pool was only 1.4% of that associated with protein.
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Chapter 6: Control of purine synthesis de novo in relation to serine
metabolism: Application of Metabolic Control Analysis
6.1 Introduction
In the general introduction (Chapter 1), the "Key Enzyme" and 
"Molecular Correlation" concepts (Weber, 1983a) were discussed as two 
possible means for the identification of a good chemotherapeutic target. 
Application of the metabolic control theory is a way in which the control 
exerted by a particular step within a defined pathway can be quantified. Any 
step which has appreciable control over the flux through a pathway involved 
in cell proliferation couid be a useful target for chemotherapy. In this chapter, 
metabolic control analysis has been applied to the serine transport step at the 
plasma membrane in relation to the pathway of purine synthesis de novo. In 
addition, the importance of SHMT for cell proliferation and purine synthesis 
has been examined.
6.1.1 General principles of metabolic control theory
Metabolic control analysis was developed as a quantitative measure of 
the extent of control exerted by a particular enzyme within a defined pathway. 
The theory was pioneered by Kacser and Burns (1973) and by Heinrich and 
Rapoport (1974) and in its simplest form involves the calculation of three 
distinct coefficients; the flux control coefficient, the elasticity coefficient and 
the response coefficient.
The flux control coefficient (C^) is defined as the fractional change in 
flux (ÔJ/J) through a defined pathway divided by the fractional change in 
enzyme activity (Ôv/Vj) (6.1).
CJ = {5J/J)/(5Vj/V|) (6.1)
The term Vj' specifically relates to the activity of an enzyme measured 
in the presence of the concentrations in vivo of substrates, products and 
effectors. A change in the enzyme activity may be accomplished by induction 
of enzyme synthesis or the use of well-characterized effectors or inhibitors.
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The value of the control coefficient may be positive or negative and will 
usually be between zero and unity. The higher the value, either positive or 
negative, the more controlling influence the enzyme has in the defined 
pathway under a particular set of conditions. The value of the control 
coefficient will probably change under a different set of conditions, such as 
through changes in enzyme activities or in metabolite concentrations. The 
sum of the flux control coefficients for all the enzymes within a defined 
pathway is unity (Kacser & Burns, 1973).
The elasticity coefficient (6%) is defined as the fractional change in 
enzyme activity measured under pathway conditions (8v/v;) divided by the 
fractional change in the concentration of an effector (5X/X) which includes the 
substrates of the enzyme under study (6.2).
= (5vj/Vi)/(8XO() (6.2)
The elasticity coefficient may take any value, positive or negative, and 
there are as many elasticity coefficients as there are metabolites and 
effectors which interact with the enzyme. This coefficient may also be 
represented by an expression which involves both an equilibrium term and a 
saturation term (Groen et ai, 1982) (6.3).
8’^  = {l/(1-(r/K)))(l-(J/Vn,ax)) (6.3)
The parameter r  is the mass action ratio (the ratio of the concentration of
products to the concentration of substrates under steady-state pathway 
conditions), K the equilibrium constant, J the flux and V^ax the maximum
velocity of the enzyme. The term r/K  is a measure of how close the reaction 
is to equilibrium and the term JA/^ax a measure of the extent of saturation
of the enzyme.
A relation also exists between the flux control and elasticity coefficients 
of two successive enzymes (E-j and E2) in a pathway with respect to their
common metabolite. The ratio of the elasticity coefficients with respect to the 
common metabolite X for the enzymes Ei and E2 respectively equals the 
ratio of the flux control coefficients for the enzymes E2 and Ei respectively 
(6.4) (Kacser & Burns, 1973).
189
(85 /£^) = -(CJ/CJ) (6.4)
The response coefficient (R^ j) for a pathway flux is defined as the 
fractional change in flux (5J/J) divided by the fractional change in the 
concentration of an effector (ÔX/X) (6.5). The effector may be a substrate or 
a product of one of the steps within the pathway, or could be a metabolite 
totally distinct from the pathway in question, but which interacts with a step in 
the pathway.
Rj = (5J/J)/(5XO<) (6.5)
Knowledge of the value of any two of the defined coefficients enables 
the immediate calcuiation of the third coefficient from equation (6.6) (Kacser 
& Burns, 1973).
CJ = R j / 8 ^  (6.6)
The definitions of the three coefficients are summarized in Fig. 6.1.
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6.2 Results and Discussion
The general introduction in Chapter 1 detailed the reasons why 
serine metabolism might be expected to exert an important controlling 
influence on nucleotide biosynthesis in rapidly proliferating cells. Such 
metabolic control could be accomplished through effects on the activity of 
SHMT, on the transport of serine into the cells or on the intracellular 
synthesis of serine. The aim of this present work was to quantify the 
importance of SHMT and the serine transport step by application of the 
metabolic control theory.
6.2.1 SHMT as a control step in purine synthesis de novo
Metabolic control analysis was applied to SHMT using the proposed 
specific inhibitor, 3-fluoro-D-alanine. The effects of 3FDA on SHMT and on 
purine synthesis de novo have been detailed in Chapters 4 and 5 
respectively. Unfortunately, the lack of reproducibility of the extent of 
inhibition of SHMT by 3FDA, together with the paradoxical effects on purine 
synthesis (apparently non-related to inhibition of SHMT), make control 
analysis in this way impossible. However, it is clear that inhibition of SHMT 
by as much as 70% does not result in any reduction in total purine synthesis 
which is at least a preliminary indication that the flux control coefficient for 
SHMT with respect to purine synthesis de novo must be low. That the activity 
of SHMT is not important in the control of purine synthesis de novo is 
supported by the lack of growth-phase related patterns of SHMT activity over 
a 96h growth period (Fig. 6.2). This observation is in contrast with results 
from experiments using Hepatoma 3924A cells where increases in SHMT 
activity of approximately two-fold were observed over the first 24h of growth 
(Snell et ai, 1987). It is noteworthy, however, that the basal activity of 
SHMT activity in MOLT-4 ceils at saturating serine concentrations in the 
assay (112nmol formaldehyde formed/h per 10® cells; see section 4.2.4, 
p. 112) was greater than the peak activity observed in the Hepatoma cell line 
(95nmol formaldehyde formed/h per 10® cells), both cell lines having similar 
logarithmic growth rates. In addition, hepatoma cells grow as a monolayer 
and exhibit contact-limited growth inhibition at confluence, whereas MOLT-4
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cells grow in suspension culture and their growth Is not limilted by this 
mechanism.
The iack of growth phase-reiated changes in SHMT activity in MOLT-4 
cultures was not, however, paralleled by a lack of change in the rate of purine 
synthesis de novo. In a single experiment, purine synthesis, SHMT activity 
and serine transport were measured at 24h intervals over a 96h growth curve 
(Fig. 6.3). In the absence of appreciable changes In SHMT activity, striking 
changes in the incorporation of radiolabel from both [i^CjNaHCOg and
[3-i4c]serine into purine were observed. This growth phase-reiated 
regulation of the purine synthetic rate in cuitured MOLT-4 ceiis must therefore 
be due to factors other than the modification of the expression of SHMT. It 
should be noted that these experiments do not exclude SHMT as an 
important controlling step in purine synthesis de novo but mereiy make this 
possibiiity less likely.
6.2.2 Serine transport as a control step in purine synthesis de novo
The transport of serine into the cell is an alternative step at which 
control of serine utilization for purine synthesis couid be exerted. The growth 
phase-related pattern of serine transport into MOLT-4 cells shows an 
opposite pattern to that of purine synthesis which gives preliminary evidence 
that the transport step may also not be important in the regulation of purine 
synthesis. The observed pattern is, however, consistent with a repression of 
transport activity upon transfer of ceils to fresh, amino-acid rich medium and 
a subsequent derepression as amino acid levels presumably become 
depleted over the 96 hour growth period. Such a regulation would be 
accomplished through system A which has been shown to account for 52% of 
total serine transport into MOLT-4 cells taken at the logarithmic phase of 
growth (see section 3.2.2.2, p. 73).
Actuai control analysis of the transport step can be accompiished 
without the need for a specific inhibitor by calcuiation of the response and the 
elasticity coefficients, in the pathway defined by incorporation of extraceiiular 
serine into purine via the one-carbon pool, caiculation of the response 
coefficient involves measurement of the effect of external serine 
concentration on the totai rate of purine synthesis. This was accomplished by 
a study of the incorporation of radiolabei from ['•^CJNaHCOs into purine over
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a range of extracellular serine concentrations. The results (Fig. 6.4) show 
that purine synthesis is saturated at serine concentrations between 0.075mM 
and 0.75mM. The saturation range observed in lectin-stimulated human 
lymphocytes was 0.2-0.6mM, but a much less detailed range of serine 
concentrations were used in those experiments (Rowe et al., 1985). In the 
hepatoma 3924A cell line, purine synthesis was saturated with serine at an 
extracellular serine concentration of 0.2mM (Natsumeda eta!., 1988).
Both these sets of observations were based upon the measurement of 
the incorporation of radiolabei from [3-i4C]serine into purine. On the basis of 
the results presented in Chapter 5, which imply an alternative source of 
one-carbon units or of serine, changes in rate measured from this radioactive 
precursor at different serine concentrations could be due to isotope dilution 
effects. This possibility was tested by measurement of the incorporation of 
radiolabei from [3-i4c]serine and [i^CJNaHGOs into purine at different
extracellular serine concentrations. Purine synthesis measured from either 
precursor has the same dependence upon the extracellular serine 
concentration (Fig. 6.5). The purine synthesis rate measured from 
[3-i4C]serine becomes saturated with serine at a rate which is approximately 
60% of the total rate (as measured from the incorporation of radiolabei from 
[ i4C]NaHC03 into purine) in cells taken from the logarithmic phase of growth.
This observation would be consistent with saturation of the supply of one- 
carbon units by SHMT with the prevalence of another source of one-carbons 
distinct from serine. Thus this alternative supply would account for 
approximately 40% of the total rate at saturating concentrations of 
extracellular serine; this value is similar to the percentage of the total rate 
observed in the total absence of extracellular serine (34%; see Fig. 6.4) for 
ceils taken from the logarithmic phase of growth.
Determination of an actual response coefficient from the plot of total 
purine synthesis versus extracellular serine concentration (Fig. 6.4) is not 
possible due to the difficulty in drawing a tangent at the normal extracellular 
medium serine concentration of 0.25mM. However, it is possible to state that 
the response coefficient is close to zero. Determination of the elasticity 
coefficient is still, therefore, of value to get an idea of the magnitude of the 
control coefficient. If the elasticity coefficient is aiso close to zero the control 
coefficient couid be close to unity. The elasticity coefficient can be 
determined at a particular serine concentration by measurement of the 
gradient of a plot of serine uptake versus concentration of extraceiluiar
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serine. The results (Fig. 6.6) show that serine transport into MOLT-4 cells is 
far from saturated around the physiological range of serine concentration
(0.02-0.19mM; see Rowe etal., 1985). The gradient of the line is 120 and for
derivation of the eiasticity coefficient this value must be normalized by 
multiplication by the transport rate and division by the serine concentration. 
This caiculation for a straight line which passes through the origin inevitably 
results in a coefficient of unity. However, the transport rate required for this 
calculation is the net rate of serine uptake and must, therefore, be corrected 
for the efflux rate at that particular serine concentration. This value has been 
previously determined at an extracellular serine concentration of 0.25mM as 
SO.Onmol serine effluxing/h per 10® cells (see section 3.2.3.2, p. 76). Thus 
the overali eiasticity coefficient is given by the equation;
8transport / \serine = 120 x (0.25/(influx rate - effiux rate))
Using an influx rate of 29.7nmol serine transported/h per 10® ceiis 
(from Fig. 6.6), the elasticity coefficient would have a value of -100. It is 
difficult to give a precise value to this coefficient because the influx and efflux 
rates are so similar but it will certainly not be close to zero. Furthermore the 
actual value of the efflux rate is in doubt because there was no certainty that 
the radioiabel leaving the cell was all associated with serine. Thus the efflux 
rate could have been over-estimated and to determine what effect this could 
have on the final control coefficient, theoretical values were calculated for 
different effiux rates using three different response coefficients (Fig. 6.7). 
The calcuiations showed that the maximum possible control coefficient 
occurs in the absence of effiux and is equivaient to the value of the response 
coefficient. As the efflux rate increases, the controi coefficient decreases in a 
linear fashion getting closer to zero as the efflux rate approaches the influx 
rate. Once the efflux rate exceeds the influx rate, the control coefficient 
becomes negative.
Overall, the results for the control analysis of the serine transport step 
in relation to purine synthesis de novo show that this step is not an important 
control point at the normal extracellular medium serine concentration of
0.25mM. The physiological range of serine concentration in plasma has been 
reported as 0.02-0.19mM (see Rowe et al., 1985). From the plot of Fig. 6.4, 
a response coefficient can be calculated at 0.025mM-serine and has a value 
of 0.4. On the basis of the argument presented above and the theoretical
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data presented in Fig. 6.7, the maximum possibie control coefficient at this 
serine concentration (0.025mM) wouid be 0.4, which would occur in the total 
absence of serine efflux. The lack of control at the transport step is not a 
surprise in view of the results of Chapter 5 which suggest the availability of an 
alternative supply of one-carbon units. Furthermore, there is an appreciable 
rate of purine synthesis measured in the total absence of extracellular serine 
(34% of maximum rate; see Fig. 6.4).
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6.3 Conclusions
The lack of growth-phase related changes In SHMT activity does not 
necessarily rule out SHMT as an important enzyme for cell proliferation in 
MOLT-4 cells. Unfortunately, metabolic control analysis of this enzyme with 
respect to the pathway of purine synthesis using the inhibitor 3FDA was not 
possible. This inhibitor had an effect on the rate of purine synthesis de novo 
which could not be explained on the basis of inhibition of SHMT. Further 
work is therefore required to ascertain conclusively whether SHMT is a 
control site for nucleotide biosynthesis.
The total transport of serine into MOLT-4 cells at the normal medium 
serine concentration of 0.25mM is not a site at which control of purine 
synthesis de novo is exerted. Although an increase in the extraceiiular serine 
concentration (in the physiological range) will result In a proportional increase 
in the rate of serine influx, the rate of incorporation of radioiabel from 
[ i4C]NaHC03 into purine remains saturated (cf. Figs. 6.6 and 6.4). One
reason for this result would be that SHMT is completely saturated with serine. 
The Km for serine of SHMT was 0.5mM (section 4.2.4, p. 112) and the totai
intracellular concentration of serine is 3.76-4.45mM (Table 3.8, p. 94). The 
enzyme is therefore likely to be saturated. The actual concentrations of 
serine in the mitochondrial and cytosolic compartments has not been 
measured, however, nor is it known which of the isozymes of SHMT supplies 
one-carbon units for purine synthesis de novo. If the mitochondrial enzyme is 
involved in this process, the rate of purine synthesis couid be limited by the 
transport of serine into the mitochondria. The lack of response of the rate of 
purine synthesis to increased extracellular serine concentration could then be 
accounted for by saturation of the transport system for serine in the 
mitochondrial membrane.
An alternative reason for this iack of response could be that the efflux 
of serine at physiological extracellular concentrations of serine is also 
unsaturated. The increased influx rate which results from an increase in the 
extracellular serine concentration might also therefore result in an increase in 
the efflux rate such that the intracellular serine concentration is maintained at 
a constant level. Thus even if SHMT, or serine transport into the 
mitochondria, were unsaturated, flux through these two steps would still occur 
at the same rate regardless of the extracellular serine concentration.
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1. Flux Control Coefficient:
C e = Fractional change in pathway flux (5J / J)
Fractional change in enzyme activity (6v; / v;)
2. Elasticity Coefficient:
£ x  = Fractional change in enzyme activity (Svj / v,)_____
Fractional change in effector concentration (ÔX / X)
3. Response Coefficient:
R x  = Fractional change in pathway flux (5J / J)_______
Fractional change in effector concentration (5X / X)
Fig. 6.1 Summary of the three coefficients used in metabolic controi 
anaiysis. The term v; relates specifically to enzyme activity under pathway 
conditions.
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Fig. 6.2 Lack of growth phase-related changes in SHMT activity. Ceils 
from the plateau phase were cultured as described in section 2.1.6 (p. 28) 
and samples removed at 24h intervals for assay of SHMT activity as 
described in section 2.2.1 (p. 28). Values are expressed as the SHMT 
activity at the appropriate time relative to that at zero hours because different 
concentrations of serine (which were not always saturating) were used for 
individual experiments. Results are the mean ± S.E.M. from four experiments.
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Fig. 6.3 Growth phase-related patterns of purine synthesis de novo, SHMT activity 
and serine transport. A sample of cells from the plateau phase were removed for the 
purine synthesis, SHMT and transport assays described here. The remaining cells were
resuspended in complete growth medium at a concentration of 1 x 10® cells/ml and further 
samples removed at 24, 48, 72 and 96h of growth. Cells were resuspended at a
concentration of 2 x 10® cells/ml in Hepes-buffered medium for the purine synthesis and 
transport assay. For the purine synthesis assay, aliquots of 1.3ml were preincubated at
37°C for 20min. The assay was initiated by the addition of 2.4pCI 300mM-[^ ^ CjNaHCOg 
(0.62pCi/pmol) or 0.125|iCI [3-^ ^C]serine plus 13pl of non-radiolabelled 300mM-NaHC03.
Incubations at 37°C were carried out for 1h and terminated by centrifugation of 1ml of cell 
suspension through oil. Rates are expressed as nmol purine synthesized/h per 10® cells. 
For the serine transport assay, aliquots of 430pl cell suspension (with ®H20 (4pCI/ml)) were 
transferred to Incubation vials and lOjxl 10SmM-NaHCOg added. Samples were 
preincubated at 37°C for 20min. The transport assay was initiated by the addition of O.ISpCi
[3-^ ^C]serine, left for Imin and then terminated by centrifugation of 400pl cell suspension 
through oil. The extracellular and intracellular volumes were calculated for each experiment 
as described in section 2.5.1 (p. 37). Rates were originally calculated as nmol serine
transported/h per pi ICW and have been converted to nmol serine transported/h per 10® cells
using a value of 1.36pl ICW per 10® cells (see section 3.2.1, p. 65). SHMT activity was 
assayed as described in section 2.2.1 (p. 28) and rates were originally calculated as nmol 
formaldehyde formed/h per mg protein. These were converted to nmol formaldehyde
formed/h per 10® cells using a value of 0.3mg total protein per 10® cells (see section 2.2.4, 
p. 31). All values shown are the mean ± s .d . from triplicate determinations in a single growth 
curve experiment.
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Fig. 6.4 Effect of extracellular serine concentration on the 
Incorporation of radioiabel from [“*^C]NaHC03 Into purine. Cells from 
the logarithmic phase were resuspended in Hepes-buffered medium at a 
concentration of 2 x 10® cells/ml. Aliquots of 1.3ml were preincubated at 
37^0 for 20min. Assays were initiated by the addition of 2.4|xCi 
300mM-[*^4c]NaHG03 (0.62|iCi/jxmol) and incubations at 37^0 carried out 
for 1h. To terminate the assay, 1ml of cell suspension was centrifuged 
through oil. Rates were originally calculated as nmol purine synthesized/h as 
a percentage of total purine and were then converted to nmol purine
synthesized/h per 10® cells using a value of 112.5nmol total purine/10® cells 
(see Table 5.3, p. 179). Values are the mean ± S.E.M. from four experiments.
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Fig. 6.5 Effect of extraceiiular serine concentration on the
incorporation of radiolabei from [I^CjNaHCOg and [S-^^CJserine into
purine for cells from the logarithmic and plateau phase. Cells from the 
logarithmic and plateau phase grown in the same week were resuspended in
Hepes-buffered medium at a concentration of 2 x 10® cells/ml. Aliquots of 
1.3ml were transferred to vials which contained 13)il of lOOx strength serine
solution and were then preincubated at 37^0 for 20min. The assay was 
initiated by the addition of 2.4ixCi 300mM-[*l4C]NaHC03 (■) or 0.125|xCi 
[3-‘i4c]serine ( a ) plus 13|xl non-radiolabelled 300mM-NaHC03 and
incubations at 37^0 carried out for 1h. The assay was terminated by 
centrifugation of 1ml cell suspension through oil. Rates were originally 
calculated as nmol purine synthesized/h as a percentage of total purine and
were then converted to nmol purine synthesized /h per 10® cells using the
values 112.5 and 94.9nmol total purine per 10® cells for logarithmic and 
plateau phase cells respectively (see Table 5.3, p. 179). Values are the 
mean ± S.D. from triplicate determinations.
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Fig. 6.6 Effect of extracellular serine concentration on the rate of serine 
Influx. Cells from the logarithmic phase were resuspended in Hepes-
buffered medium at a concentration of 2 x 10® cells/ml. Aliquots of 425|xl 
were transferred to tubes containing 4.5|liI of lOOx strength serine solutions. 
The tubes were capped and 10p,l 135mM-NaHC03 (prepared in medium) 
added through the seal. The samples were preincubated for 20min and then 
transport measurements initiated by the addition of 10|xl [3-** ^ Qjserine such 
that the specific activity was 1.3|iCi/|imol serine for all samples except that 
containing the lowest concentration of serine for which the specific activity 
was 7.2|xCi/|xmol. Samples were left for Imin and transport measurements 
terminated by centrifugation of 400|xl cell suspension through oil. Rates were 
originally calculated as nmol serine transported/h per pi ICW and were 
converted to nmol serine transported/h per 10® cells using a value of 1.36pl
ICW per 10® cells (see section 3.2.1, p. 65). Values are the mean ± S.E.M. 
from three experiments.
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Fig. 6.7 Theoretical effect of the efflux rate on the control coefficient 
for serine transport. The data from Fig. 6.6 were used to calculate the 
control coefficient for serine transport by determination of the elasticity 
coefficient at different theoretical efflux rates and using theoretical response 
coefficients of 0.2, 0.5 and 1.0.
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CHAPTER 7
FINAL CONCLUSIONS
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Chapter 7; Final conclusions
7.1 Quantitative overview of serine metabolism in MOLT-4 cells
The results in this thesis enable a quantitative assessment of serine 
metabolism in MOLT-4 cells to be carried out. The serine influx rate (Fig. 6.6, 
p. 202) and efflux rate (section 3.2.3.2, p. 76) are both 30nmol serine 
transported/h per 10® cells. The total rate of purine synthesis de novo, 
measured by incorporation of radioiabel from [i^CjNaHCOg into purine, was
3.9nmol purine synthesized/h per 10® cells (Table 5.6, p. 182). This rate is 
equivalent to the utilization of 7.8nmol serine/h per 10® cells on the 
assumption that the two one-carbon units required for the synthesis of one 
purine molecule are derived from two molecules of serine. The amount of 
serine released by protein degradation was estimated on the assumption that 
6.6% of total protein by mass was serine. This rate was 6.3nmol serine 
released/h per 10® cells (section 5.2.4.5, p. 155). The rate of serine 
utilization for net protein formation can be estimated from the celi doubling 
time. The fractional change in the amount of protein per hour is 4.1% (see 
section 5.2.4.1, p. 147). The amount of protein per 10® cells is 0.3mg 
(section 2.2.4, p. 31) and the protein deposition rate during the logarithmic 
phase is therefore 12.3|xg/h per 10® cells. This is equivalent to 7.73nmol 
serine utiiized for net protein deposition/h per 10® cells, on the assumption 
again that 6.6% of total protein by mass is serine. The total rate of protein 
synthesis, accounting for that required to balance the rate of protein 
degradation (6.3nmol serine/h per 10® cells). Is 14.0nmol serine utilized/h per 
10® cells (7.7 + 6.3). The rate of purine synthesis measured from the 
incorporation of radiolabei from extracellular [6-’i4C]glucose Into purine was 
only 0.2nmol purine synthesized (and therefore glucose utilized) per hour per 
10® cells (Fig. 5.19, p. 175). This rate corresponds to the one-carbon supply 
via serine, assuming that carbon 6 of glucose can only be incorporated into 
purine via carbon 3 of serine. The various rates involved in the metabolism of 
serine are shown in Fig. 7.1.
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7.2 Possibility for an endogenous supply of serine
The fact that the serine efflux rate is the same as the influx rate
necessitates an endogenous supply of serine. This supply would have to be
at a rate of at least 15.5nmol serine synthesized/h per 10® cells to satisfy the
requirements of purine synthesis (7.8nmol serine utilized/h per 10® cells) and
net protein synthesis (7.7nmol serine utilized/h per 10® cells) alone (See Fig.
7.1). The total supply of non-radiolabelled serine, represented by that
derived from protein degradation (6.3nmol/h per 10® cells) and that derived
from an alternative source (15.5nmol/h per 10® cells), would therefore be
21.8nmol serine/h per 10® cells. The intracellular specific activity of serine
could then become, at most, 58% of the extracellular value. This is of an
appropriate magnitude to account for the difference in rates of purine
synthesis measured from the incorporation of radioiabel from [3-'*^C]serine 
and from p^CjNaHCOs into purine (Table 5.6, p. 182).
One possible source of serine could be glucose but incorporation of 
radioiabel from extracellular [6-i4C]glucose into purine at an extraceiluiar 
serine concentration of 0.25mM was only 0.6% of the serine influx rate. The 
rate of serine synthesis from extracellular glucose cannot therefore account 
for the difference observed between the rates of purine synthesis measured 
from the incorporation of radioiabel from [l^CjNaHCOg and [3-i4c]serine into
purine. It is possible however that non-radiolabelled glucose derived from 
rapid turnover of intracellular stores such as glycogen could contribute to the 
serine pool and thereby cause isotopic dilution of radiolabelled serine 
transported into the cells. This cell type is not however usually considered to 
have large stores of glycogen. It is also important to remember that the 
measurements made using radiolabelled glucose were at an extracellular 
glucose concentration of 0.25mM. It could therefore be argued that at a more 
physiological concentration of glucose, incorporation of radioiabel into purine 
might be higher. No increase was observed, however, when the 
concentration of glucose was increased to ImM at the same specific activity 
of [6-"i4c]glucose (result not shown).
Other possible exogenous sources of non-radiolabelled serine, such 
as glycine and serum protein, were also dismissed in these studies (Table 
5.8, p. 184). The actual source of the putative endogenously-derived serine 
therefore remains unclear. Turnover of phospholipid (phosphatidyl serine) 
could contribute non-radiolabelled serine to the intracellular serine pool but
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net production of serine by this route would not be expected; rather net 
synthesis ought to occur to furnish newly-synthesized cells with their 
complement of phospholipid.
In rat kidney, significant rates of serine synthesis were evident from 
glutamine, glutamate and aspartate (Lowry et ah, 1986). The pathway for 
this conversion is thought to involve gluconeogenesis and the phosphorylated 
pathway of serine biosynthesis. Glutamine and glutamate enter the TCA 
cycle as 2-ketoglutarate and can be converted via the TCA cycle to 
oxaloacetate which in turn can be transaminated to aspartate by the 
mitochondrial aspartate aminotransferase (Fig. 7.2). Aspartate can exit the 
mitochondria by the malate-aspartate shuttle and can be converted back to 
oxaloacetate by a transamination reaction catalysed by cytosolic aspartate 
aminotransferase. The enzyme phosphoenolpyruvate carboxykinase 
converts the oxaloacetate to phosphoenolpyruvate which in turn can be 
converted to 3-phosphoglycerate, the precursor for the formation of serine by 
the phosphorylated pathway (see Fig. 1.1, p. 17), by a reversai of giycoiysis 
(Fig. 7.2). Phosphoenolpyruvate carboxykinase is, however, only considered 
to be expressed in tissues active in gluconeogenesis (liver and kidney) and 
not therefore in lymphocytes. On this basis, glutamine, glutamate and 
aspartate are not likely to be precursors of serine in MOLT-4 ceiis. 
Furthermore, the activity of the phosphorylated pathway of serine 
biosynthesis has been reported to be low in both normal and leukaemic 
lymphocytes, relative to the other cell types studied (Pizer & Regan, 1972). 
The enzymes of the phosphorylated pathway are presumably expressed in 
MOLT-4 cells on the basis that incorporation of radiolabei from 
[6-‘i4c]glucose and [1 -i^Cjglucose into purine does indeed occur, at least in 
the absence of extracellular serine (Table 5.9, p. 185). Similarly, 
incorporation of radioiabel from [i4C]glucose into serine has been noted in 
normal proliferating human lymphocytes in culture (Snell & Barnett, 1988). 
However, to account for the observation that glucose does not contribute 
significantly to the serine pool, the supply of 3-phosphoglycerate from 
glutamine, glutamate or aspartate would have to be over seventy times 
higher than that from glucose (in the absence of another significant source of 
non-radiolabelled glucose). For proliferating lymphocytes, the rate of 
glutamine utilization is four-fold greater than that of glucose (Newsholme et 
al., 1985) but this difference couid not account for the low incorporation of 
radioiabel from [6-‘i^C]glucose into purine. By the same line of argument.
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any source of serine which involves the operation of the phosphorylated 
pathway is unlikely because the rate of supply of 3-phosphoglycerate would 
have to be over seventy times higher than the rate of glycolysis.
In the experiments with rat kidney where glutamine, glutamate and 
aspartate were precursors of serine, lactate or pyruvate were ineffective as 
precursors of serine although they were good gluconeogenic substrates 
(Lowry et al., 1986). In addition, glucose was a poor precursor of serine. 
These results were unexpected because all these precursors should 
adequately supply the 3-phosphoglycerate pool (Fig. 7.2). One possible 
reason for these observations is that only glutamine, glutamate and 
aspartate, and not the other precursors, increased the concentration of 
glutamate in the cell. This increase could cause an increase in the rate of 
transamination of phosphohydroxypyruvate and therefore in the steady-state 
concentration of phosphoserine, which in turn could increase the flux through 
phosphoserine phosphatase to serine. The possibility for an alternative 
pathway for the synthesis of serine from glutamine, glutamate and aspartate, 
which does not involve the glycolytic intermediates, would also explain these 
observations. In addition, the operation of such a pathway would help explain 
the observations reported in this thesis. The enzymes of the 
non-phosphorylated pathway (see Fig. 1.1, p. 17) are expressed In kidney but 
are thought to be involved in serine catabolism (Snell, 1986). The enzymes 
of this pathway are only thought to be expressed in gluconeogenic tissues 
and this expression is lost upon neoplastic transformation (Snell & Weber, 
1986). The same situation is evident for the expression of serine 
dehydratase and therefore this enzyme and the non-phosphorylated pathway 
are unlikely to be involved in serine synthesis In MOLT-4 cells. The actual 
involvement of these enzymes In serine synthesis should not however be 
ruled out without further investigation of their expression In this cell type.
The major precursor of serine in rat kidney is glycine through the 
coupled reactions of the glycine cleavage enzyme and mSHMT (Lowry et al., 
1986; see also Fig. 5.16, p. 172). The evidence presented against the 
operation of this pathway in MOLT-4 cells is that incorporation of radioiabel 
from [1-I4c]glycine and [2-i4C]glycine into purine is identical (Table 5.6, 
p. 182). If the pathway were operative in these cells, radioiabel from 
[2-i4c]glycine would become associated with serine by the action of mSHMT 
in the form of glycine per $e and also 5,10-CH2THF formed as result of
glycine cleavage activity. Radiolabei from [l-'^^CJglycine would, on the other
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hand, only become associated with serine as glycine itself, because glycine 
cleavage activity would result in the loss of radioiabel as CO2. Thus
increased incorporation of radioiabel from [2-i4c]glycine into purine relative 
to that from [1 -'i^Cjglycine would be expected if the pathway operates.
The glycine may be derived from a source alternative to that from 
uptake from the extracellular medium or from the activity of cSHMT. The 
degradation of hydroxyproline occurs in liver mitochondria and yields 
glyoxylate which can undergo a transamination reaction to form giycine 
(Rowsell et ai, 1972; see Sneli, 1984). This pathway has been proposed to 
operate in a mouse lymphoma cell line to supply glyoxylate for the synthesis 
of serine (Keefer et al., 1985). The concentration of hydroxyproline in the 
Hepes-buffered medium used for the experiments reported in this thesis was 
0.14mM which is potentially sufficient to supply glycine and serine in the 
amounts required for purine synthesis de novo. Furthermore, an alternative 
route of metabolism of this compound in MOLT-4 cells is not immediately 
obvious. By utilization of this proposed pathway of hydroxyproline 
degradation, glycine may be generated in the mitochondria independently of 
cytosolic processes. An absence of glycine transport into mitochondria would 
then have to be invoked to explain the lack of difference between 
incorporation of radiolabei from [1-'*4c]glycine or [2-i4C]glycine into purine 
(Table 5.6, p. 182).
7.3 Possibility for a source of one-carbon units alternative to serine
There is evidence reported in this thesis that opposes the possibility 
for an endogenously-derived cytosoiic source of serine. The transport of 
serine into MOLT-4 cells is far from saturated at physiological concentrations 
of extracellular serine (0.02-0.19mM; see Rowe et al., 1985). This means 
that the rate of supply of extracellular radiolabelled serine to the cytosol will 
increase in proportion to an increase in the extracellular concentration of 
serine. Assuming that the rate of synthesis of a putative endogenous source 
of serine is constant over the physiological range of extracellular serine 
concentrations, the rate of purine synthesis measured from the incorporation 
of radioiabel from [3-’i^C]serine into purine should continue to approach the 
total rate measured by [l^qNaHCOg incorporation as the extracellular serine
concentration is increased. This is, however, not the case, in that the rate of
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purine synthesis measured from [3-‘*^C]serine becomes saturated with serine 
at a rate which is 60% of the total rate (see p. 193). In fact, the rates of 
purine synthesis accounted for by the difference between the rates measured 
from the incorporation of radioiabel from p^CJNaHCOs and from
[3-i4c]serine into purine, do not vary to any great extent with changes in the 
extracellular serine concentration (mean difference (± S.D.) between rates at 
five serine concentrations in Fig. 6.5 was 1.17 ± 0.20nmoi purine 
synthesized/h per 10® ceiis). These results would therefore be consistent 
with the availability of a constant supply of one-carbon units from a source 
alternative to serine. If SHMT is saturated with serine, the increased serine 
influx which would result from an increase in the extracellular serine 
concentration would not affect the rate of supply of one-carbon units to the
5,10-CH2THF pool. Even if SHMT were not saturated with serine, a constant 
supply of 5,10-CH2THF by SHMT could be maintained if the cytosolic serine 
concentration was held constant by a parallel increase in efflux rate with an 
increase in the influx rate. Thus constant rates of supply of one-carbon units 
from an alternative source and from the reaction catalysed by cSHMT would 
be maintained when the extracellular serine concentration is altered within 
the physiological range.
If there is not a substantial endogenous source of serine, the 
quantitation of the various metabolic routes of serine must be reconsidered 
(Fig. 7.3). To account for the serine required for net protein synthesis 
(7.7nmol/h per 10® cells) and for purine synthesis de novo (4.7nmol/h per 10® 
cells, assuming one-carbon units from serine account for 60% of the total rate 
of purine synthesis), a net serine uptake from the extracellular medium of 
12.4nmol serine/h per 10® cells is required. The efflux rate could be over­
estimated because there is no certainty that the radioiabel which effluxes the 
cell is all associated with serine. If it is not, a proportion of the intracellular 
radiolabei derived from the uptake of [3-**4c]serine would be associated with 
a metabolite other than serine and this would mean that the intracellular 
serine concentration measured from the uptake of radioiabel (Table 3.8, 
p. 94) has also been over-estimated. Thus the difference between the 
intracellular serine concentration measured by [3-l^C]serine uptake and by 
amino acid analysis would become greater and this would further implicate an 
endogenous supply of serine itself. The possibility that the efflux rate has 
been over-estimated is not therefore consistent with the absence of a 
substantial endogenous source of serine.
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Possible sources of one-carbon units other than serine include 
leucovorin, tryptophan, histidine and glycine (via the action of the 
mitochondrial glycine cleavage system without serine synthesis by mSHMT). 
These metabolites as extracellular sources of one-carbon units have however 
all been dismissed for reasons given earlier in Chapter 5 (Tabie 5.8, p. 184). 
Other possible sources which have not been investigated in the present work 
inciude mitochondrial choline catabolism (see Fig. 5.7, p. 163) or the supply 
of 5,10-GH2THF from methionine via the methionine synthetase and
5,10-GH2THF reductase activities. These activities are however generally
thought to operate only in the direction of methionine biosynthesis in vivo 
although oxidation of 5-GH3THF to formate and GO2 has been observed in
rat liver upon administration of methionine (Lumb et ai., 1989).
7.4 Possible role of mitochondrial SHMT in the supply of one-carbon 
units for purine synthesis
Recent evidence has implicated a role of mSHMT in the supply of 
one-carbon units for use in cytoplasmic processes (Barlowe & Appling, 1988). 
Rat liver mitochondria in vitro were able to convert carbon 3 of serine, and the 
methyl carbon of sarcosine, to formate. This conversion can be 
accomplished by the sequential activities of 5,10-GH2THF dehydrogenase,
5.10-GHTHF cyclohydrolase and 10-GHOTHF synthetase (see Fig. 5.5, 
p. 161). All these activities were demonstrated in extracts prepared from rat 
liver mitochondria. Furthermore, the formate rapidly exits the mitochondria 
and can be converted to 10-GHOTHF through the ATP-dependent reaction 
catalysed by cytosolic 10-GHOTHF synthetase. The 10-GHOTHF can then 
be utilized directiy for two of the reactions of purine synthesis de novo (see 
Fig. 5.1, p. 157) or can be converted to 5,10-GH2THF for use in pyrimidine
synthesis. This conversion could be accomplished by the sequential action of
5.10-GHTHF cyclohydrolase and 5,10-GH2THF dehydrogenase. The 
operation of these enzymes in the direction of 5,10-GH2THF formation might
be expected on the basis that the NADP+/NADPH ratio is low (0.011) in rat 
liver (Green et ai., 1988). An alternative source of 5,10-GH2THF would
presumably be from serine through the action of cSHMT.
The role of mSHMT in the production of one-carbon units for purine 
synthesis is an attractive proposition for MOLT-4 ceils with regard to the high
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proportion of this isozyme present in the mitochondria (90%) (see section 
4.2.3, p. 110). An additional coupling of mSHMT with the glycine cleavage 
enzyme would generate a further one-carbon unit from the product glycine 
(Fig. 7.4) which would not be radiolabelled if [3-i4C]serine was used as the 
precursor. Thus if two one-carbon units are formed from each serine 
molecule, the actual stoichiometry which relates serine utilization to purine 
synthesis (measured from the incorporation of radioiabel from [3-"i4c]serine 
into purine) would be 1:1. The rates of purine synthesis measured by the 
incorporation of radioiabel from [3-i4C]serine and from [6-‘>4c]glucose into 
purine would then have to be doubled which would bring the values much 
closer to the total rate of purine synthesis.
The production of two one-carbon units from serine via mSHMT and 
the glycine cleavage enzyme would still require either a net uptake of serine 
from the extracellular medium or an alternative endogenous production of 
serine. A cytosolic source of endogenously-derived serine Is opposed by the 
results presented in Fig. 6.5 as discussed earlier in this chapter (p. 209). 
However, if serine could be endogenously-derived in the mitochondria as a 
substrate for mSHMT, then an increase in the concentration of extracellular 
serine would not affect this serine pool if the system which transports serine 
into the mitochondria remains saturated. Under these circumstances, the 
isotope dilution of [3-'i4C]serine taken up into cells from the medium would 
first depend on the relative rates of serine uptake and protein degradation (as 
measured in this thesis). The isotope dilution would then also depend on the 
relative rates of transport of serine across the mitochondrial membrane and 
of the endogenous supply of serine within the mitochondria.
An intramitochondrial source of serine (other than glycine by the action 
of mSHMT) is not at all obvious for this cell type. It is interesting, however, 
that at least two enzymes of the non-phosphorylated pathway (see Fig. 1.1, 
p. 17), including the aminotransferase which interconverts serine and 
hydroxypyruvate, are located in the mitochondria (see Snell, 1984). The 
three enzymes involved effect the conversion of serine to 2-phosphoglycerate 
in tissues involved in gluconeogenesis. It is interesting to hypothesize that in 
MOLT-4 cells, enzymes of the non-phosphorylated pathway are expressed 
for serine synthesis in the mitochondria rather than for serine catabolism. In 
addition, the inhibitory effect of certain glycolytic intermediates on the activity 
of D-glycerate dehydrogenase (see Snell, 1984) might explain the inhibition 
of the incorporation of radioiabel from [i^CjNaHCOg into purine in the
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absence of extracellular serine at high extracellular glucose concentrations 
(Fig. 5.18, p. 174). The precursor for serine synthesized by the non- 
phosphorylated pathway is the glycolytic intermediate, 2-phosphoglycerate, 
and so the lack of incorporation of radioiabel from [6-i4C]gIucose would still 
be difficult to explain. The availability of an intermediate of the non- 
phosphorylated pathway from an intramitochondrial source would have to be 
invoked to explain the apparent non-participation of glucose in one-carbon 
production.
7.5 Final comments and scope for future work
Overall, the results presented in this thesis are most consistent with an 
involvement of mSHMT in the supply of one-carbon units for purine synthesis 
de novo together with the availability of an intramitochondrially-derived 
source of serine. This statement is based upon the following observations. 
There is a large proportion of the total SHMT located in the mitochondria 
(90%) in MOLT-4 cells. The fact that the rates of serine influx and of serine 
efflux are so similar necessitates an endogenous source of serine to satisfy 
the rates of net protein synthesis and nucleotide synthesis. This would also 
account for the lack of control at the serine transport step with respect to the 
pathway of purine synthesis de novo. An endogenous supply of serine is 
unlikely to be derived in the cytosolic compartment because an increase in 
the extracellular serine concentration (in the physiological range where serine 
influx remains far from saturated) does not result in increased isotopic dilution 
of the putative non-radiolabelled supply of serine (Fig. 6.5, p. 201). 
Furthermore, the most obvious source of endogenously-derived cytosolic 
serine is from 3-phosphoglycerate via the phosphorylated pathway but 
incorporation of radiolabei from [6-i4C]glucose or [1-"*^C]glucose into purine 
was not observed in the presence of extracellular serine (0.25mM). In the 
absence of extracellular serine, it is possible that the phosphorylated pathway 
becomes operative because incorporation of radioiabel from glucose into 
purine was observed. Serine has been shown to inhibit phosphoserine 
phosphatase (Fell & Snell, 1988) and removal of serine from the extracellular 
medium would therefore be expected to result in an increased activity of the 
phosphorylated pathway.
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In the presence of extracellular serine, the results in this thesis are 
better explained if endogenously-derived serine is formed in the 
mitochondria. Thus increased isotopic dilution of a mitochondrial serine pool 
upon an increase in the extracellular serine concentration could be avoided if 
the transport of serine into the mitochondria remained saturated. The 
identification of an intramitochondrially-derived source of serine as a 
substrate for mSHMT requires further investigation. The presence or 
absence of the mitochondrial enzyme, serine aminotransferase, should 
certainly be verified. The possibility that carbon atoms from precursors such 
as glutamine, glutamate and aspartate, can supply the one-carbon pool could 
also be investigated by using the radioiabeiled precursors.
Whether or not SHMT is a control site for purine synthesis de novo 
(and indeed for nucieotide synthesis in general) remains to be elucidated. 
The gene for the cytosolic enzyme from rabbit liver has been cloned in our 
laboratory and transfected into the COS cell line. Transfection of the gene 
together with a regulatory promoter into MOLT-4 cells could enable regulation 
of the expression of this enzyme. If this could be achieved, the effect of a 
regulated increased expression of cSHMT on the rate of purine synthesis de 
novo could be investigated and a flux control coefficient calculated. 
Alternatively, the expression of SHMT could be inhibited by Increased 
concentrations of anti-sense oligonucleotides to the mRNA for SHMT and a 
control coefficient with respect to purine synthesis determined In this way. 
Similar experiments ought also to be performed with the gene for mSHMT in 
view of its possible role in purine synthesis de novo.
Evidence has been presented recently (from a network thermodynamic 
computer model of one-carbon metabolism) that Inhibition of SHMT In LI 210 
cells by greater than 99% would decrease purine synthesis by less than 10% 
(Strong et al., 1990). These workers referred however to cSHMT and not to 
the mitochondrial isoform. The proposal that one-carbon units for
cytoplasmic processes are synthesized In the mitochondria by mSHMT 
(Barlowe & Appling, 1988) could lead to the identification of novel 
chemotherapeutic targets of serine metabolism. Two such targets are the 
transport of formate out of mitochondria and the transport of serine into 
mitochondria. A third chemotherapeutic target could be the cytosolic 
10-GHOTHF synthetase which activates formate for use in purine synthesis 
de novo. Using the same computer model mentioned above, complete 
inhibition of SHMT plus 90% inhibition of 10-GHOTHF synthetase resulted in
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70% inhibition of purine synthesis de novo (and 90% inhibition of thymidylate 
synthesis) (Strong et al., 1990). Neither the mitochondrial transport of 
formate or serine nor mSHMT, the mitochondrial folate-dependent enzymes 
or cytosolic 10-CHOTHF synthetase, are targets for inhibitors of nucleotide 
biosynthesis in current use. They therefore offer new alternatives as potential 
targets for the design of anticancer drugs.
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Fig. 7.1 Quantification of serine metabolism in IVIOLT-4 cells. These 
values have been calculated for cells taken from the logarithmic phase of 
growth and using an extracellular serine concentration of 0.25mM. The 
incubation medium was RPMI 1640 (with 0.6mM-glutamine and 
1.5mM-bicarbonate but without folic acid) buffered with 25mM-Hepes to 
pH7.4 at 37°C and supplemented with 10% (v/v) dialysed PCS and 
lOnM-leucovorin. The rates shown are expressed as nmol serine/h per 10® 
cells. The low rate from glucose represents that from extracellular 
radiolabelled glucose only, and does not take into account possible dilution of 
the radioiabel by intracellularly-derived glucose.
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Fig. 7.2 Biosynthesis of serine from glutamine, glutamate and 
aspartate. The abbreviations used are: GDH, Glutamate dehydrogenase; 
2-Kg, 2-Ketoglutarate; OAA, Oxaloacetate; PEP, Phosphoenolpyruvate; 
2-PGA, 2-Phosphoglycerate; 3-PGA, 3-P^osphoglycerate.
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Fig. 7.3 Quantification of serine metabolism in MOLT-4 celis which 
includes a source of one-carbon units other than those derived from 
serine. The values shown are those calculated for cells taken from the 
logarithmic phase of growth and using an extracellular serine concentration of 
0.25mM. The incubation medium was RPMI 1640 (with O.SmM-glutamine 
and 1.5mM-bicarbonate but without folic acid) buffered with 25mM-Hepes to 
pH7.4 at 37°C and supplemented with 10% (v/v) dialysed PCS and 
lOnM-leucovorin. The rates shown are expressed as nmol serine/h per 10® 
cells. The low rate from glucose represents that from extracellular 
radiolabelled glucose only, and does not take into account possible dilution of 
the radiolabel by intracellularly-derived glucose.
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Fig. 7.4 Synthesis of two one-carbon units from one molecule of serine 
by a proposed coupling of mSHMT with the glycine cleavage enzyme.
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Appendix A: Abbreviations and Statistical Analysis
Reference to amino acids is always to the L-isomer unless otherwise stated. 
NaHCOg-buffered RPMI 1640 refers to the folate-free medium (see Table 2.1, p. 45). 
NaHCOg-buffered medium refers to the above medium supplemented with 10% (v/v)
dialysed foetal calf serum and 10nM-leucovorin. Hepes-buffered RPMI 1640 refers to 
folate-free medium in whidi 25mM-Hepes has replaced the NaHCOg and which has been
buffered to pH7.4 at 37°C with NaOH. Hepes-buffered medium refers to the above medium 
supplemented with 10% (v/v) dialysed foetal calf serum and lOnM-leucovorin. Glutamine 
was always prepared fresh and added to this medium to a final concentration of 0.6mM.
Other abbreviations used in this thesis are as follows:
Inhibitors
AIB:
BCH:
BCG:
MeAlB
3FDA:
2-Aminoisobutyric acid
2-Aminobicyclo-[2.2.1]heptane-2-carboxylic acid
3-Aminobicyclo-[3.2.1 ]octane-3-carboxylic acid
2-(Methylamino)-isobutyric acid
3-Fluoro-D-alanine
Enzymes
SHMT : Serine hydroxymethyltransferase
cSHMT : Cytosolic SHMT
mSHMT : Mitochondrial SHMT
LDH : Lactate dehydrogenase
CS : Citrate synthase
DHFR : Dihydrofolate reductase
Folate Compounds
DHF : Dihydrofolate
THF : Tetrahydrofolate
10-CHOTHF : N'^ O.formyltetrahydrofolate
5.10-CHTHF : N^, N"* O_methenyltetrahydrofolate
5.10-CH2THF : N^, N‘iO-methylenetetrahydrofolate
5-CHgTHF : N^-methyltetrahydrofolate
Miscellaneous
Carbogen : 95% O2 / 5% CO2
DEAE : Diethylaminoethyl
ICW ; Intracellular water (Intracellular space)
PRPP : 5'-Phosphoribosyl pyrophosphate
AMP : Adenosine 5'-monophosphate (Adenylate)
GMP : Guanosine 5'-monophosphate (Guanylate)
IMP : Inosine 5-monophosphate (Inosinate)
PP| : Pyrophosphate
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FCS: Foetal calf seoim
PCA: Perchloric acid
EDTA: Ethyldiaminotetraacetic acid
Tris : T ris(hydroxymethyl)-methylamine
DTNB: 5,5’-Dithiobis-(2-nitrobenzoate)
PITC : Phenyiisothiocyanate
BCA: Bicinchoninic add
BSA: Bovine serum albumin
p. : Page
Statistical analysis
The statistical significance of the difference between two experimental values was 
determined by the Student's t-test. Where error bars are not shown in Figures, it is because 
they are within the symbol unless othenvise stated.
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Appendix B: Source of materials
Aldrich Chemical Company Ltd., Dorset, Gillingham, Dorset 
Norit A charcoal
Amersham International, Amersham, Bucks.
[1-‘*4C]Glucose, [6-”*^ C]Glucose, [1-i^C]Glycine, [2-’>^C]Glycine, [3-^ ^CJSerine, 
[U-^ ^C]Sucrose, pHJWater
BDH Chemicals Ltd., Poole, Dorset
Ammonia, Dimethylsulphoxide, Dinonyl phthalate, Formaldehyde, Glacial acetic acid. 
Glucose, Hydrochloric acid, Magnesium sulphate. Perchloric acid. Potassium dihydrogen 
orthophosphate. Silicone fluid D.C. 550, Silver nitrate. Sodium acetate (trihydrate), Sodium 
bicarbonate. Sucrose, Toluene, Triethylamine, Tris
Boehringer Corporation (London) Ltd, Lewes, Sussex 
ATP, NADH
CEA, Gif-sur-Yvette, France
[ring-2-^ ^C]T ryptophan
Dupont (UK) Ltd., NEN Research Products, Stevenage, Herts.
[i4c]Sodium bicarbonate
Gibco BRL, Paisley, Scotland
Earle's Balanced Salts solution (EBSS)
Foetal calf serum (FCS)
RPM11640 powdered medium (without folate and sodium bicarbonate)
RPMI 1640 powdered medium (without folate, serine, glycine, histidine, tryptophan, 
glutamate, glutamine, glucose, glutathione (reduced form) and sodium bicarbonate)
Merck, Sharp and Dohme, Division of Merck & Co., Inc., Rahway, N. J.
3-Fluoro-D-alanine (gift)
Packard Ltd., Pangbourne, Berks.
Pico Fluor"^ 40 universal liquid scintillation solution
223
Rathburn Chemicals Ltd., Walkerburn, Scotland 
Methanol (HPLC grade)
Sigma Chemical Company Ltd., Poole, Dorset
All amino acids
Adenine, pHJAdenine, BCA protein assay reagents. Bovine serum albumin, Cycloserine, 
Digitonin, Dimedone, 5,5'-Dithiobis-(2-nltrobenzoate) (DTNB), Ethyldiaminotetraacetic acid 
(EDTA), Firefly lantern extract, Folinic acid (leucovorin, Ca +^ salt), Gentamicin sulphate. 
Glutamine, Guanine, A/-2-hydroxyethyipiperazine-A/-2-ethanesulphonic acid (Hepes), 
Heptane sulphonate, Hypoxanthine, 2-Mercaptoethanol, Oxaloacetic . acid, 
Phenyiisothiocyanate (PITC), Pyridoxal phosphate. Sodium pyruvate. Sodium arsenate 
(heptahydrate), Tetrahydrofolic acid, Triton X-100, Trypan Blue
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Appendix C: Calculation of ionic strength
The ionic strength (^ i) of a solution Is given by equation (0.1) where'm' 
Is the molality of the solution for a particular Ion (equivalent to the molarity for 
a dilute solution) and 'z' is the charge on that Ion. The concentration of the 
various Ions In a solution therefore needs to be calculated before the ionic 
strength can be determined.
p = 0.5 X Z mz2 (C.1)
0.1 Phosphate buffer
The concentration of phosphate Ions In the assay buffer can be 
calculated from the Henderson-Hasselbalch equation (0.2).
pH = pKa + logio ([Conjugate base]/[acid]) (0.2)
For the phosphate buffer used In the SHMT assay (60mM-phosphate 
(K+), pH7.4) an equilibrium exists between the monoprotic (conjugate base) 
and the diprotic (acid) phosphate Ions.
H2PO4 HPO42- 2500, pH7.4, pKa= 6.82 (Dawson et al., 1986)
The pKa value decreases by 0.003 per 1^0 rise in temperature. Thus 
at 3700 the corrected pKg value Is 6.784. Use of this value in equation (0.2) 
results In equation (0.3).
logic ([HPO421AH2PO4 ]) = 0.616 (0.3)
The ratio of the concentrations of HPO42- to H2PO4" can therefore be 
calculated (0.4).
[HP042-]/[H2P04-] = 4.13 (0.4)
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From a knowledge of the total potassium phosphate concentration 
used in the assay (60mM) equation (C.5) arises.
[HPO42-] + [H2PO4-] = 60 (C.5)
Thus simultaneous equations (0.4) and (0.5) can be solved for 
[HPO42-] and [HPO4-]. The calculated concentrations are 11.7mM for 
H2PO4'  and 48.3mM for HPO42-. The concentrations of PO42- due to proton 
dissociation from HPO42- and of H3PO4 due to proton association with 
H2PO4- will be negligible because the pKg values for these processes (12.38
and 2.15 (25°0) respectively (Dawson et al., 1986)) are so far removed from 
the assay buffer pH of 7.40.
The potassium Ions In the buffer must also of course be taken Into 
account for the calculation of the Ionic strength. These Ions will balance the 
charges of the HPO42- and H2PO4- Ions. Each HPO42- ion will be balanced
by two K+ Ions therefore equivalent to a concentration of 96.6mM. Each 
H2PO4" Ion will be balanced by one K+ ion therefore equivalent to a
concentration of 11.7mM. Thus the total concentration of K+ is 108.3mM.
Substitution of all these concentrations Into equation (C.1) enables a 
calculation of the Ionic strength of 60mM-phosphate (K+) buffer, pH7.4 at 
370c  as shown In equation (0.6).
(I = 0.5 X  ((0.0117x1)+ (0.0483x4)+ (0.1083x1)) (C.6)
The calculated Ionic strength Is 0.157M. The same procedure can be 
employed to calculate the Ionic strength of any concentration of phosphate 
buffer.
0.2 Hepes buffer
Hepes (A/-2-hydroxyethylplperazlne-Af-2-ethanesulphonlc acid) has 
two lonlzable groups with pK^ values as shown (Good et ai, 1966).
HOOHgOHgN+iT^OHgOHgSOg-
\
pKai = 3 pKa2 = 7.55 (200C)
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Application of the Henderson-Hasselbalch equation (C.2) to the 
ionizable group with a pKg value of approximately 3 at a pH of 7.40 reveals
that the ratio of the conjugate base (non-protonated form and therefore 
uncharged) to the acid (protonated form and therefore charged) will be 
greater than 25000 to 1. The concentration of the charged protonated form 
will therefore be negligible at pH7.4 and will not contribute significantly to the 
Ionic strength.
The pKa for the other lonlzable group is 7.55 at 20°C and this value 
decreases by 0.014 per 1°C rise In temperature. Thus the corrected pKgg at 
37°C Is 7.31. From the Henderson-Hasselbalch equation (C.2), the ratio of 
the concentration of conjugate base (unprotonated and therefore charged) to 
the acid (protonated and uncharged) will be 1.23 (C.7).
[R-S03-]/[R-S03H] = 1.23 (C.7)
If, for example, the concentration of Hepes In the assay Is 25mM, then 
the concentrations of the conjugate base Ions and the acid can be calculated 
by use of simultaneous equations as described for the phosphate buffer. The 
concentration of R-SO3" Is calculated In this way as 13.79mM. The charge
on these Ions will be balanced by an equal concentration of potassium Ions. 
The Ionic strength can then be calculated using equation (C.1) and has a 
value of 0.014M. The Ionic strengths for the concentrations of Hepes used in 
the experiment depicted In Fig. 4.4 (p. 117) are shown in Table 0.1.
0.3 Contribution of other assay components to the ionic strength
There are of course other components In the assay mixture. The PLP 
and THF are present at much lower concentrations than the Ions In the assay 
buffer and. If they are Indeed Ionized to any extent, the contribution of their 
charged groups to the overall Ionic strength will be negllgllble. The only other 
component which will have an appreciable concentration In the assay is 
sucrose (64mM final concentration; see Table 4.2, p. 125) but this component 
Is uncharged and will not contribute to the ionic strength. The contribution of 
Hepes present In the sucrose buffer (lOmM) and also In the THF stock
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solution (50mM) (see Table 4.2, p. 125) was taken Into account as part of the 
total Hepes concentrations shown In Table C.1.
The Inclusion of additional Ions In the assay (e.g. 150mM-NaCI) was 
also carried out to increase the Ionic strength (see Table 4.1, p. 124). The 
contribution to the Ionic strength by Ions with a single charge will be equal to 
the final concentration of the Ionic compound added. For example, use of 
150mM-NaCI will result In a concentration of Na+ of 150mM and a 
concentration of Ch of 150mM. Thus the Ionic strength (equation (C.1)) Is 
equal to half the sum of these two concentrations, that is 0.15M.
Table C.1 Calculated ionic strengths for different concentrations of 
Hepes at pH7.4 and 37°C.
[Hepes] (mM) Ionic Strength (M)
27 0.015
72 0.040
162 0.089
312 0.172
390 0.215
490 0.270
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